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Summary 
THESIS TITLE:  
Environmental stimuli shape adaptive immunity by enhancing T helper cell 
differentiation and the germinal centre response 
 
NAME: Marisa Stebegg 
Immune cells have evolved to respond to external danger signals and to incorporate information 
about environmental cues to adapt their differentiation and effector function. Because of this, it is 
important that immune cells are studied in the context of their surroundings. In this thesis, I 
investigated the roles of environmental endoplasmic reticulum (ER) stress, the gut microbiome and 
ageing on adaptive immunity. Immune cells have been shown to integrate inflammatory signalling 
with the ER stress response pathway. This response is triggered by a variety of environmental 
stresses such as low nutrient availability, hypoxia and mechanical stress. I found that the ER stress 
response acts as a potent driver of T helper 17 (Th17) cell differentiation resulting in Th17 cells 
with a pathogenic gene expression signature. This suggests a link between ER stress-inducing 
conditions such as low nutrient availability, and the pathology of Th17 cell-mediated autoimmune 
diseases. Another physiological scenario in which the immune microenvironment changes is during 
ageing. Ageing-related changes of the gut microbiome have recently been linked to increased frailty 
and systemic inflammation. This change in microbial composition with age occurs in parallel with 
a decline in function of the gut immune system, however it is not clear if there is a causal link 
between the two. Here, I establish that the defective germinal centre (GC) reaction in Peyer’s 
patches in the small intestine of aged mice can be rescued by co-housing of adult and aged mice, 
and via faecal transfers from adult into aged mice. This demonstrates that the poor GC reaction in 
aged animals is not irreversible, and that it is possible to improve immune responses in older 
individuals by replenishing the gut microbiome. To determine whether GC responses can also be 
improved in peripheral lymph nodes, we investigated the role of defective helper T cell priming in 
aged mice. We observed that the age-associated defect in the GC reaction is partly due to impaired 
T cell priming by dendritic cells (DCs). By boosting type I interferon signalling in DCs at the time 
of immunisation, I was able to improve T cell priming and GC formation in aged mice. This 
demonstrates that not only the gut microbiome, but also DCs are exciting targets to improve GC 
responses in ageing and highlights the importance of environmental stimuli in shaping adaptive 
immunity.  
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 INTRODUCTION  
1.1 The immune system 
The human body is constantly exposed to a wide variety of viruses, bacteria, fungi and parasites, 
many of which are pathogens that can cause disease, while others are commensals that live in and 
on us without causing any harm. The host immune system consists of many different cells which 
have evolved to recognise and control these microorganisms (Chaplin 2010). The different types of 
immune cells can be broadly subdivided into belonging to one of two main arms of the immune 
system: the evolutionary-ancient innate immune system and the adaptive immune system, which is 
only present in vertebrates (Figure 1.1). Innate immune cells encompass dendritic cells (DCs), 
macrophages, mast cells and granulocytes, all of which are important early responders to infections 
and help to instruct adaptive immune responses. The adaptive immune system comprises T and B 
cells, both of which mount highly specific immune responses and can generate immune memory. 
Innate lymphoid cells, including natural killer (NK) cells, are a specialised immune cell subset at 
the interface between the innate and adaptive immune system. They can be seen as the innate 
counterpart to T cells, as they arise from the same progenitor cells as T cells, but do not express 
adaptive immune receptors.  
In order to recognise self from non-self, immune cells rely on two main types of surface receptors. 
The first type of receptors is found on cells of the innate immune system, whose limited set of germ-
line encoded pattern recognition receptors (PRRs) recognises molecular patterns shared between a 
wide range of microorganisms (Janeway & Medzhitov 2002). These receptors help innate immune 
cells to act as quick responders to pathogenic infections. The second type of receptors is found on 
adaptive immune cells. These receptors are assembled from a combination of different gene 
segments into a huge combinatorial variety of receptors, each of which recognises a unique feature 
termed antigen (Bonilla & Oettgen 2010). The human body was estimated to contain more than 
1012 adaptive immune cells, which can carry any one of more than 1014 potential different receptors, 
thus forming a huge antigen receptor repertoire to recognise almost any invading pathogen (Alberts 
et al. 2002a; 2002b). Once antigen receptors on adaptive immune cells bind to their cognate antigens, 
and receive appropriate co-stimulatory signals, these cells are activated to clonally expand, then 
differentiate into effector or memory cells (Cantrell 2015). Memory cells persist in the body for 
long periods of time and mount quick and potent immune responses when they re-encounter the 
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same antigen. As a result, the adaptive immune system does not only generate specific immune 
responses, but it also provides long-lasting immune protection against re-infections. This thesis will 
specifically focus on primary T cell-dependent immune responses. 
 
Figure 1.1: Schematic representation of immune cell development. Self-renewing long-term 
haematopoietic stem cells (LT-HSCs) in the bone marrow give rise to progenitor cells which 
differentiate to generate all types of immune cells. First, short-term haematopoietic stem cells (ST-
HSCs) are formed, which generate multipotent progenitor (MPP) cells. These differentiate into 
common myeloid progenitors (CMP) or common lymphocyte progenitor (CLP) cells. CMP cells 
give rise to the innate immune arm by developing into granulocyte-macrophage progenitors (GMP), 
which differentiate into granulocytes, monocytes and dendritic cells (DCs). CLP cells, on the other 
hand, give rise to all adaptive immune cells, such as B cells, T cells, natural killer (NK) cells as 
well as some DC subsets. This image was adapted and republished with the permission of the 
American Society of Hematology from Blank & Karlsson 2015 (Blank & Karlsson 2015); 
permission conveyed through Copyright Clearance Center, Inc. 
1.2 Interactions between the immune system and its 
microenvironment 
The immune system has evolved to respond to environmental stimuli, to recognise and protect the 
body from insults and infections. As a result, immune cells are highly responsive to changes in their 
microenvironment. Adaptive immune cells in particular need to integrate soluble signals from their 
environment with signals they receive from innate immune cells which act as antigen-presenting 
cells (APCs) (Mueller & Coles 2014). For their optimal activation, adaptive immune cells need to 
Figure 1: Sch matic representation of haematopoi sis. Self-re ewing long-t rm
haematopoietic stem cells (LT-HSCs) give rise to progenitor cells which differentiate
to give rise to all types of immune cells. First, short-term haematopoietic stem cells
(ST-HSCs) are formed, which gen rate multipotent progenitor (MPP) cells. These
differentiate into common myeloid progenitors (CMP) or common lymphocyte
progenitor (CLP) cells. CMP cells give rise to the innate immune arm by developing
into granulocyte-macrophage progenitors (GMP), which differentiate into
granulocytes, monocytes an dendritic cells. CLP cells, on the other hand, give ris
to all adaptive immune cells, such as B cells, T cells, natural killer (NK) cells as well
as some DC subsets. Image adapted from Ulrika Blank and Stefan Karlsson 2015
[4].
CLP
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bind their cognate antigen while receiving co-stimulatory signals from APCs. Typically, these 
interactions between innate immune cells and adaptive immune cells are facilitated within 
secondary lymphoid organs (SLOs). 
1.3 Secondary lymphoid organs (SLOs)  
SLOs bring immune cells of the innate and adaptive immune system in close proximity, to facilitate 
the interaction of rare antigen-specific T or B cells with antigen-bearing APCs to trigger the 
initiation of adaptive immune responses (McComb et al. 2013). After their development from 
haematopoietic stem cells in the bone marrow (Figure 1.1) (Blank & Karlsson 2015), cells of both 
the innate and adaptive immune system recirculate through the blood, the lymphatic systems and 
the SLOs, which comprise the spleen, lymph nodes (LNs) and Peyer’s patches (PPs). All SLOs 
develop during embryogenesis, and are characterised by their distinctive physical organisation of 
immune cells into different zones (Matsuno et al. 2010; Ruddle & Akirav 2009). This spatial 
segregation is achieved by chemokines, soluble signalling molecules which attract cells by binding 
to chemokine receptors on the cell surface. This induces chemotaxis, the directed migration of cells 
towards the chemokine source. In the T cell area, T cells co-localise with fibroblastic reticular cells 
(FRCs), which secrete the C-C motif chemokine ligands CCL19 and CCL21. These attract C-C 
motif chemokine receptor 7 (CCR7)-expressing T and DCs to the T cell zone. In all SLOs except 
the spleen, the T cell area also contains high endothelial venules (HEV), specialised capillaries 
which allow T cells to enter SLOs from the blood stream (Matsuno et al. 2010). The B cell follicle 
is clustered around C-X-C motif chemokine ligand 13 (CXCR13)-expressing follicular dendritic 
cells (FDCs), a chemokine which is recognised by C-X-C motif chemokine receptor 5 (CXCR5) on 
the surface of B cells (Chang & Turley 2015). This distinct architecture sets SLOs apart from other 
less-organised lymphoid tissues, such as mucosa-associated lymphoid tissues (MALT) (Matsuno et 
al. 2010). The main function of SLOs is to collect antigens from the peripheral sites and bring them 
into contact with recirculating T and B cells. SLOs are highly interconnected with the lymphatic 
and vascular circulatory systems (Matsuno et al. 2010), allowing for the constant entry (and efflux) 
of T cells, B cells, and antigen-carrying APCs through the blood or lymphatic vessels. Afferent 
lymphatic vessels also drain free antigen from peripheral tissues (Ruddle & Akirav 2009). This 
optimises the chances of antigen to come into contact with cells of the adaptive immune system for 
the generation of antigen-specific immunity. 
 1.Introduction: Secondary lymphoid organs (SLOs) 
 
4 
1.3.1 Lymph nodes (LNs)  
LNs are encapsulated SLOs which collect antigens from the peripheral lymphatic system (Figure 
1.2) (Stebegg, Kumar, Silva-Cayetano et al. 2018). Each LN drains antigens from a specific part of 
the body (Ruddle & Akirav 2009): inguinal LNs, for instance, drain antigen from the skin in the 
lower half of the body, while mesenteric LNs are the gut-draining LNs. LNs are covered in a capsule, 
which surrounds the subcapsular sinus (SCS) (Ruddle & Akirav 2009). Underneath the SCS, the 
outer cortex contains B cell follicles with FDCs, while the inner para-cortex harbours the T cell 
zone and FRCs. The medulla in the centre of the LN contains a mix of immune cells, including DCs, 
macrophages and plasma cells, and serves as exit point from immune cells into the efferent 
lymphatics (Ruddle & Akirav 2009). For immune cells to exit the lymph node, they need to 
upregulate their sphingosine-1-phosphate (S1P) receptor (S1PR1). This receptor directs migration 
towards the chemokine S1P, whose concentration is high in the blood and lymphatics, but low in 
LNs (Chang & Turley 2015). This allows for the constant efflux and influx of adaptive immune 
cells into LNs, where they are exposed to antigens imported via the lymph. This makes LNs a highly 
effective induction site for adaptive immune responses against peripheral infections. 
1.3.2 The spleen 
The spleen drains antigens from the blood, and has three main compartments (Matsuno et al. 2010): 
the white pulp, the red pulp and the in-between marginal zone (MZ). All three compartments are 
formed around central blood arteries which branch off the trabecular artery. These arteries are 
embedded into the while pulp, which can be subdivided into the B cell follicle and the peri-arterial 
lymphoid sheath (PALS), corresponding to the T cell zone. This PALS is encompassed by the MZ, 
which contains specialised MZ B cells and MZ macrophages (Ruddle & Akirav 2009). The blood 
empties from the central arteries into the red pulp, which surrounds the MZ and helps to filter 
damaged cells from the blood, before it re-enters the blood stream via the splenic sinuses. Because 
of this specialised structure, the spleen is the optimal induction site for immune responses against 
blood-borne antigens.  
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Figure 1.2: Schematic depiction of the specialised secondary lymphoid organ (SLO) 
architecture of lymph nodes (LNs). LNs can be subdivided into different regions: the T cell zone 
and B cell follicles. In the T cell zone, fibroblastic reticular cells (FRCs) generate a CCL19 and 
CCL21 gradient which attracts T cells and dendritic cells (DCs) from the blood stream via high 
endothelial venules (HEVs). Follicular dendritic cells (FDCs) in the B cell zone, in contrast, 
generate a CXCL13 gradient that attracts and retains B cells. Upon infection or immunisation, 
antigen drains into the LN via afferent lymphatic vessels into the subcapsular sinus (SCS) to trigger 
the activation of lymphocytes. Immune cells exit the LN via the medullary region in the centre of 
the LN. This image was created and kindly provided by Alyssa Silva-Cayetano (Stebegg, Kumar, 
Silva-Cayetano et al. 2018). 
1.3.3 Peyer’s patches (PPs)  
PPs are non-encapsulated lymphoid tissues associated with the wall of the small intestine (Matsuno 
et al. 2010). This is a single epithelial layer which forms the body’s largest mucosal surface. In 
mice, it covers an area of almost 1.5m2, which is a hundred times larger than their skin surface 
(Casteleyn et al. 2010). The intestinal epithelium is essential for the digestion and absorption of 
nutrients as well as the protection against enteric pathogens. It is subdivided into two major 
segments: the small intestine and the large intestine. The large intestine consists of the colon and 
terminates in the rectum (Mowat & Agace 2014). While it has little digestive functions, it is crucial 
for the reabsorption of water and ultimately the excretion of indigestible food components. PPs are 
Figure 7 chematic depiction of the specialised secondary lymphoid organ
(SLO) a chitecture in lymph nodes (LN ). LNs can be subdivided into different
regions: the T cell zone and B cell follicles. In the T cell zone, fibroblastic reticul r
cells (FRCs) gener e a CCL19 and CCL21 gradient which attracts T cells and
dendritic c lls (DCs) from the blood stream via high e dothelial venul s (HEVs).
Follicular dendritic cells (FDCs) in the B cell zone, in contrast, generate a CXCL13
gradient that attracts and retains B cells. Upon infection or immunisation, antigen
drains into the LN via afferent lymphatic vessels into the subcapsular sinus (SCS) to
trigger the activation of lymphocytes. Immune cells exit the LN via the medullary
region in the centre of the LN. This image was created by Alyssa Silva-Cayetano
(Stebegg, Cayetano, Kumar et al. 2018, [78]).
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only found in the small intestine, which in mice is subdivided into the duodenum close to the 
stomach, the jejunum and the ileum leading up to the caecum. Its main functions are the digestion 
of food and the absorption of nutrients (Mowat & Agace 2014). In mice, 6–12 PPs are interspersed 
along the whole length of the small intestine, while the human intestine contains 100–200 PPs 
(Reboldi & Cyster 2016).  
PPs are unique SLOs in that they are neither encapsulated nor linked with afferent lymphatics 
(Reboldi & Cyster 2016). Instead, PPs take up antigens directly from the gut lumen via the follicle-
associated epithelium (FAE) and its underlying subepithelial dome (SED). PPs consist of varying 
numbers of B cell follicles intersperse with T cell zones. Immune cells enter PPs via HEVs and exit 
to the gut-draining mesenteric LN via efferent lymphatics. Due to their distinct anatomical location 
close to the intestinal lumen, they are continuously exposed to antigen stimulation from the gut 
microbiota, a complex mix of bacteria, fungi, viruses and protozoa which populates the whole 
intestine (Reboldi & Cyster 2016). As a result, PPs differ from LNs and the spleen in their immune 
functions: they are important to mount antigen-specific immune responses against intestinal 
pathogens and toxins, and have also been proposed to help control the composition of the gut 
microbiota (Macpherson et al. 2008).  
1.3.3.1 Cross-talk of PPs with the gut microbiome 
It is estimated that the human body is populated by ~3.8 ´ 1013 bacterial cells (Sender et al. 2016). 
Of all organs, the intestine contains by far the highest concentration of commensal bacteria. While 
the concentration of dietary antigens decreases along the small intestine, the amount of commensal 
microorganisms increases, peaking in the large intestine (Moens & Veldhoen 2012). Studies of gut 
microbial diversity were long hampered by the lack of culture conditions for many gut bacteria. 
16S rDNA sequencing technology now enables the identification of commensal bacterial species 
composition without the need for prior in vitro cultures (Jovel et al. 2016). The 16S rDNA gene 
encodes the RNA-component of the ribosomal 16S subunit, which is characterised by alternating 
highly-conserved and hypervariable regions. While the conserved regions only differ between high-
level phylogenetic taxa, the hypervariable regions can be used to estimate evolutionary relations 
down to the species level (Rosselli et al. 2016). As a result, 16S rDNA sequencing can be used to 
computationally infer taxonomic identifications of a mix of bacteria. 16S rDNA sequencing 
revealed that, similar to humans, the murine gut core microbiome consists of two main phyla: 
Firmicutes (especially the Lachnospiraceae, Ruminococcaceae and Lactobacillaceae families) and 
Bacteriodetes (mainly Porphyromonadaceae and Rikenellaceae). In addition, Proteobacteria, 
Actinobacteria, Deferribacteres and Verrucomicrobia are also present in most mouse strains 
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(Clavel et al. 2016; Kostic et al. 2013). These commensal bacteria take on many functions: they 
help with the digestion of certain nutrients (e.g. by fermenting complex carbohydrates that the host’s 
digestive enzymes cannot process (Mowat & Agace 2014)), maintain epithelial barrier integrity, 
influence host metabolism and support the development and priming of the immune system (Moens 
& Veldhoen 2012). A disruption of these functions, e.g. by a change in the composition of the gut 
microbiota, is termed dysbiosis and has many negative implications for the host (Clavel et al. 2016). 
Therefore, maintenance of balanced cross-talk between the host and its microbiome is crucial to 
sustain health. PPs play an important part in this cross-talk by providing immune protection against 
intestinal pathogens and have been suggested to control the composition of the gut microbiota by 
producing commensal-specific IgA antibodies (Macpherson et al. 2008).  
1.4 T-dependent immune responses 
T cells are crucial for cell-mediated adaptive immunity. They integrate information from their 
environment, e.g. cytokines or antigen presented by other immune cells, to either directly or 
indirectly fight infections in an antigen-specific manner. T cells can be broadly subdivided into 
CD4, CD8, γδT and natural killer T (NKT) cells: CD4 T cells and γδT cells secrete large amounts 
of effector cytokines to instruct immune responses by other immune cells. CD8 T cells can directly 
remove infected or damaged host cells, and NKT cells can do both (Pennock et al. 2013).  
For T cell activation, peptide antigens need to be presented to T cells by APCs. In addition to 
recognising antigen, T cells require co-stimulatory signals to be activated. These are delivered when 
co-stimulatory receptors on T cells bind co-stimulatory ligands on APCs (Pennock et al. 2013). 
Antigen-mediated stimulation of T cells is achieved by peptide-loaded major histocompatibility 
complex class I (MHC-I) and class II (MHC-II) molecules on APCs. These peptide-MHC-I and -II 
complexes interact with the T cell receptor (TCR) and co-receptors on the surface of T cells (Blum 
et al. 2013).  
CD8 T cells express cluster of differentiation (CD) 8 co-receptors, which bind to MHC-I molecules. 
MHC-I classically presents intracellular antigens, which are digested in the cytoplasm and loaded 
onto MHC-I molecules in the endoplasmic reticulum (ER). MHC-II molecules, on the other hand, 
are bound by CD4 co-receptors on CD4 T cells and present peptides which are generated from 
phagocytosed antigens in lysosomes (Blum et al. 2013). Correspondingly, CD8 T cells recognise 
intracellular antigens, e.g. virus-derived peptides or tumour-associated antigens, and are specialised 
on the removal of virus-infected cell as well as damaged or mutated tumour cells (Zhang & Bevan 
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2011). CD4 T cells, known as helper T (Th) cells, predominantly recognise extracellular antigens 
and secrete effector cytokines to instruct immune responses.  
γδ T cells can express both CD4 and CD8 co-receptors. They are a rare T cell subset which already 
acquires its effector functions in the thymus (Vantourout & Hayday 2013). This allows γδ T cells 
to initiate rapid immune responses against non-peptide antigens such as phospholipids and 
alkylamines at epithelial barrier sites where many γδ T cells reside (Chien et al. 2014; Vantourout 
& Hayday 2013). NKT cells recognise lipid antigens presented on CD1, a MHC-like molecule 
(Bennstein 2017), in a CD4- and CD8-independent manner. Similar to CD4 T cells, they produce 
large amounts of cytokines such as IFN-g, IL-4 and IL-13, and they can additionally act as cytotoxic 
T cells (Balato et al. 2009). This thesis focuses on CD4 T cell-dependent immune responses, 
especially the role of CD4 T cells as drivers of autoimmune disease and instructors of B cell 
responses. 
1.4.1 CD4 T cells 
CD4+ αβ T cells are subdivided into different CD4 T cell subsets, each characterised by the 
expression of a master transcription factor and subset-specific signature cytokines. These determine 
the distinct effector functions of each Th cell subset (Gagliani & Huber 2017; Pennock et al. 2013). 
The first Th cells subsets to be described were Th1 and Th2 cells (Mosmann et al. 1986), but now 
also Th9 cells, Th17 cells, regulatory T (Treg) cells, T follicular helper (Tfh) and T follicular 
regulatory (Tfr) cells are well-established CD4 T cell subsets (Caza & Landas 2015).  
1.4.1.1 Th1, Th2 and Th9 cells 
Th1 cells form under the influence of IL-12 and are characterised by their expression of the T-box 
transcription factor T-bet. They are crucial mediators of cellular immunity against intracellular 
pathogens by secreting IFN-γ (Gagliani & Huber 2017). Th2 cells are essential to control 
extracellular parasitic infections. GATA Binding Protein 3 (GATA3)-expressing Th2 cells 
differentiate in response to IL-4 and produce the signature cytokines IL-4, IL-5 and IL-13 
(Luckheeram et al. 2012). Th9 cells were first described as a subset of Th2 cells, but are now 
considered to be a distinct Th cell subset. They are generated when exposed to a combination of IL-
4 and transforming growth factor (TGF)-β (Veldhoen et al. 2008b). This triggers the expression of 
their master transcription factor interferon regulatory factor (IRF4) and IL-9, the Th9 signature 
cytokine (Adamu et al. 2017; Dardalhon et al. 2008; Veldhoen et al. 2008b). While Th1, Th2 and 
Th9 cells mount important immune responses against pathogens, Th1 cells have also been 
implicated in the pathology of autoimmune disease, while imbalances in Th2 and Th9 cells have 
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been associated with allergies (Valenta et al. 2009). Thus, it is important that Th1, Th2 and Th9 
responses are kept in check. 
1.4.1.2 Treg cells  
Treg cells were first described in 1995 (Sakaguchi et al. 1995). They are characterised by expression 
of the forkhead box protein 3 (Foxp3) and high levels of CD25 on their cell surface (Fontenot et al. 
2003; Hori et al. 2003; Khattri et al. 2003). These cells can either arise in the thymus – so-called 
thymic Treg (tTreg) cells – or be generated de novo from naïve CD4 T cells in the periphery under 
the influence of IL-2 and TGF-β. The latter are termed peripheral Tregs (pTregs) (Gagliani & Huber 
2017). Treg cells exert important immunosuppressive functions by producing the anti-inflammatory 
cytokines IL-10 and TGF-β. They also express co-stimulatory inhibitors, such as cytotoxic T-
lymphocyte-associated protein 4 (CTLA-4), which inhibits T cell responses in a cell contact-
dependent manner (Gagliani & Huber 2017). Mice and humans lacking Treg cells suffer from a 
severe autoinflammatory disorder, demonstrating the important role of Treg cells for regulating 
immune responses (Bennett et al. 2001; Brunkow et al. 2001; Wildin et al. 2001).  
1.4.1.3 Th17 cells 
Th17 cells are most abundant at epithelial barrier sites where they provide immune protection 
against extracellular bacteria and fungi (Weaver et al. 2013). Th17 cell differentiation is classically 
driven by the combined actions of IL-6 and TGF-β (Harris et al. 2007; Mangan et al. 2006; 
Veldhoen et al. 2006a). This induces the Signal transducer and activator of transcription (STAT)3-
dependent expression of the Th17 lineage-specific markers RORγt and RORα, transcription factors 
of the retinoic acid receptor-related orphan receptors (ROR) family (Caza & Landas 2015; 
McGeachy et al. 2007; Veldhoen et al. 2006a). Th17 cell differentiation also depends on the aryl 
hydrocarbon receptor (AhR) and hypoxia-inducible factor 1 alpha (HIF1a) (Dang et al. 2011; 
Veldhoen et al. 2008a). Th17 cells produce high levels of the pro-inflammatory cytokines IL-22, 
IL-17A and IL-17F which attract neutrophils and stimulate a wide range of other immune cells to 
secrete pro-inflammatory cytokines and chemokines. IL-17A and IL-17F also induce the secretion 
of antimicrobial peptides at epithelial barrier sites (Korn et al. 2009). Thus, Th17 cells provide an 
important functional link between the adaptive and innate immune system. They have also been 
suggested to both promote and inhibit cancer growth depending on the type of cancer (Bailey et al. 
2014; Muranski et al. 2008; Wang et al. 2009; Wu et al. 2009). More importantly, Th17 cells were 
found to be key mediators of many autoimmune diseases where they are often enriched at sites of 
inflammation (Maddur et al. 2012). Amongst others, they have been directly implicated in the 
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immunopathology of rheumatoid arthritis, psoriasis, and multiple sclerosis (MS), an autoimmune 
disorder associated with axon demyelination in the central nervous system and progressive 
neurological deterioration (Bedoya et al. 2013; Jadidi-Niaragh & Mirshafiey 2011). Work from 
both in vitro and in vivo experiments revealed that Th17 cell pathogenicity is linked with their 
propensity to adopt a Th1-like cell phenotype and produce the inflammatory cytokines GM-CSF 
and IFNg under the influence of IL-23 (El-Behi et al. 2011; Ghoreschi et al. 2010; Hirota et al. 
2011; Jain et al. 2016; McGeachy et al. 2007). In addition to IL-23-driven Th17 cell pathology, 
other environmental factors, such as high salt concentrations or the presence of different AhR 
ligands, have also been shown to influence Th cell differentiation and pathogenicity (Quintana et 
al. 2008; Veldhoen et al. 2008a; Wu et al. 2013). In this report, a novel role for the endoplasmic 
reticulum (ER) stress response as a driver of pathogenic Th17 cell differentiation is described, 
highlighting the strong impact of another environmental stimulus on the generation of Th17 cells 
with pathogenic versus protective properties.  
1.4.1.4 Tfh and Tfr cells  
Both T follicular helper (Tfh) and T follicular regulatory (Tfr) cells are found in lymphoid structures 
called germinal centres (GCs). Here Tfh cells provide B cell help via direct T-B cell contacts and 
the production of IL-21 for the generation of highly-specific antibody responses, while Tfr cells 
have suppressive functions. Both cell types express the master-transcription factors Bcl6 (B cell 
CLL/Lymphoma 6) as well as high levels of PD-1 (programmed cell death protein 1) and CXCR5. 
Tfr cells additionally express Foxp3, the master regulator of regulatory T cells (Linterman et al. 
2011; Vinuesa et al. 2016). The role of Tfh and Tfr cells in regulating the GC response will be 
discussed in more detail in section 1.3.2.4. 
1.4.2 CD4 T cell development 
CD4 T cells are generated in the thymus from T cell progenitors arising from haematopoietic stem 
cells in the bone marrow (Koch & Radtke 2011). Bone marrow is the soft tissue in the cavities of 
bones, which forms an essential survival niche for haematopoietic stem cells (Gurkan & Akkus 
2008). The niche is shaped by a stroma formed of reticular cells and mesenchymal stem cells. Here, 
haematopoietic stem cells differentiate into common lymphoid progenitor (CLP) cells, which, 
amongst others, give rise to T cell progenitors. These cells leave the bone marrow and migrate 
towards the thymus (Koch & Radtke 2011). The thymus is a primary lymphoid organ located 
between the heart and the sternum (Pearse 2006). Its two lobes can be subdivided into an outer 
lymphocyte-rich cortex and the inner medulla, a tight stromal network of thymic epithelial cells 
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(Ciofani & Zúñiga-Pflücker 2007). T cell development takes place in both these regions. The 
generation of T cells is most effective during childhood when the thymus is largest, before thymic 
atrophy is initiated during puberty (Palmer 2013).  
Bone marrow-derived T cell progenitor cells arrive in the thymic cortex, where Notch-1 signalling 
commits them to the T cell differentiation pathway (Ciofani & Zúñiga-Pflücker 2007). In the 
subcapsular zone of the cortex, they undergo somatic rearrangements of their TCR genes to generate 
receptors with a large variety of unique specificities (Koch & Radtke 2011). TCRs are dimers, 
which can be formed either of a combination of a TCRα and β chain, or γ and δ chains (Krangel 
2009). Depending on which TCR chain is successfully recombined first, a small subset of cells 
commits to the γδ T cell lineage, while the majority of cells will enter the αβ T cell fate via a process 
called β-selection (Koch & Radtke 2011). After recombination of their TCRβ chain, these αβ T cell 
precursors then enter the double-positive stage by upregulating both their CD4 and CD8 co-
receptors and move on to the medulla, where they recombine their TCRα chain. The completed αβ 
TCR interacts with self-peptide-MHC complexes on thymic stromal cells, e.g. thymic epithelial 
cells and DCs in the medulla (Ciofani & Zúñiga-Pflücker 2007). Double-positive T cells with 
intermediate affinity for these MHC-self-antigen complexes receive positive survival signals and 
finally commit to single-positive CD4 or CD8 T cell lineages (Koch & Radtke 2011).  
To prevent the generation of self-reactive T cells, cells with high affinity for self-antigens are then 
eliminated by negative selection. Some of the self-reactive T cells can alternatively develop into 
tTreg cells by the combined action of TCR and IL-2 signalling (Hsieh et al. 2012). All surviving 
cells, including non-self-reactive and tTreg cells, upregulate S1PR1 which allows them to leave the 
thymus as mature CD4 or CD8 T cells and seed SLOs and peripheral tissues (Koch & Radtke 2011).  
1.4.2.1 Somatic recombination of the TCR 
Somatic recombination of the TCR genes during T cell development is crucial for the generation of 
antigen-specific adaptive immunity. The germline TCR gene locus encodes arrays of V (variable), 
D (diversity) and J (joining) genes, which need to be spliced together to form one TCR chain in a 
process called somatic recombination (Figure 1.3) (Krangel 2009). The near-to-random 
combination of V, D and J segments of each TCR chains can theoretically generate more than 
1 ´ 106 unique TCRs, with varying affinities for different antigens (Bonilla & Oettgen 2010; 
Glusman et al. 2001).  
Somatic recombination is driven by the recombinase-activating genes 1 (RAG1) and 2 (RAG2), 
which are part of the V(D)J recombinase complex (Bonilla & Oettgen 2010). This complex binds 
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recombination signal sequences at the borders of V, D and J segments. Here it cleaves the DNA, 
giving rise to hairpin structures. Then Artemis acts as an endonuclease to generate 5’ and 3’ 
overhangs at the DNA break sites. The overhangs from one J and one D segment are joined by DNA 
repair enzymes, before the J-D segment is linked with one of the V segments by a similar process 
(Bassing et al. 2002). This process of non-homologous end-joining is imperfect and can lead to the 
addition or removal of bases at the ligation site. In addition, the terminal deoxyribonucleotidyl 
transferase (TDT) enzyme actively adds a random sequence of 1-5 nucleotides to the ligation site, 
resulting in so-called junctional diversity of the recombined TCR. This further increases the number 
of receptors theoretically generated from the germline locus to 1015 (Davis & Bjorkman 1988), but 
can also result in the generation of abrogated or non-functional TCRs. Only T cell precursors which 
express fully-functional TCR proteins on their surface can receive positive survival signals and 
differentiate into mature T cells (Koch & Radtke 2011). 
Figure 1.3: Schematic representation of somatic TCRβ chain rearrangements. The TCRβ 
chain is generated by V(D)J recombination of its germline DNA. First, one J segment is joint with 
a D segment during DJ-recombination, then this gene segment is linked with a V gene and its 
leading peptide during V(D)J recombination. The recombined variable region contains 
complementary-determining regions (CDRs), such as CDR3, which are part of the antigen-binding 
domains of the TCR. The final TCRβ chain is formed by transcriptional splicing of its mRNA 
transcript. This image was taken from Migalska et al. 2018, licenced under CC BY 4.0 © 2018 
(Migalska et al. 2018). 
Figure 3: Schematic representation of somatic TCRβ chain rearrangements.
The TCRβ chain is generated by VDJ recombination of its germline DNA. First, one J
segment is joint with a D segment during DJ-recombination, then this gene segment
is linked with a V gene and its leading peptide during VDJ recombination. The
recombined variable region contains complementary-determining regions (CDRs),
such as CDR3, which are part of the antigen-binding domains of the TCR. The final
TCRβ chain, as depicted on the right, is formed by transcriptional splicing of its
mRNA transcript. This image was modified from Migalska et al. 2018 [24].
V       D       J         C
germline DNA
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1.4.3 CD4 T cell activation 
CD4 T cells leave the thymus as naïve cells which recirculate through the body via the blood and 
SLOs. To fulfil their immune functions, these naïve cells need to be activated by professional APCs. 
As described above, this is dependent on peptide-MHC-mediated triggering of the TCR combined 
with additional stimulation of the T cell via co-stimulatory receptors (Pennock et al. 2013). This 
initiates the clonal expansion of T cells. Cytokines further direct CD4 T cell differentiation into 
distinct effector phenotypes, by inducing the expression of subset-specific master transcription 
factors (Bonilla & Oettgen 2010).  
1.4.3.1 T cell activation by dendritic cells (DCs) 
DCs are the main APC for the initiation of CD4 T cell-dependent immune responses (Segura 2016). 
Generally, DCs are classified into resident DCs, which reside in SLOs, and migratory DCs which 
circulate between tissues. These are further subdivided into conventional DCs (cDCs), 
plasmacytoid DCs (pDCs), Langerhans cells and monocyte-derived DCs based on their functions 
(Segura 2016) (Table 1.1; Figure 1.4).  
Activated DCs provide all three signals required for T cell activation and differentiation: signal one 
is provided when DCs take up antigen, internalise it and present peptide-MHC-II complexes to CD4 
T cells (Webb & Linterman 2017). Upon activation of PPRs on the surface of DCs by PAMPs, DCs 
also provide signal two by upregulating the expression of co-stimulatory molecules on their surface 
(Krishnaswamy et al. 2018). PAMP-dependent activation also triggers signal three – the production 
of the cytokines which drive Th cell subset-specific differentiation (Krishnaswamy et al. 2018; 
Webb & Linterman 2017). 
Co-stimulation is essential to trigger T cell activation (Pennock et al. 2013). Signalling via the TCR 
alone induces T cell anergy, a state of hypo-responsiveness to further TCR stimulation. Only if a T 
cell receives simultaneous stimulation via its TCR and its co-stimulatory receptors, it will become 
fully activated. As co-stimulatory ligands on DCs are only upregulated in the presence of foreign 
antigens or inflammation, this helps to prevent activation of the adaptive immune system in the 
absence of an infection (Pennock et al. 2013). The primary co-stimulatory receptor on T cells is 
CD28 (Harding et al. 1992), but other immunoglobulin superfamily and tumour necrosis factor 
(TNF) receptor superfamily (TNFRSF) members, such as CD40, CD27, OX-40, 41BB, can also act 
as co-stimulatory receptors. When they interact with their ligands on activated DCs (CD80/CD86, 
CD40 ligand (CD40L), CD70, OX-40L and 41BBL respectively), these receptors promote T cell 
survival and proliferation (Chen & Flies 2013).  
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Table 1.1: Overview of dendritic cell (DC) subsets. DCs can be subdivided into several subsets, 
depending on their origin and functions. Plasmacytoid DCs (pDCs) and classical DCs (cDC) arise 
from a common DC progenitor, while Langerhans cells and monocyte-derived DCs are generated 
from embryonic monocytes and monocytes in infected tissue, respectively. Characterisation of the 
different DC subsets by marker genes is not trivial - this table lists a selection of subset-specific 
marker genes as used in this report and cited literature.  
Upon T cell activation, the TCR and all its co-stimulatory molecules are clustered at the 
immunological synapse, which is formed at the interface of DC-T cell contact. This clustering 
facilitates the recruitment of signalling kinases such as Src protein tyrosine kinases to the TCR 
(Figure 1.5) (Cantrell 2015; Ghosh 2004). These first phosphorylate immunoreceptor tyrosine-
based activation motifs (ITAMs) on CD3 proteins, then ZAP-70 (zeta chain of TCR-associated 
protein kinase 70) is recruited to these ITAM sites and activates a cascade of downstream 
phosphorylation events. This results in the activation of phospholipase Cγ1 (PLCγ1) which converts 
phosphatidylinositol 4,5-bisphosphate (PIP2) into the second messengers diacylglycerol (DAG) and 
inositol trisphosphate (IP3) (Matthews & Cantrell 2009). While DAG activates the protein kinase C 
q (PKCq) and the MAPK/Erk pathways to promote NF-κB (nuclear factor 'kappa-light-chain-
enhancer' of activated B-cells) signalling, IP3 triggers the release of Ca2+ from the endoplasmic 
reticulum (ER) which leads to the activation of the transcription factor NFAT (nuclear factor of 
activated T cells) (Cantrell 2015). Co-stimulatory molecules further enhances these signalling 
pathways and also activate PI3 kinase (PI3K), which promotes Akt and PKCq activities (Chen & 
DC subset Selected marker genes 
(by Guilliams et al. 2016) 
Origin Functions 
pDC B220+PDCA-1+ common DC 
progenitor 
Production of type I interferons, 
e.g. during viral infections 
(Swiecki & Colonna 2015) 
cDC1 Batf3+Xcr1+CD8aa+/- 
CD103+/- 
common DC 
progenitor 
Cross-presentation of 
phagocytosed antigen to CD8 T 
cells via MHC-I (Merad et al. 
2013) 
cDC2 Irf4+CD172α+CD11b+/- common DC 
progenitor 
CD4 T cell activation via MHC-
II (Krishnaswamy et al. 2018) 
Langerhans 
cells 
Langerin+CD24+ embryonic 
monocytes 
Modulation of T cell responses 
in the skin (Doebel et al. 2017) 
Monocyte-
derived DCs 
Ly6chighCD64high generated from 
monocytes in 
infected tissue 
Diverse functions, including 
CD4 T cell activation, cross-
priming of CD8 T cells and 
direct anti-microbial activities 
(Domínguez & Ardavín 2010) 
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Flies 2013). Combined, these signalling cascades enhance T cell proliferation and survival. This is 
accompanied by dramatic changes in T cell metabolism, associated with an increase in the uptake 
of nutrients and switching from oxidative phosphorylation to aerobic glycolysis. This allows 
activated T cells to generate enough biomass for clonal expansion and to produce large amounts of 
effector cytokines (Michalek & Rathmell 2010). 
 
Figure 1.4: Schematic representation of dendritic cell (DC) differentiation. DCs can be 
subdivided based on their ontogeny and localisation (resident versus migratory). Monocyte-
macrophage DC progenitors (MDPs) give rise to monocytes and common DC progenitors (CDPs). 
Monocytes do not only generate macrophages, but also develop into myeloid DCs and Langerhans 
cells, which also arise from embryonic precursors. CDPs, in turn, differentiate into plasmacytoid 
DCs (pDCs) and pre-conventional DCs (pre-cDCs). Interferon regulatory factor 4 (IRF4) 
expression in pre-cDCs drives differentiation into cDC2s, whereas the expression of the basic 
leucine zipper ATF-like transcription factor 3 (BATF3) leads to the development of cDC1s. On the 
right, cell surface markers for the identification of the different DC subsets are listed. Image 
modified from Krishnaswamy et al. 2018, licenced under CC BY 4.0 © 2018 (Krishnaswamy et al. 
2018). 
 
Figure 2: ti r presentation of dendritic cell (DC) diff rentiation. DCs
can b subdivided based on their ontogeny and localisation (resident versus
migratory). Mon cyte-macrophage DC progenit rs (MDPs) give rise to mo ocytes
and common DC progenitors (CDPs). Monocytes d not only generate
macrophages, but also develop into myeloid D s and Langerhans cells, which also
arise from embryonic precursors. CDPs, in turn, differentiate into plasmacytoid DCs
(pDCs) and pre-conventional DCs (pre-cDCs). Interferon regulatory factor 4 (IRF4)
expression in pre-cDCs drives differentiation into cDC2s, whereas the expression of
the basic leucine zipper ATF-like transcription factor 3 (BATF3) leads to the
development of cDC1s. On the right, cell surface markers for the identification of the
different DC subsets are listed. Image modified from Krishnaswamy et al. 2018 [14].
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Inhibitory co-receptors prevent T cell activation-induced changes by dampening the signalling 
pathways downstream of the TCR and co-stimulatory receptors. CTLA-4 and PD-1 are the most 
prominent inhibitory receptor and restrict T cell activation in several ways (Pennock et al. 2013): 
similar to CD28, CTLA-4 binds to CD80 and CD86, but with higher affinity than CD28, physically 
preventing CD80/CD86-CD28 interactions. CTLA-4 can also transcytose CD80/CD86, removing 
them from the surface of DCs and thereby limiting CD28 co-stimulation (Buchbinder & Desai 
2016). CTLA-4 and PD-1 can also recruit intracellular phosphatases, which dampen TCR 
downstream signalling by dephosphorylating and inactivating important signalling nodes, such as 
PLCγ1 and PKCq (Chen & Flies 2013).  
Figure 1.5: Schematic illustration of the T cell receptor (TCR) signalling network. When the 
TCR on CD4 T cells recognises antigen in the context of CD4 and CD28 co-stimulation, 
downstream signalling is initiated to mediate T cell activation. During this process, ZAP70 (zeta 
chain of TCR-associated protein kinase 70) is recruited to the membrane to activate the 
phospholipase C γ1 (PLCγ1). PLCγ1 converts phosphatidylinositol 4,5-bisphosphate (PIP2) into 
diacylglycerol (DAG) and inositol trisphosphate (IP3). While DAG activates the protein kinase C 
delta (PKCq) and the MAPK/Erk pathways to promote NF-κB signalling, IP3 initiates the release 
of Ca2+ from the endoplasmic reticulum (ER), resulting in the activation of the transcription factor 
NFAT (nuclear factor of activated T cells). Illustration reproduced courtesy of Cell Signaling 
Technology, Inc. (www.cellsignal.com) (Ghosh 2004).  
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This demonstrates that CD4 T cells have evolved to integrate many signals from their environment 
to adapt their functions. As described above, they require antigen-presentation and co-stimulation 
from DCs to be activated. Cytokines produced by these APCs can further drive their differentiation 
into different effector T cell subsets. In a cell-contact dependent manner and by producing distinct 
cytokines themselves, they then instruct immune responses by other immune cells to generate 
context-specific immune responses. While this is crucial to mount antigen-specific immune 
responses, dysregulated T cell responses have also been associated with chronic inflammatory and 
autoimmune diseases. Therefore, it is crucial to improve our understanding of how environmental 
changes impact CD4 T cell-dependent immune responses.  
1.5 B cells 
Upon activation, B cells can either terminally differentiate into plasma cells, which produce large 
amounts of antigen-specific antibodies, the secreted form of their antigen receptor - the B cell 
receptor (BCR) - , or differentiate into IL-10-producing, immunosuppressive B regulatory cells, 
which are important for immunological tolerance (Lu et al. 2017; Rosser & Mauri 2015). This 
report will mainly focus on B cell-mediated antibody responses which are dependent on plasma cell 
differentiation initiated by activated CD4 T cells in a process called T cell help, or in a T-
independent manner. The resulting antibodies are secreted at mucosal surfaces or circulate the body 
in the blood stream to provide immune protection by directly neutralising pathogens or marking 
them for removal by other immune cell types (Lu et al. 2017).  
1.5.1 B cell subsets  
B cells development takes place in the foetal liver and in the bone marrow, giving rise to two B cell 
subsets: B-1 and B-2 cells (LeBien & Tedder 2008). B-1 cells are solely derived from the foetal 
liver early during development and are retained in the host thereafter through self-renewal 
(Baumgarth 2011). These cells are rare in SLOs and mainly populate the peritoneal and pleural 
cavities as well as mucosal surfaces such as the intestine. They express a restricted BCR repertoire 
which is polyreactive. Even in the absence of an antigenic stimulus, these are secreted as natural 
antibodies of the IgM and IgA isotypes to help protect the body from invading bacteria, e.g. upon 
intestinal lesions (Fagarasan et al. 2010). Conversely, B-2 cells can be derived from both the foetal 
liver and the bone marrow. They seed SLOs as naïve follicular B cells or MZ B cells (Figure 1.6) 
(LeBien & Tedder 2008). MZ B cells are a specialised B cell subset in the spleen. Similar to B-1 
cells, they recognise T-independent carbohydrate and phospholipid antigens to produce IgM 
antibodies early during an immune response, but can also response to protein antigen in a T-
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dependent manner (Hoffman et al. 2016; Phan et al. 2005; Song & Cerny 2003). Naïve B cells 
reside in B cell follicles and are best characterised for raising T cell-dependent antibody responses. 
They express both IgM and IgD BCR isotypes on their surface and are constantly replenished from 
the bone marrow. Upon activation, they expand clonally and can differentiate into either memory 
B cells or plasma cells that secrete large amounts of antibodies (LeBien & Tedder 2008).  
1.5.2 B cell development  
In the bone marrow, B-2 cells are generated from CLPs which first give rise to proB cells (Hardy 
& Hayakawa 2001; LeBien & Tedder 2008; Yam-Puc et al. 2018). proB cells are the earliest stage 
of B cell development. They express the E2A transcription factor, the B cell marker B220 and 
paired box 5 (Pax-5), a master regulator of B cell development. Upon downregulation of E2A, they 
differentiate into preB cells, which undergo somatic rearrangements of their antigen receptor 
(Hardy & Hayakawa 2001). Immature B cells, which have successfully recombined their BCR, can 
then leave the bone marrow and seed SLOs in the periphery (Figures 1.6 & 1.7) (LeBien & Tedder 
2008). 
Figure 1.6: Schematic depiction of B cell development. Common lymphoid progenitor (CLP) 
cells give rise to proB and preB cells in the bone marrow. After successful V(D)J recombination of 
their B cell receptor (BCR), IgM-expressing immature B cells leave the bone marrow and migrate 
to secondary lymphoid organs (SLOs) like the spleen. Here, transitional B cells differentiate into 
marginal zone B cells or follicular B cells, which express both IgM and IgD BCRs on their surface. 
Upon activation, both B cell subtypes can differentiate into memory B cells and short-lived plasma 
cells in a germinal centre (GC)-independent fashion. Follicular B cells can migrate to the B cell 
follicle and seed GCs. During the GC response, GC B cells clonally expand and hypermutate their 
BCR which, after selection, can lead to enhanced antigen affinity. B cells exiting the GC reaction 
generate memory B cells and long-lived plasma cells which secrete high-affinity antibodies. Image 
modified from Yam-Puc et al. 2018, licenced by F1000 Research under CC BY © 2018 (Yam-Puc 
et al. 2018). 
 
Figure 6: Schematic depiction of B cell development. Common lymphoid
progenitor (CLP) cells give rise to proB and preB cells in the bone marrow. After
successful VDJ recombination of their B cell receptor (BCR), IgM-expressing
immature B cells leave the bone marrow and migrate to secondary lymphoid organs
(SLOs) like the spleen. Here, transitional B cells differentiate into follicular B cells,
which express both IgM and IgD BCRs on their surface. Alternatively, they form
marginal zone B cells, which can secrete antibodies in a T cell-independent manner.
When follicular B cells are activated by cognate antigen in the context of T cell help,
they either form germinal centres (GCs) or differentiate into memory B cells and
short-lived plasma cells in an extrafollicular response. During the GC response, GC
B cells clonally expand and hypermutate their BCR for enhanced antigen affinity. B
cells exiting the GC reaction form long-lived plasma and memory B cells which
secrete high-affinity antibodies. Image modified from Yam-Puc et al. 2018 [65].
v
v
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1.5.2.1 V(D)J recombination of the BCR 
B cell development is tightly linked with the rearrangement of their antigen receptor genes. The 
BCR, also known as immunoglobulin, consists of two heavy and two light chains (Lu et al. 2017). 
Both chains are subdivided into a constant and variable region: the constant region remains constant 
during B cell development, but can be subject to class switch recombination (CSR) upon B cell 
activation. The variable region encodes the region of the BCR that binds antigen. The final BCR 
configuration is generated by rearrangements of various gene segments during B cell development 
(Lu et al. 2017). Immunoglobulin rearrangements are very similar to V(D)J recombination of the 
TCR in T cells (described in section 1.4.2.1). Each heavy and light chain is encoded by a large gene 
locus which contains several V, D and J genes (Schroeder & Cavacini 2010). During B cell 
development, RAG-1 and RAG-2 generate double-strand breaks at the immunoglobulin locus to 
first join one of the J genes with a D gene. The D-J pair is then recombined with a V gene to form 
a complete immunoglobulin chain. Somatic rearrangements occur independently for the light and 
heavy chains, which are then combined to form a functional BCR, resulting in the theoretical 
combinatorial diversity of almost 2 ´ 106 different immunoglobulins (Janeway et al. 2001; Johnston 
et al. 2006; Schroeder & Cavacini 2010; Ye 2004). In addition, a random number of nucleotides 
can be lost or gained during the DNA repair process at D-J and V-DJ ligation sites, further 
increasing BCR diversity by junctional diversification (Janeway et al. 2001).  
V(D)J recombination of the immunoglobulin heavy chain takes place in proB cells (Figure 1.7) 
(González et al. 2007; LeBien & Tedder 2008). Random mutations during V(D)J recombination 
can lead to the expression of a truncated or misfolded heavy chain. Only if the recombined heavy 
chain is functional, it can associate with a so-called surrogate light chain formed of λ5 and VpreB. 
The resulting complex is termed pre B cell receptor (pre-BCR), which, similar to the BCR, 
assembles with the accessory proteins Igα and Igβ (Hardy & Hayakawa 2001). Assembly and 
signalling downstream of the pre-BCR are required to advance B cell development. This is an 
important safety test, to make sure that only B cells with a functional heavy chain go on to 
differentiate into preB cells and rearrange their light chain locus. Formation of the pre-BCR stops 
V(D)J recombination by the downregulation of RAG1 and RAG2 (Schroeder & Cavacini 2010). 
proB cells then divide a few times, before they turn into preB cells, which reactivate RAG1 and 
RAG2 to rearrange their BCR light chain (Naradikian et al. 2014). B cell development in the bone 
marrow is completed, when, after successful VJ recombination of the light chain locus, a mature 
BCR is expressed on the surface of the immature B cell. These cells carry a functional BCR of the 
IgM isotype on their surface.  
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75 % of immature bone marrow B cells bind to self-antigens (Wardemann et al. 2003), however to 
limit autoimmunity, cells carrying these BCRs are eliminated from the B cell pool via two 
mechanisms: cell death or receptor editing (Naradikian et al. 2014). The latter is dependent on the 
reactivation of RAG1 and RAG2 expression for another round of light chain rearrangements to 
modify the antigen-specificity of the BCR. Despite this control mechanism, some self-reactive B 
cells manage to exit from the bone marrow via the blood stream. In the periphery, negative selection 
of these cells continues by exclusion of these cells from the B cell follicle, anergy, developmental 
arrest or lack of T cell help (Manjarrez-Orduño et al. 2009). Together, these tolerance mechanisms 
protect the body from auto-reactive B cells, which are generated as a by-product of BCR 
diversification by V(D)J recombination.  
 
Figure 1.7: Schematic illustration of V(D)J rearrangements and class switch recombination 
(CSR) of the heavy chain of the B cell receptor (BCR). During B cell development, the BCR 
germline locus undergoes V(D)J recombination. This gives rise to a mature BCR, which is 
expressed as IgM on the surface of mature B cells. Upon antigen-dependent activation of B cells 
CSR can occur, leading to expression of a new immunoglobulin isotype such as IgA. During the 
germinal centre (GC) response, somatic hypermutation (SHM) of the V(D)J locus can additionally 
take place. Circles depicted next to constant regions of the heavy chain locus (CH) represent switch 
regions. Dotted lines on V, D, and J segments represent hypermutated genes after SHM. This image 
was modified and republished with the permission of the American Society of Hematology from 
González et al. 2007 (González et al. 2007); permission conveyed through Copyright Clearance 
Center, Inc. 
1.5.3 B cell activation 
B cells are activated when they recognise their cognate antigen via their BCR. BCRs can either bind 
soluble antigen or antigen presented on the surface of FDCs, macrophages and DCs (Batista & 
Figure 7: Schematic illustration of VDJ rearrangements and class switch
recombination (CSR) of the heavy chain of the B cell receptor (BCR). During B
cell development, the BCR germline locus undergoes VDJ recombination. This gives
rise to a mature BCR, which is expressed as IgM on the surface of mature B cells.
Upon antigen-dependent activation of B cells CSR can occur, leading to expression
of a new immunoglobulin isotype such as IgA. During the germinal centre (GC)
r sponse, somatic hyper utation (SHM) of the VDJ locus can additionally take
place. Circles d picted next to constant regions of the heavy chain locus (CH)
represent switch regions. Dotted lines on V, D, and J segments represent
hypermutated genes after SHM. Image modified from David González et al. 2007
[67].
CSRSHM in GCs 
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Harwood 2009). Antigen recognition leads to the upregulation of CCR7 on the surface on B cells, 
which allows them to migrate from the B cell follicle towards FRC-derived chemokines CCL19 
and CCL21 in the T cell zone (Okada et al. 2005). At the T-B border between the T cell zone and 
the B cell follicle, B cells present antigen to T cells. This interaction provides B cells with survival 
and co-stimulatory signals. T cell-dependent signals induce the expansion of B cells (Chan et al. 
2009) whose progeny can then either migrate to the B cell follicle and seed the GC response or 
enter an extrafollicular response. The latter leads to their differentiation into memory B cells or 
short-lived plasma cells, which secrete the first wave of antibodies essential for the early response 
against infections while the GC reaction is established (MacLennan et al. 2003). 
1.5.4 Class-switch recombination 
Upon B cell activation, the immunoglobulin heavy chain can undergo somatic recombination of its 
immunoglobulin constant region in a process called class-switch recombination (CSR) (Figure 1.7) 
(Schroeder & Cavacini 2010). In the mouse, eight constant regions are found in the heavy chain 
locus downstream of the V(D)J region (Shimizu et al. 1982). Each constant region contains an 
upstream switch region, which can be recombined with any switch region of the other constant 
regions during CSR (Schroeder & Cavacini 2010). The class switching process is mediated by 
activation-induced cytidine deaminase (AID), an enzyme which initiates CSR at switch sites by 
deaminating cytosines (Stavnezer & Schrader 2014). Enzymes of the base excision repair (BER) 
and mismatch repair (MMR) pathways are then recruited to the mutated sites, where they induce 
DNA double-strand breaks (DSBs). These breaks are subsequently recombined by non-homologous 
end-joining (NHEJ), adding a new constant region to the 3’ end of the heavy chain locus (Stavnezer 
& Schrader 2014). Like this, different isotypes, or antibody classes distinguished only by their C-
terminal region, can be generated in addition to the initial IgM and IgD isotypes: IgA, IgE, IgG1, 
IgG2, IgG3, - and IgG4 in humans only (Schroeder & Cavacini 2010). These constant regions do 
not interact with antigen, but modulate the effector functions of the secreted antibody: neutralisation 
of target antigens, activation of immune cells by binding to antibody isotype-specific Fc receptors 
(FcRs), or activation of the complement system by binding to C1q (Hoffman et al. 2016). Antibody 
isotypes determine the predominant antibody effector function. IgA, for instance, is important to 
neutralise antigens at mucosal surfaces, while IgE activates mast cells by binding to their IgE-
specific FcR (Schroeder & Cavacini 2010). Thus, somatic rearrangements modulate not only 
antigen specificity of the BCR, but also its effector functions.  
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1.6 Germinal centre (GC) responses 
GCs are where antigen-specific B cells somatically mutate the variable region of their antigen 
receptor to improve BCR affinity in an antigen-specific manner (Figure 1.8) (Stebegg, Kumar, 
Silva-Cayetano et al. 2018). They then form memory B cells and long-lived plasma cells that secrete 
antibodies with high antigen-binding affinity (Vinuesa et al. 2016). Alternatively, B cells can also 
form antibody secreting plasma and memory B cells in a GC-independent manner, but these cells 
usually display lower affinity because of the lack of somatic hypermutation (SHM) at extrafollicular 
sites (Bortnick & Allman 2013; MacLennan et al. 2003).  
For a GC reaction to be initiated, B cells need to recognise their cognate antigen via their BCR and 
to interact with antigen-activated T cells at the T-B border (Okada et al. 2005). Activated B cells 
then migrate back into the B cell follicle and form GC B cells (Pereira et al. 2009). GC B cells first 
expand clonally as centroblasts in the dark zone (DZ) of the germinal centre. Centroblasts express 
the proliferation marker Ki67 and are retained in their niche by expressing CXCR4, which is 
attracted to the chemokine CXCL12 secreted by CXCL12-expressing reticular cells (CRCs) in the 
DZ (Allen et al. 2004). Here, centroblasts undergo SHM of their antigen receptor gene (Bannard et 
al. 2013). SHM is mediated by AID, the same enzyme that catalyses CSR. During SHM, the repair 
of AID-induced U:G mismatches results in point mutations of the BCR gene (Peled et al. 2008). 
This can have several outcomes: SHM can disrupt the BCR structure or generate BCRs either with 
improved antigen affinity or novel antigen-specificity. This can lead to the unintentional emergence 
of auto-reactive B cell clones with the potential to cause autoimmune diseases if they are not 
appropriately censored in the GC. 
To make sure that SHM in the GC response only gives rise to B cells with improved affinity to 
foreign antigen, they require, for their survival, positive selection signals from Tfh cells and FDCs 
in the light zone (LZ) (Mesin et al. 2016). To get access to FDCs and T cells, centroblasts need to 
differentiate into centrocytes which upregulate CXCR5 (Allen et al. 2004). CXCR5 is the receptor 
for CXCL13, a chemokine produced by FDCs in the LZ. Here, centrocytes test their BCR by taking 
up antigen from the surface of FDCs and presenting it to Tfh cells (Suzuki et al. 2009). These cells 
provide positive selection for B cells with high antigen affinity. B cells with high affinity for antigen 
take up more antigen from FDCs, and are therefore able to present more peptide-MHC-II complexes 
to Tfh cells and form longer-lasting T-B cell interactions (Gitlin et al. 2014; Shulman et al. 2014). 
As a result, they outcompete lower affinity B cell clones by receiving stronger survival signals. 
Besides Tfh cells, GCs also contain Foxp3+ Tfr cells, which dampen the GC response and prevent 
the expansion of auto-reactive B cells (Vanderleyden et al. 2014).  
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Together these selection mechanisms culminate in the generation of long-lived antibody-producing 
plasma and memory B cells with improved antigen affinity. These cells provide specific immune 
protection, not only to the primary infection, but also to reinfections for up to several decades 
(Mesin et al. 2016; Takemori et al. 2014).  
Figure 1.8: Schematic representation of the germinal centre (GC) response. GCs are 
specialised structures formed in B cell follicles upon infection or immunisation. They consist of 
two compartments: the dark zone (DZ) and light zone (LZ). The DZ is where B cells form 
centroblasts which expand clonally and undergo somatic hypermutation (SHM) to enhance their 
antigen affinity. This compartment is shaped by CXCL12-producing reticular cells (CRCs), which 
attract and retain the CXCR4-expressing centroblasts. When centroblasts upregulate CXCR5 and 
differentiate into centrocytes, they migrate towards follicular dendritic cells (FDCs) in the LZ, 
which express the CXCR5-ligand CXCR13. Here, centrocytes capture antigens from the surface of 
FDCs and present them to T follicular helper (Tfh) cells for B cell selection. Only centrocytes with 
high antigen affinity receive vital survival signals from Tfh cells and can exit the GC as long-lived 
plasma or memory B cells. T follicular regulatory (Tfr) cells dampen the GC response to prevent 
the emergence of autoreactive B cell clones. This image was created and kindly provided by Alyssa 
Silva-Cayetano (Stebegg, Kumar, Silva-Cayetano et al. 2018).  
 
1.6.1 Tfh cells  
Tfh cells are required for the initiation of the GC response, as shown in Bcl6fl/flCd4cre/+ mice, which 
lack Tfh cells and cannot form GCs (Hollister et al. 2013). Tfh cells are generated when naïve CD4 
T cells in SLOs are primed by antigen-presenting DCs. The resulting Tfh cell precursors (pre-Tfh 
cells) upregulate Bcl6, CXCR5 and Epstein-Barr virus-induced gene 2 (EBI2), while 
Figure 8: Schematic representation of the germinal centre (GC) response. GCs
are specialised structures formed in B cell follicles upon infection or immunisation.
They consist of two segments: the dark zone (DZ) and light zone (LZ). The DZ is
where B cells form centroblasts which expand clonally and undergo somatic
hypermutation (SHM) to enhance their antigen affinity. This compartment is shaped
by CXCL12-producing reticular cells (CRCs), which attract and retain the CXCR4-
expressing centroblasts. When centroblasts upregulate CXCR5 and differentiate into
centrocytes, they migrate towards follicular dendritic cells (FDCs) in the LZ, which
express the CXCR5-ligand CXCR13. Here, centrocytes capture antigens from the
surface of FDCs and present them to T follicular helper cells for B cell selection. Only
centrocytes with high antigen affinity receive vital survival signals from T follicular
helper (Tfh) cells and can exit the GC as long-lived plasma or memory B cells. T
follicular regulatory (Tfr) cells dampen the GC response to prevent the emergence of
autoreactive B cell clones. This image was created by Alyssa Silva-Cayetano
(Stebegg, Cayetano, Kumar et al. 2018, [78]).
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downregulating CCR7 (Li et al. 2016; Webb & Linterman 2017). This leads to the migration of 
pre-Tfh cells to the T-B border, where concentrations of the CXCR5-ligand CXCL13 are higher. 
Even if several DC subtypes have been shown to activate T cells and induce their migration to the 
T-B border, here migratory cDC2s seem to be the dominant Tfh-priming DC subset, especially 
under conditions of low antigen availability (Krishnaswamy et al. 2017; 2018).  
As described above, CD4 T cells require three signals to be activated and differentiate into Tfh cells 
(Krishnaswamy et al. 2018): antigen-specific interactions of their TCR with peptide-MHC-II on 
DCs, co-stimulation and signals from cytokines. Activated cDC2s provide all three signals: signal 
one is provided when DCs take up antigen, internalise it and present peptide-MHC-II complexes to 
T cells (Webb & Linterman 2017). Upon activation of PRRs on the surface of DCs by PAMPs, they 
also provide signal two by upregulating the expression of CD40L, OX40L, the inducible T cell 
costimulatory ligand (ICOSL), CD80 and CD86, all of which interact with co-stimulatory receptors 
on the surface of T cells to enhance TCR signalling and boost Tfh differentiation (Krishnaswamy 
et al. 2018). PAMP-dependent activation also triggers signal three – the production of the cytokines 
such as IL-6, an important driver of Tfh cell differentiation (Eddahri et al. 2009; Webb & Linterman 
2017). In addition, PAMPs induce the production of type I interferons (IFNs) by DCs. Type I IFN, 
which comprise several a and b IFNs, is an enhancer of Tfh cell differentiation (Cucak et al. 2009). 
Type I IFNs were proposed to act on Tfh cells by enhancing the DC-dependent production of IL-6 
and IL-27 cytokines known to favour Tfh cell differentiation (Batten et al. 2010; Cucak et al. 2009; 
Gringhuis et al. 2014). IFNAR signalling can also promote the secretion of IL-1β by DCs, which 
enhances the expression of Bcl6, CXCR5 and the inducible T cell co-stimulator (ICOS) by Tfh cells 
(Barbet et al. 2018). Taken together, this demonstrates that cDC2 cells are potent inducers of Tfh 
cell differentiation at the T-B border and are therefore crucial to initiate GC responses.  
At the T-B border, SLAM-associated protein (SAP)-dependent interactions between antigen-
activated T and B cells are further required to enable full Tfh cell differentiation (Qi et al. 2008). 
Mature Tfh cells are characterised by their expression of the transcription factor Bcl6 and the 
chemokine receptor CXCR5 which facilitates follicular homing (Victora & Nussenzweig 2012). 
Tfh cells also express high levels of the co-stimulatory molecules CD40L, PD-1 and ICOS (Webb 
& Linterman 2017). These molecules are important mediators of GC B-Tfh interactions, as GC B 
cells express their interacting partners CD40 and ICOSL (Vinuesa et al. 2016). CD40-CD40L 
interactions are crucial for GC formation, as CD40L on Tfh cells provide important survival signals 
to GC B cells (Casamayor-Palleja et al. 1996; Foy et al. 1993; Takahashi et al. 1998). Tfh cells also 
secrete IL-21 and IL-4 cytokines to regulate GC B cell selection. IL-21 enhances Bcl6 expression 
in GC B cells (Linterman et al. 2010), while IL-4 was shown to support GC B cell selection as well 
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as CSR (Cunningham et al. 2004). Competition of B cells for these factors is crucial to ensure that 
only B cells with high antigen affinity exit the GC reaction. 
The random mutation process during SHM can lead to the emergence of auto-reactive B cell clones 
with the potential to cause autoimmune diseases. Therefore, the ongoing GC reaction needs to be 
tightly regulated. An excess number of Tfh cells in the GC leads to impaired B cell selection and 
the emergence of self-reactive B cell clones which ultimately cause autoimmunity (Linterman et al. 
2009; Vinuesa et al. 2005). 
1.6.2 Tfr cells  
Tfr cells are negative regulators of the GC response. They have been reported to restrain the 
production of antibodies, while favouring the emergence of antigen-specific B cell clones (Stebegg, 
Kumar, Silva-Cayetano et al. 2018). Tfr cells derive from Foxp3+ precursors and share phenotypic 
characteristics of Tfh cells, including expression of Bcl6 and CXCR5 (Aloulou et al. 2016). Similar 
to Tfh cells, Tfr cell differentiation seems to follow a multi-step, Bcl6-dependent differentiation 
process which relies on both antigen presentation from DCs and interactions with activated B cells 
(Stebegg, Kumar, Silva-Cayetano et al. 2018). Upon immunisation, Tfr cells are recruited into the 
GC, where they regulate the GC response via CTLA4-mediated suppression (Sage et al. 2014; Wing 
et al. 2014) and by impairing GC B and Tfh cell metabolism, causing the downregulation of 
important GC B cell effector molecules such as AID (Sage et al. 2016). This negative regulation by 
Tfr cells is important to control GC size (Linterman et al. 2011; Wollenberg et al. 2011) and to 
prevent the emergence of auto-reactive B cells (Fu et al. 2018). 
1.6.3 Specialised GCs in PPs  
In PPs, specialised GC responses give rise to IgA antibodies (Figure 1.9) (Kawamoto et al. 2014; 
Reboldi & Cyster 2016; Stebegg, Kumar, Silva-Cayetano et al. 2018). Like other GCs, B cells 
within PP GCs undergo SHM of the Ig locus, followed by selection of B cells bearing BCRs that 
bind antigen with high affinity. One key difference to peripheral LNs is that in PPs CSR to the IgA 
isotype occurs (Craig & Cebra 1971). In AID-deficient animals that lack CSR and SHM, there is 
aberrant expansion of anaerobic gut commensals and extensive immune hyperplasia (Fagarasan et 
al. 2002; Suzuki et al. 2004). Patients with selective IgA deficiency also exhibit changes in their 
gut microbiome, associated with increased Th17-cell associated inflammation (Fadlallah et al. 
2018). This demonstrates the key role that IgA antibody responses play in the control of the gut 
microbiota.  
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IgA antibodies exist as dimers and are secreted at all mucosal surfaces. In the gut, IgA is secreted 
into the gut lumen by M cells, specialised epithelial cells above the SED of PPs. Once in the gut, 
IgAs bind to a wide range of commensal bacteria and alter the composition of the microbiota 
through a variety of mechanisms (Macpherson et al. 2012). These include blocking interactions of 
bacteria with the host, trapping antigens in the intestinal mucus or interfering with the invasive 
properties of pathogens (Macpherson et al. 2012). In addition, IgA antibodies assist with the 
controlled intestinal uptake of bacterial antigens to boost local antigen-specific gut immune 
responses (Pabst 2012; Rey et al. 2004).  
Figure 1.9: Depiction of Peyer’s patches (PPs) and their role in producing commensal-specific 
IgA antibodies. On the left, a confocal immunofluorescence image of a murine PP is shown. Blue 
Ki67+ GC B cells demarcate the PP germinal centre (GC). CD3+ T cells are shown in green, 
follicular IgD+ B cells in orange and Foxp3+ cells in pink. On the right, a schematic illustration of 
a PP is shown. The GC reaction in PPs, which is controlled by T follicular helper (Tfh) and T 
follicular regulatory (Tfr) cells, generates plasma and memory B cells which secrete somatically 
hypermutated IgA antibodies. These antibodies are secreted into the intestinal lumen, where they 
bind to the surface of a wide range of commensal bacteria, helping to control the composition of 
the gut microbiota. The gut microbiota in turn induces the generation of Foxp3+ T regulatory cells 
and the production of IgA antibodies by B cells in gut lining. This figure was reprinted from 
Kawamoto et al. 2014 with permission from Elsevier © 2014 Elsevier Inc. (Kawamoto et al. 2014). 
 
It is not clear whether this is mediated by IgA antibodies generated in a GC-dependent or -
independent fashion. Evidence suggesting that functional IgA antibodies can be generated 
independently of GCs comes from studies in which mice lack either T-dependent immune responses 
(CD28-deficient mice and CD40-deficient mice) or Tfh cells (Bcl6fl/flCd4cre/+). All these animals 
have high IgA antibody titres, and Bcl6fl/flCd4cre/+ mice were also shown to have near-to-normal 
levels of bacterial IgA-coating, and relatively normal composition of the microbiota (Bergqvist et 
al. 2006; Bunker et al. 2015; Gärdby et al. 2003). However, SHM of IgA antibodies mainly occurs 
in GCs and analysis of mice that express a variant of AID that can facilitate CSR, but not SHM, 
Figure 9: Depiction of Peyer’s patches (PPs) and their role in producing
commensal-sp cific IgA antibodies. On the l ft, a onfocal immunofl orescence
image of a urine PP is shown. The PP was excised, fixed in periodate-lysine-
paraformaldehyde (PLP), dehydrated in sucrose and mounted in OCT medium,
before 10!m section were cut and stained with anti-CD3 (green), anti-IgD (orange),
anti-Ki67 (blue) and anti-Foxp3 (pink) antibodies and imaged on a Zeiss780
microscope. Blue Ki67+ GC B cell demarc te the PP germinal ntre (GC). On th
right, a schematic illustration of a PP is shown. The GC reaction in PPs, which is
controlled by T follicular helper (Tfh) and T follicular regulatory (Tfr) cells, generates
plasma and memory B cells which secrete somatically hypermutated IgA antibodies.
These antibodies are secreted into the intestinal lum , where they bind to th
surface of a wide range of commensal bacteria, helping to control the composition of
the gut microbiota. The gut microbiota in turn induces the generation of Foxp3+ T
regulatory cells and the production of IgA antibodies by B cells in gut lining. This
image was modified from Kawamoto et al. 2014 [126].
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revealed that this strain exhibited aberrant expansion of commensal bacteria and increased bacterial 
translocation into mesenteric LNs (Wei et al. 2011). This suggests that GC responses in the PP play 
a role in the maintenance of microbial homeostasis. 
1.6.3.1 Immune regulation of GCs in PPs by Tfh and Tfr cells 
Given the distinct architecture and location of PPs, their regulatory mechanisms are unique from 
those in other SLOs. Most importantly, Tfh and Tfr cells in PPs are responsive to modulation by 
the gut microbiota. The ensuing plasticity in T cell regulation allows PP GCs to respond adequately 
to intestinal infections or changes in the gut microbiota (Stebegg, Kumar, Silva-Cayetano et al. 
2018). 
PPs provide a unique environment for Tfh cell differentiation, where the “rules” established for Tfh 
cell development are frequently broken. Exclusively in the gut, Tfh cells can derive from RORγt+ 
Th17 cells (Hirota et al. 2013) and Foxp3+ Treg cells (Tsuji et al. 2009). The precise mechanism 
for this is unclear, but it may be driven by stimuli from the microbiota, as microbial sensing plays 
an important role for Tfh differentiation in the gut. Microbial ATP was shown to control Tfh cell 
differentiation in PPs via interactions with the ATP-gated ionotropic P2X7 receptor (Proietti et al. 
2014). Moreover, the Th17 cell-promoting segmented filamentous bacteria (SFB) were shown to 
drive the differentiation of PP Tfh cells (Fei Teng et al. 2016). The egress of these “unusual” PP 
Tfh cells into systemic sites can have dire consequences for health, as they were reported to 
exacerbate auto-antibody responses in arthritis (Fei Teng et al. 2016). This demonstrates the ability 
of intestinal Tfh cells to integrate multiple signals from the gut microbiota for their development, 
with implications not only for gut, but also systemic immunity. Therefore, control of Tfh cell 
development, and their maintained residence in the gut is critical for organismal health (Stebegg, 
Kumar, Silva-Cayetano et al. 2018). 
Similar to Tfh cells, PP Tfr cells have gut-specific features. In PP GCs, the Tfh/Tfr ratio is increased 
compared to peripheral GCs (Kato et al. 2014), making PP GCs resemble the early stages of a GC 
reaction. This has been proposed to enable the expansion of low affinity B cell clones early in the 
response (Ramiscal & Vinuesa 2013) and is consistent with the proposal of Reboldi et al. (Reboldi 
& Cyster 2016), who suggested that GCs in PPs resemble early GCs in order to favour the quick 
generation of diverse low-affinity antibodies in response to microbial antigens. Interestingly, gene 
expression profiling of Tfr cells from PPs and LNs revealed that PP Tfr cells, unlike LN Tfh cells, 
express the helper cytokine IL-4 (Georgiev et al. 2018). This could point to a different, potentially 
less suppressive, role of Tfr cells within PPs. 
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As discussed above, Tfr cells are considered to be negative regulators of the GC response, but the 
data about their functionality in PPs is not clear. STAT3-deficient mice, which lack Tfr cells but 
have PP Tfh cells, have no observable changes in PP GC size or IgA production in the gut (Wu et 
al. 2016). However, in an adoptive transfer model Kawamoto et al. implicated Tfr cells in the 
regulation of IgA-mediated control of the gut microbiome: the supplementation of T cell-deficient 
hosts with Treg cells increased IgA production and induced dramatic changes in the composition 
of the microbiota (Kawamoto et al. 2014). This is consistent with the observation that depletion of 
Treg cells results in a drop in IgA levels (Cong et al. 2009). Together, this suggests that both Tfr 
functionality as well as the Tfh/Tfr ratio in PPs are adjusted to allow for optimal control of the gut 
microbiota, although further work is required to precisely define the role of Tfr cells in PPs. 
1.6.3.2 Immune regulation of GCs in PPs by the gut microbiota 
The gut microbiota is a crucial, but often underappreciated, regulator of the GC response in the gut 
as well as of the systemic immune system (Stebegg, Kumar, Silva-Cayetano et al. 2018). Germ-
free mice, which lack any form of bacterial colonization, exhibit evident deficits in the maturation 
of their gut-associated lymphoid tissues, including PPs and mesenteric LNs. Their PPs are small 
and produce limited amounts of IgA antibodies (Round & Mazmanian 2009). In addition, these 
mice are more susceptible to enteric infections and their systemic immune response to infections is 
also stunted (Fagundes et al. 2012; Khosravi et al. 2014). This demonstrates a strong dependency 
of the immune system on the microbiota. There is evidence that some bacteria and their products 
directly affect the GC response in PPs. Transfer of a diverse microbiota into wild-type mice 
increases GC B cell numbers as well as bacterial IgA-coating (Kawamoto et al. 2014). Bacterial 
products can also directly act on immune cells in the PP: microbial ATP controls Tfh cell 
differentiation (Proietti et al. 2014) and short-chain fatty acids, a diverse group of bacterial 
metabolites, were shown to boost plasma cell differentiation and intestinal antibody production in 
PPs (Kim et al. 2016; Wu et al. 2017). This demonstrates the strong impact of the microbiota on 
the GC response. Thus, the interplay of the immune system with the microbiota cannot be neglected 
when studying the regulation of intestinal GCs. 
To test if ageing affected this cross-talk, we investigated whether age-associated changes in the 
composition of the murine gut microbiota were linked with changes in PP GCs of aged mice. 
Intriguingly, faecal microbiota transplantation from adult into aged mice reversed an ageing-related 
defects of the GC reaction in PPs. These data confirm that the gut microbiota has a strong impact 
on GCs in PPs and that an age-associated decline in the GC response can be reversed by changes in 
its microenvironment.  
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1.6.4 The GC response in ageing 
A very successful medical intervention for the prevention of infectious diseases is vaccination, 
which generates long-lived humoral immunity by triggering GC responses and extrafollicular 
responses in the absence of an infection. The efficacy of vaccination is reduced in older people, 
possibly due to an age-associated impairment of the GC reaction (Aberle et al. 2013; Gustafson et 
al. 2018; Linterman 2014). Ageing is a complex process, broadly defined as the age-dependent 
deterioration of the biological functions of an organism with time. This is associated with a plethora 
of age-associated defects (López-Otín et al. 2013): on a molecular level, there is age-related 
telomere shortening, the accumulation of genetic mutations, epigenetic changes, accumulation of 
defective mitochondria and of unfolded proteins due to alterations in the ER stress response (Brown 
& Naidoo 2012; López-Otín et al. 2013). On the cellular level, the communication between cells is 
affected and there is a reduction in tissue regeneration, associated with the accumulation of 
senescent cells which secrete large amounts of pro-inflammatory cytokines, a phenotype known as 
the senescence-associated secretory phenotype (Linterman 2014; López-Otín et al. 2013; Tchkonia 
et al. 2013).  
Similar to other cells, the functions of immune cells are negatively affected by age both in a cell-
intrinsic and -extrinsic manner, but the relative contribution of these effects is still unclear 
(Nikolich-Žugich 2018). The continued exposure to antigen over time leads to an age-related 
increase of antigen-experienced memory cells, while the pool of naïve immune cells, which can 
respond to novel antigen, progressively shrinks with advancing age (Nikolich-Žugich 2018). This 
is associated with an increased susceptibility to infections, a significant cause of death in old age 
(Kline & Bowdish 2016). 
In mice, advancing age is correlated with a decline in GC size. This is associated with the reduced 
formation of high-affinity plasma cells, a reduction in SHM and serum antibody levels (Eaton et al. 
2004; Kosco et al. 1989; Kraft et al. 1987; Linterman 2014; van Dijk-Härd et al. 1997; Yang et al. 
1996). Interestingly, ageing seems to affect GCs in PPs differently from GCs in the spleen and LNs. 
Several studies reported on reduced antigen-specific antibody responses in the gut of both BALB/c 
and C57BL/6 mice (Kato et al. 2003; Kawanishi & Kiely 1989; Koga et al. 2000), but this was not 
correlated with a decrease in the overall amount of secreted IgA in the intestine (Senda et al. 1988; 
Thoreux et al. 2000). Also, while there is progressive loss of GC B cells in murine PPs during 
ageing (González-Fernández et al. 1994), several paper reported on increasing numbers of 
somatically mutated antibodies in the PPs of aged mice. This is in contrast to the reduced SHM 
observed in LNs (Banerjee et al. 2002) and is probably due to successive accumulation of mutations 
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in memory B cells in the gut over the life time of the mouse (Banerjee et al. 2002; González-
Fernández et al. 1994; Rogerson et al. 2003). 
Age-associated defects in the output of the GC response are linked with changes in T cells, B cells 
as well as the GC microenvironment (Figure 1.10) (Gustafson et al. 2018; Linterman 2014; 
Nikolich-Žugich 2018). Yang et al. used adoptive transfers of aged B cells into young hosts to 
demonstrate that B cells from aged mice are fully capable of forming GCs in a young environment, 
but their rate of SHM is reduced (Yang et al. 1996). In contrast, adoptive transfers of T cells from 
aged animals into a young environment, resulted in the formation of smaller GCs with reduced 
antibody output (Eaton et al. 2004). This suggests that, while B cells from aged mice are impaired 
in SHM, the age-associated decline in the magnitude of the GC response is mainly driven by defects 
in the T cell compartment. Increasing the naïve T cell output from the thymus, however, is not 
sufficient to rescue the ageing GC phenotype (Lefebvre et al. 2012). What is more, young T cells 
transferred into aged hosts prior to immunisation form fewer Tfh cells than in young hosts, 
suggesting that T cell priming by DCs is impaired in old age (Lefebvre et al. 2012).  
DCs from aged host have a defect in phagocytosis and express lower levels of co-stimulatory 
molecules (Agrawal et al. 2007),(Moretto et al. 2008). In addition, Tfh-mediated B cell help was 
also shown to be impaired in advanced age. Sage et al. observed higher numbers of Tfh in aged 
mice compared to young mice, but these cells seem to be less able to provide B cell help (Sage et 
al. 2015). B cell help from memory Tfh cells during recall responses is also impaired in aged 
individuals (Yu et al. 2012). This is linked with the reduced expression of the important co-
stimulatory molecules ICOS and CD40L on the surface of aged T cells, combined with increased 
levels of co-inhibitory PD-1 (Sage et al. 2015). What is more, Sage et al. observed a relative 
increase of suppressive Tfr cells over Tfh cells in the LNs of aged mice (Sage et al. 2015). Like Tfh 
cells, aged Tfr cells expressed increased levels of PD-1 and lower levels of ICOS and Foxp3, but 
this did not affect their suppressive capacities. Thus, reduced GC responses are linked with reduced 
B cell help from Tfh cells in the context of increased suppression by Tfr cells (Sage et al. 2015). 
There are many efforts to enhance GC responses in aged individuals to improve immune responses 
to infections and vaccinations in the ageing population. Modifications of the vaccine adjuvant 
(Frech et al. 2005) or administration of increased antigen doses (Remarque et al. 1993) were shown 
to improve vaccination responses in older subjects. This suggests that the age-related defect in the 
GC response is not irreversible, and can be targeted therapeutically to improve immune protection 
in older individuals. 
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Our study investigated whether T cell priming by DCs in aged individuals could be improved to 
enhance GC responses. This led to the discovery of a novel link between reduced co-stimulation by 
cDC2s in aged mice with defective IFN signalling in the same cells. By enhancing type I IFN 
signalling at the site of immunisation, we were able to restore CD80 and CD86 expression levels 
on cDC2s and improved the formation of Tfh cells in aged animals. This confirms that age-
associated defects in the GC response are not irreversible and that DCs are a potent target to improve 
vaccine responses in the ageing population. 
 
Figure 1.10: Schematic overview of age-associated changes in the germinal centre (GC) 
response. Upon infection or immunisation, naïve CD4 T cells (Na) are recruited from the blood 
into secondary lymphoid organs (SLOs), where they interact with antigen-presenting dendritic cells 
(DCs). Here, DCs prime naïve CD4 T cells to differentiate into pre T follicular helper (Tfh; pTFH) 
cells which migrate towards the B-cell follicle. These pre-Tfh cells interact with activated B cells 
to differentiate into mature Tfh (TFH) cells which migrate into the GC. Interactions between Tfh 
cells and GC B cells during the GC response facilitate the generation of long-lived high affinity 
antigen-producing plasma cells as well as the release of Tfh cells (*TFH) from the SLOs back into 
the blood. The GC response is negatively controlled by T follicular regulatory (Tfr; TFR) cells. 
During ageing, the GC response is affected in many ways: firstly, fewer naïve CD4 T cells are 
available to seed the GC. Secondly, Tfh cell priming by DCs and B cells is impaired and there is a 
relative increase in inhibitory Tfr cells. Thirdly, Tfh cells recruited from the circulation during recall 
responses seem to have a reduced capacity for B cells help in aged individuals. Together, this results 
in the reduced production of antigen-specific antibodies. This image was taken from Gustafson et 
al. 2018, © 2018 (Gustafson et al. 2018). 
Figure 11: Schematic overview of age-associated changes in the germinal
centre (GC) response. Upon infection of immunisation, naïve CD4 T cells (Na) are
recruited from the blood into secondary lymphoid organs (SLOs), where they interact
with antigen-presenting dendritic cells (DCs). Here, DCs prime naïve CD4 T cells to
differentiate into pre T follicular helper (Tfh; pTFH) cells which migrate towards the B-
cell follicle. These preTfh cells interact with activated B cells to differentiate into
mature Tfh (TFH) cells which migrate into the GC. Interactions between Tfh cells and
GC B cells during the GC response facilitate the generation of long-lived igh affinity
antigen-producing plasma cells as well as the release of memory Tfh cells (*TFH)
from the SLOs back into the blood. The GC response is negativ ly controlled by T
follicular regulatory (Tfr; TFR) cells. During ageing, the GC response is affecte in
many ways: Firstly, fewer naïve CD4 T cells are availabl to seed the GC. Secondly,
Tfh cell priming by DCs and B cells is impaired and there is a relative increase in
inhibitory Tfr cells. Thirdly, memory Tfh cells in aged individuals seem to have a
reduced capacity for B cells help during recall responses. Together, this results in the
reduced production of antigen-specific antibodies. Image modified from Gustafson et
al. 2018 [176].
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1.7 The immune system and the endoplasmic reticulum 
(ER) stress response pathway 
Immune cell differentiation and effector functions can be influenced by environmental cues such as 
local metabolite availability (Kominsky et al. 2010), salt concentrations (Kleinewietfeld et al. 2013; 
Wu et al. 2013) and low oxygen pressure (McNamee et al. 2013). All of these conditions are potent 
inducers of the ER stress response pathway and often occur at sites of active immune responses, 
e.g. sites of inflammation or in GCs. This results in a strong association between immune cell 
function and the ER stress response (Bettigole & Glimcher 2015).  
1.7.1 The ER stress response 
The ER is a large organelle integrating many essential cellular functions: this is where lipids and 
proteins are synthesised and folded and where intracellular Ca2+ is stored (Bettigole & Glimcher 
2015). These functions are closely interlinked, with perturbations in one adversely affecting the 
others, triggering a powerful stress response known as the unfolded protein response (UPR) or ER 
stress response (Bettigole & Glimcher 2015). The ER stress response is initiated upon protein 
misfolding and intersects with many other stress or inflammatory signalling pathways (Hotamisligil 
2010). It consists of three individual branches which act in a coordinated manner and depend on the 
activation of three different ER transmembrane effector proteins: inositol requiring enzyme 1 
(IRE1), PKR-like ER kinase (PERK), and the activating transcription factor-6 (ATF-6) (see Figure 
1.11) (So 2018; Todd et al. 2008).  
Under steady-state conditions, IRE1, PERK and ATF-6 all interact closely with the ER-resident 
HSP70-type chaperone BiP (also known as Hspa5 or GRP78) which inhibits their activation. BiP 
has high affinity for unfolded proteins, so when unfolded proteins accumulate in the ER, BiP is 
titrated away from IRE1, PERK and ATF-6, allowing the full UPR to ensue (Bettigole & Glimcher 
2015). The IRE1 signalling axis is the most evolutionary conserved of all ER stress response 
pathways, leading to the expression of the transcription factor X-box binding protein 1(XBP1), 
which induces many ER stress-mediated gene expression changes (Bettigole & Glimcher 2015). 
PERK, when activated, induces phosphorylation of the eukaryotic translation-initiation factor 2 
(EIF2). Phosphorylated EIF2 loses its activity as initiator of mRNA translation, thereby arresting 
most mRNA translation. At the same time, EIF2 phosphorylation results in increased expression 
levels of the transcription factor ATF-4 which binds to UPR-regulated elements (UPREs) in the 
promoter-region of ER stress-associated genes (Todd et al. 2008). ATF-6 is usually retained in the 
ER membrane, but upon ER stress, its cytoplasmic ATF-6 fragment is released to act as a 
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transcription factor (see Figure 1.11). Together, these three pathways induce global changes in gene 
expression, protein translation, protein folding and degradation.  
1.7.2 The impact of ER stress on immune responses 
Historically, the UPR has been studied as a stress response to protein misfolding, but it also 
modulates immune cell development and inflammatory signalling (So 2018). Iwakoshi et al. 
demonstrated that Xbp-1 expression is important for the development and survival of pDCs and 
cDCs (Iwakoshi et al. 2007). In plasma cells, antibody production is dependent on the expression 
of the ER stress-induced transcription factor Xbp-1 (Shaffer et al. 2004). Studies on T cells revealed 
that antigenic stimulation of the TCR induces ER stress. The ensuing ER stress response is 
important to shape T cell effector functions, e.g. by enhancing Th2 cell differentiation or increasing 
the production of pro-inflammatory cytokines such as IFN-g and TNF-a (Kamimura & Bevan 2008; 
Scheu et al. 2006; Thaxton et al. 2017; Wheeler et al. 2008). Likewise, the ER stress response 
enhances the secretion of pro-inflammatory cytokines, such as IL-23, IL-6, TNF-a and type I IFNs, 
by both DCs and macrophages (Bettigole & Glimcher 2015; Hu et al. 2011; Martinon et al. 2010; 
Smith et al. 2008). This could be mediated by NF-κB signalling, as all 3 UPR branches induce NF-
κB activation either by reducing the translation or causing the degradation of the NF-κB repressor 
IκB (Garg et al. 2012). This allows NF-κB to translocate into the nucleus, where it drives the 
expression of many pro-inflammatory cytokines and other immune-modulatory proteins.  
Taken together, this demonstrates that there is a strong bidirectional cross-talk between the immune 
system and the ER stress response. This allows immune cells to quickly adapt their effector 
functions to changes in their local microenvironment, such as shifts in nutrient availability or local 
oxygen levels.  
Sites of inflammation in many autoimmune disorders are often characterised by low oxygen and 
nutrient availability – conditions that trigger ER stress responses (Morito & Nagata 2012; Zhang & 
Kaufman 2008). These sites also often contain pathogenic Th17 cells (Tesmer et al. 2008). This 
raises the question, whether the ER stress response could be a driver of Th17 cell differentiation 
and pathogenicity? In this thesis, I demonstrate that ER stress drives the generation of Th17 cells, 
whose gene expression signature strongly resembles previously-described Th17 cells with a highly 
pathogenic gene signature (Lee et al. 2012). 
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Figure 1.11: Schematic overview of the ER stress response. The ER stress response consists of 
three individual branches which depend on the activation of three different ER transmembrane 
proteins: inositol requiring enzyme 1 (IRE1), PKR-like ER kinase (PERK), and the activating 
transcription factor-6 (ATF-6). Together, these proteins induce global changes in gene expression 
and protein homeostasis. Under steady-state conditions, the ER-resident chaperone BiP inhibits 
their activation. When misfolded proteins accumulate in the ER, BiP is titrated away from IRE1, 
PERK and ATF-6, allowing the unfolded protein response (UPR) to ensue. Activated IRE1 
catalyses an unconventional splicing reaction of Xbp1 which yields the highly active transcription 
factor XBP1S. Activated PERK phosphorylates the eukaryotic translation-initiation factor 2 (EIF2), 
which consequently loses its activity as initiator of mRNA translation, thereby arresting most 
mRNA translation. EIF2 phosphorylation also results in increased expression levels of the 
transcription factor ATF-4 which binds to UPR-regulated elements (UPREs) in the promoter-region 
of ER stress-associated genes. Once BiP releases ATF-6, this transcription factor translocates into 
the nucleus, where it activates gene transcription at ER-stress response elements (ERSEs). This 
image was reprinted from Todd et al. 2008 with permission from Springer Nature © 2008 (Todd et 
al. 2008). 
  
Figure 10: Schematic overview of the ER stress response pathway. The ER
stress response consists of three individual branches which depend on the activation
of three different ER transmembrane proteins: inositol requiring enzyme 1 (IRE1),
PKR-like ER kinase (PERK), and the activating transcription factor-6 (ATF-6).
Together, these proteins induce global changes in gene expression and protein
homeostasis. Under steady-state conditions, the ER-resident chaperone BiP inhibits
their activation. When misfolded proteins accumulate in the ER, however, BiP is
titrated away from IRE1, PERK and ATF-6, allowing the unfolded protein response
(UPR) to unfold. Activated IRE1 catalyses an unconventional splicing reaction f
Xbp1 which yields the highly ac ve transcription factor XBP1S. Activated PERK
phosph ryl tes the eukaryotic translation-initiatio factor 2 (EIF2), which
consequently loses its activity as initiator of mRNA translation, thereby a re ting most
mRNA translation. EIF2 phosphorylation also results in increas d expression levels
of the transcription factor ATF-4 which binds to UPR-regulated elements (UPREs) in
the promoter-region of ER stress-associated genes. Once BiP releases ATF-6, this
transcription factor translocates into the nucleus, where it activates gene
transcription at ER-stress response elements (ERSEs).The image was modified from
Todd et al. 2008 [157].
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1.8 Aim & Objectives 
During an ongoing immune response, immune cells incorporate information about their 
microenvironment to adapt their differentiation pathways and effector functions accordingly. This 
is achieved by the integration of inflammatory signalling with the ER stress response pathway, 
which is triggered by a variety of environmental stresses such as low nutrient availability, hypoxia 
and mechanical stress (Bettigole & Glimcher 2015). The first part of this report focusses on how 
Th17 cell differentiation and pathogenicity is affected by ER stress. I demonstrate that ER stress 
drives the generation of Th17 cells with a pathogenic gene signature even in the absence of TGFb. 
As a result, these cells cause Th17 cell-associated symptoms in experimental-autoimmune 
encephalitis (EAE) experiments, a mouse model of multiple sclerosis (MS). This suggests a 
potential link between ER stress and Th17 cell-mediated autoimmune pathology.  
In the second part of this thesis, I investigated whether age-associated defects in the GC response 
could be linked with changes in its microenvironment. PPs always contain active GCs due to 
constant stimulation from the gut microbiota. These GCs are an important source of IgA antibodies, 
which have been suggested to help control the composition of the gut microbiome (Macpherson et 
al. 2012). I observed reduced GC B cells in the PPs of aged mice, which were correlated with 
distinct age-associated changes in the composition of their gut microbiota. Faecal microbiota 
transplantation from adult into aged mice was able to reverse these ageing-related defects. These 
data reveal that the gut microbiota is a potent stimulator of GCs in PPs and that the age-dependent 
decline in the GC response can be reversed by changes in the microbiota.  
Whether the microbiota boosts the GC reactions by acting directly on adaptive immune cells or on 
other cells in their environment, such as APCs, is not clear. There is strong evidence that the 
defective GC reaction in peripheral LNs of aged animals is partly due to impaired T cell priming 
by DCs (Linterman 2014). We observed impaired T cell priming in aged mice, which was correlated 
with reduced type I interferon signalling in cDC2 cells upon immunisation. By boosting type I 
interferon signalling in DCs at the time of immunisation, Tfh cell differentiation in peripheral LNs 
of aged mice was enhanced. This shows that not only the gut microbiota, but also DCs can be 
targeted to improve GC responses in aged mice and highlights the importance of environmental 
stimuli in shaping adaptive immunity
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 MATERIAL AND METHODS 
 Animal work 
All mice listed in Table 2.1 were bred and maintained in the Babraham Institute Biological Support 
Unit (BSU), where BALB/c and C57BL/6Babr mice were also aged. No primary pathogens or 
additional agents listed in the FELASA recommendations (FELASA working group et al. 2014) 
were detected during health monitoring surveys of the stock holding rooms. Ambient temperature 
was ~19-21˚C and relative humidity 52 %. Lighting was provided on a 12 hour light: 12 hour dark 
cycle including 15 minute ‘dawn’ and ‘dusk’ periods of subdued lighting. After weaning, mice were 
transferred to individually ventilated cages with 1-5 mice per cage. Mice were fed CRM (P) VP diet 
(Special Diet Services) ad libitum and received seeds (e.g. sunflower, millet) at the time of cage-
cleaning as part of their environmental enrichment. All mouse experimentation was approved by 
the Babraham Institute Animal Welfare and Ethical Review Body. Animal husbandry and 
experimentation complied with existing European Union and United Kingdom Home Office 
legislation and local standards. Young mice were 6-14 weeks old, and aged C57BL/6 and BALB/c 
mice 90-105 weeks old at the time of starting an experiment. All experimental mice were housed 
in the same room. To control for changes in the microbiome due to circadian rhythm, faecal 
microbiota transplantation (FMT) and faecal pellet collections were always performed at 10am and 
3pm, respectively. Due to limited availability of aged male BALB/c mice, all BALB/c experiments 
were conducted with females. For all other strains, experiments were conducted with both male and 
female mice.  
 Co-housing of adult and aged mice 
2-3 adult females were consolidated with 2-3 aged females per cage, with a maximum of five mice 
per cage. After 30-40 days of co-housing, Peyer’s patches (PPs), mesenteric lymph nodes (mLNs) 
and faecal bacteria were harvested for flow cytometric analysis. Blood samples were obtained by 
cardiac puncture and spun at 13,000 rpm for 15 minutes at room temperature. The serum 
supernatants were collected and stored at -20˚C for enzyme-linked immunosorbent assays (ELISAs). 
Faecal supernatants from the contents of the colon and ileum were weighed and incubated for 10 
minutes on ice in 12-14 µl sterile-filtered phosphate-buffered saline (PBS) per mg of faeces (70-
85 mg/ml faecal input). The samples were then vortexed for 1 minute and spun at 500 g at 4˚C for 
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5 minutes to pellet bigger particles. 80-100 µl of the supernatant containing faecal bacteria was 
transferred to a fresh tube, topped up with PBS to reach a total volume of 1 ml and spun at 10,000 g 
at 4˚C for 5 minutes to pellet bacteria. The supernatants containing free IgA (at a final concentration 
of 5-8.5 mg/ml faecal input) were harvested and stored at -20˚C, while bacterial pellets were stained 
for flow cytometry as described below. Faecal pellets were collected from all mice before co-
housing and at the end of the experiment and stored at -80˚C for 16S rDNA sequencing.  
Name Strain ID Source Ref. 
C57BL/6 C57BL/6Babr JAX/BBU*  
BALB/c BALB/c Charles Rivers/BBU*  
Il17acre Il17atm1.1(icre)Stck B. Stockinger (Hirota et al. 2011) 
Rosastop-YFP Gt(ROSA)26Sortm1(EYFP)Cos JAX (Srinivas et al. 2001) 
Rosastop-tdRFP Gt(ROSA)26Sortm1Hjf JAX (Luche et al. 2007) 
Ragcre Rag1tm1(cre)Thr JAX/ BBU* (McCormack et al. 2003) 
Xbp1fl Xbp1tm2Glm  L. Glimcher/A. Kaser (Hetz et al. 2008) 
2D2 TCR Tg(Tcra2D2)1Kuch JAX (Bettelli et al. 2003) 
Cd4cre Tg(Cd4-cre)1Cwi JAX (Lee et al. 2001) 
Bcl6fl Bcl6tm1.1Dent A. Dent (Hollister et al. 2013) 
Ifnar1ko Ifnar1tm2a(EUCOMM)Wtsi U. Kalinke (Skarnes et al. 2011) 
Ifnar1cre Ifnar1tm1Uka U. Kalinke (Le Bon et al. 2006) 
Cd11ccre B6.Cg-Tg(Itgax-cre)1-1Reiz/J R. Roychoudhuri (Caton et al. 2007) 
OTII TCR (TCR)OT2 K. Okkenhaug (Barnden et al. 1998) 
TCR7 TCR Tg(TcraBO4H9.1)7Aog A. O’Garra (Neighbors et al. 2006) 
UbiquitinGFP Tg(UBC-GFP)30Scha/J M. Turner (Schaefer et al. 2001) 
H2+/- B6.129S2-H2dlAb1-Ea/J A. Liston (Madsen et al. 1999) 
Table 2.1: List of mouse strains. *BBU=Babraham Breeding Unit 
 Faecal microbiota transplantation (FMT) 
FMT was achieved by oral gavage of faecal slurry. For this, recipient mice were starved for 2 hours 
prior to FMT. The faecal slurry was obtained by pooling faecal pellets from up to 14 donor mice. 
The pellets were weighed and resuspended by vortexing at full speed for 1 minute in 1 ml PBS per 
300 mg of faeces. After pelleting larger particles by centrifugation at 500 g for 5 minutes, the 
supernatant was collected as faecal slurry for FMT. Each recipient mouse received 150µl of faecal 
slurry by oral gavage no more than 1 hour after the initial collection of faecal pellets from donor 
mice. The remaining slurry was stored at -80oC for 16S rDNA sequencing. Following FMT, the 
cages of recipient mice were replenished with dirty bedding and fresh faecal pellets from donor 
mice once and twice a week respectively. Faecal pellets for 16S rDNA sequencing were collected 
the day before FMT and at the end of the experiment, and were stored at -80˚C for DNA extraction. 
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Three weeks after FMT, PPs, mLNs and faecal bacteria were harvested for flow cytometric analysis, 
while bloods and faecal supernatants from the ileum and colon were collected for ELISAs. Blood 
samples were obtained by cardiac puncture and spun at 13,000 rpm for 15 minutes at room 
temperature. The serum supernatants were collected and stored at -20˚C for ELISAs. Faecal 
supernatants from the contents of the colon and ileum were weighed and incubated for 10 minutes 
on ice in 12-14 µl sterile-filtered PBS per mg of faeces (70-85 mg/ml faecal input). The samples 
were then vortexed for 1 minute and spun at 500 g at 4˚C for 5 minutes to pellet bigger particles. 
80-100 µl of the supernatant containing faecal bacteria was transferred to a fresh tube, topped up 
with PBS to reach a total volume of 1 ml and spun at 10,000 g at 4˚C for 5 minutes to pellet bacteria. 
The supernatant containing free IgA (at a final concentration of 5-8.5 mg/ml faecal input) was 
harvested and stored at -20˚C, while the bacterial pellet was stained for flow cytometry as described 
below. 
 Oral immunisations  
For oral immunisations mice were starved for 2 hours prior to administration of antigen. They were 
then orally gavaged with 200 µl PBS containing 37.5 µg/ml cholera toxin (CTx, Sigma #C8052) 
plus 37.5 µg/ml NP-CTx or, in the case of Bcl6fl/flCd4cre/+ mice and their littermate controls, 
50 µg/ml CTx plus 5mg/ml ovalbumin (Albumin from chicken egg white, Sigma #SLBQ9036V). 
NP-CTx was generated in-house as described below. Oral immunisations were performed three 
times on day 0, 7, and 14. Control groups were gavaged with PBS only. On day 21, PPs, mLNs, 
blood and faecal contents were harvested. In cases where oral immunisations were combined with 
FMT, oral immunisations with NP-CTx/CTx were conducted on day 2, day 8 and day 15 after FMT 
before mice were harvested on day 22. PPs, mLNs and faecal bacteria were harvested for flow 
cytometric analysis, while bloods and faecal supernatants from the ileum and colon were collected 
for ELISAs. Blood samples were obtained by cardiac puncture and spun at 13,000 rpm for 15 
minutes at room temperature. The serum supernatants were collected and stored at -20˚C for 
ELISAs. Faecal contents from the colon and ileum were weighed and incubated for 10 minutes on 
ice in 5 ml sterile-filtered PBS per g of faeces (200 mg/ml faecal input). The samples were then 
vortexed for 1 minute and spun at 10,000 g at 4˚C for 10 minutes to pellet bacteria and debris. The 
supernatant containing free IgA was harvested and stored at -20˚C. 
 Subcutaneous immunisations  
Mice were immunized with NP-KLH (4-Hydroxy-3-nitrophenylacetyl-Keyhole Limpet 
Hemocyanin), NP-1W1K, OVA (ovalbumin) or HEL (Hen Egg Lysozyme) in Alum or Ea-GFP in 
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Incomplete Freund Adjuvant (IFA). IFA (#F5506) and HEL (Lysozyme from chicken egg white, 
#62970) and OVA (Albumin from chicken egg white; #A5503) were purchased from Sigma-
Aldrich, Imject Alum (#77161) was purchased from Thermo Fisher Scientific and NP-KLH was 
purchased from Biosearch Technologies (#N-5060-25). Ea-GFP fusion protein was produced in-
house by Wim Pierson from XL-1 blue E.coli carrying the pTRCHis-Eα-GFP vector as described 
by Rush and Brewer (Rush & Brewer 2010). NP-1W1K was generated from NP-e-Aminocaproyl-
OSu (Biosearch Technologies, #N-1021-100), which was conjugated to Streptavidin by Jonathan 
Clark from the Babraham Institute Biological Chemistry facility, and biotinylated 1W1K peptide 
(custom-made by Cambridge Research Biochemicals “biotin-GSGEA-W-GALANKA-V-DKA-
acid”). These compounds were conjugated at a 1:6 ratio of NP-SA to 1W1K-biotin in 400 µl PBS 
for 1 hour at room temperature. Unbound peptide was then removed by two consecutive rounds of 
dialysis using Centriprep® centrifugal filters with an Ultracel® 10K membrane (Sigma #4304) by 
spinning at 13,000 rpm for 6 minutes at room temperature. NP-1W1K was freshly conjugated for 
each experiment. Purified NP-1W1K, NP-KLH, OVA and HEL were first diluted in PBS, then the 
same volume of Alum was added dropwise to the solution while shaking until a final concentration 
of 50 µg/ml HEL, 500 µg/ml OVA, 500 µg/ml NP-KLH or 330-500 µg/ml NP-1W1K was reached. 
After 30 minutes of vortexing, 100 µl of the emulsion were injected subcutaneously (s.c.) into the 
hind flanks of recipient mice. 1 mg/ml Ea-GFP was emulsified in IFA by trituration through a 20 g 
needle. 200 µl of this emulsion were injected subcutaneously into the hind flanks of recipient mice. 
Mice were euthanised at different time points after immunisation, as indicated in the main text or 
figure legends, when bloods and draining inguinal LNs were collected. Blood samples were 
obtained by cardiac puncture and spun at 13,000 rpm for 15 minutes at room temperature. The 
serum supernatants were collected and stored at -20˚C for ELISAs. 
In some cases, mice were treated with IFNAR1 blocking antibodies (BioXCell #BE0241), CTLA4-
Ig (Orencia® Abatacept) or Aldara cream containing 5 % imiquimod (MEDA Pharma) prior to, or 
at the time of immunisation. IFNAR1 blocking was achieved by intraperitoneal injection of 0.75 mg 
of anti-IFNAR1 blocking antibody or the appropriate isotype control (BioXCell #BE0083) in 200 µl 
PBS 20 hours before immunisation with Ea-GFP. To block CD28 co-stimulation, 500 µg of 
Abatacept were injected intraperitoneally right before immunisations with HEL in Alum. For 
Aldara treatment, mice were shaved on their backs 2-3 days before subcutaneous immunisations 
into their hind flanks. Directly after immunisation, 50-125 mg of Aldara were applied topically to 
the shaved backs of the anaesthetised animals. The cream was left to absorb for five minutes before 
the mice were returned to their cages. Aldara-treated and untreated control mice were housed in 
separate cages to avoid cross-contamination by grooming. 
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 NP-CTx conjugation and quality control 
NP-CTx was generated by conjugating NP-e-Aminocaproyl-OSu (Biosearch Technologies #N-
1021-100) with CTx (Sigma #C8052) following a protocol adapted from N. Lycke by A. Iseppon 
and B. Stockinger (Bergqvist et al. 2013). First, 2 mg/ml CTx was dialyzed in distilled water for 
two days at 4˚C in a Slide-A-Lyzer Dialysis Cassette (0.5-3 ml size with a 10K cut-off; Thermo 
Fisher Scientific #66380) before mixing it with an equal volume of 0.1 M NaHCO3 and 20 
equivalents of 10 mg/ml NP-eA-OSu per mole CTx. The mixture was incubated overnight at 4˚C 
during constant rotation and then transferred into a fresh Slide-A-Lyzer dialysis cassette. The 
mixture was dialyzed twice against 0.05 M NaHCO3 followed by PBS. The final protein 
concentration was determined using a BCA assay (Thermo Fisher Scientific #23227). 0.5 mg/ml 
aliquots of NP-CTx were stored at -80˚C until use. 
 
The NP-CTx conjugation ratio was assessed by ELISA. For this, ELISA plates (Thermo Fisher 
Scientific 96F Maxisorp #456537) were coated with 2.5 µg/ml NP-CTx or NP conjugated to bovine 
serum albumin (BSA) in varying conjugation ratios (NP(2)-BSA, NP(7)-BSA and NP(20)-BSA; 
Biosearch Technologies #N-5050L-H) and incubated at 4˚C overnight. The next day, plates were 
washed 4 times in 0.05 % Tween 20 (Sigma #P1379) in PBS wash buffer and blocked with 
1 % BSA in PBS for 1 hour at room temperature. After an additional wash step, serum from a NP-
KLH-immunised mouse was loaded onto the plates at a starting dilution of 1:200 in 1 % BSA/PBS. 
This initial dilution was titrated down the plate at a 1:4 ratio. The plates were incubated for 2 hours 
at room temperature and after another wash step, the plates were incubated with 50 µl of polyclonal 
goat anti-mouse IgG1 HRP-conjugated antibodies (Abcam #ab97240; diluted 1:10,000 in PBS) for 
2 hours at room temperature. After a last wash step the plates were developed with 100 µl/well 
TMB (3, 3', 5, 5' – Tetramethylbenzidine; Biolegend #421101) for up to 20 minutes, when the 
reaction was stopped with 50 µl/well 0.5 M H2SO4. A PHERAstar FS microplate reader (BMG 
Labtech) was used to measure absorbance at 450 nm. Absorbance values from serially diluted 
samples were plotted and values which fell into the linear range of the curve were selected to 
calculate endpoint titres. The NP-CTx conjugation ratio was approximated by comparing its 
endpoint titre with the endpoint titre of NP-BSA at its different conjugation ratios.  
 Experimental autoimmune encephalitis (EAE) 
Direct EAE experiments were conducted by Marc Veldhoen and Verena Brucklacher-Waldert, who 
induced direct EAE by subcutaneous immunisations with 250 µl myelin oligodendrocyte 
glycoprotein (MOG) 35-55 peptide (ProImmune Ltd.) emulsified in Complete Freund’s Adjuvant 
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(CFA; IFA (Sigma # F5506) supplemented with 250 µl mycobacterium tuberculosis extract H37Ra 
(Difco #231141)). The animals also received intraperitoneal injections with 200 ng pertussis toxin 
(List Biological Laboratories #181) on days 0 and 2. Tauroursodeoxycholic acid (TUDCA) 
treatments were started the day prior to MOG/CFA immunisation with a 500 mg/kg dose and were 
followed with daily intraperitoneal administration at 250 mg/kg. For adoptive-transfer EAE 
experiments, 2D2 MOG-specific TCR transgenic animals were injected subcutaneously with 
250 µg MOG35–55 peptide emulsified in CFA. The animals showed no clinical signs of EAE until 
day 9, when draining lymph nodes and spleens were harvested. Single cell suspensions were re-
stimulated over a period of 4 days with 20 µg/ml MOG35–55 peptide in complete IMDM (Iscove's 
Modified Dulbecco's Media (=IMDM, Sigma #I3390) supplemented with 2 mM L-glutamine, 
100 U/ml penicillin, 100 µg/ml streptomycin, 200 µM 2-mercaptoethanol, and 5 % foetal bovine 
serum (FBS)) at 37˚C in a 7 % CO2 atmosphere. Some cultures were treated with either a 
combination of 25 ng/ml IL-6, 0.4 ng/ml TGFβ and 4 µg/ml anti–IFN-γ antibodies (conventional 
“IL6/TGFβ” Th17 condition) or 25 ng/ml IL-6 plus 2 µM cyclopiazonic acid (=CPA in “IL6/CPA” 
condition). Table 2.2 contains more information about the compounds used. On day 4, cultured 
cells were collected and washed in PBS. 1.5 ´ 107 of these MOG-reactivated cells were injected 
into sub-lethally irradiated C57BL/6 mice (exposed to 450 rad γ-irradiation) by intravenous 
injection. Classical clinical signs of EAE were assessed blindly and according to the following 
scores: 0, no signs of disease; 1, flaccid tail; 2, impaired righting reflex and/or gait; 3, partial hind 
limb paralysis; 4, total hind limb paralysis; and 5, total hind limb paralysis with partial forelimb 
paralysis. Mice were humanely killed when they started to score 5, lost more than 20 % of their 
initial weight or displayed symptoms of atypical EAE such as head tilting and ataxia. 
 T helper cell cultures 
For T cell differentiation in vitro, brachial, axial, inguinal and mesenteric LNs as well as spleens 
were isolated and processed into single cell suspensions by mashing through 70 µm filters. Viable 
lymphocytes were then separated from the remaining cells in Lympholyte-M Cell Separation 
medium (Cedarlane #CL5030) during a 15 minute centrifugation step at 1250 g. Naive CD4+ 
CD62L+ T cells were obtained using Milteny’s CD4+CD62L+ T Cell Isolation Kit II (#130-093-
227) following the manufacturer’s instructions. Cells were cultured in IMDM (Sigma #I3390) 
supplemented with 2 mM L-glutamine, 100 U/ml penicillin, 100 µg/ml streptomycin, 200 µM 2-
mercaptoethanol, and 5 % FBS. Th17, Th1 and Treg cells were differentiated in 24-well or 96-well 
plates coated with 2 µg/ml anti-CD3 and 2 or 5 µg/ml anti-CD28.  
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For conventional Th17 cell differentiation, T cells were cultured in the presence of 25 ng/ml IL-6, 
0.4 ng/ml TGFβ and 4 µg/ml anti–IFN-γ antibodies. 3 ng/ml IL-12 was used to drive Th1 cell 
differentiation. Treg cells were obtained from a combined treatment of 5 ng/ml TGFβ with 5 µg/ml 
anti–IFN-γ antibodies. To modulate the ER stress response in culture, cells were treated with: 0.5-
10 µM CPA, 1-10 µM of the pyruvate analogue BrPA (3-bromopyruvate) or 500 µM of the general 
ER-stress inhibitor TUDCA. 10 µg/ml anti-TGFβ antibodies were used to block the activity of 
endogenous TGFβ in FBS in complete cell culture medium. Compounds are listed in Table 2.2. 
Cytokines Supplier (#Catalogue number) Final concentration 
Recombinant human IL-6 PeproTech #AF-200-06 25 ng/ml 
Recombinant murine IL-12 PeproTech #210-12 
 
3 ng/ml 
Recombinant human TGFβ1 PeproTech #100-21 0.4 – 5 ng/ml 
 
ER-stress modulators 
  
CPA Sigma # C1530 0.5 – 10 µM 
TUDCA Sigma #T0266 0.05 – 2 mM 
BrPA Sigma #16490 1.0 – 10 µM 
   
Neutralising antibodies   
anti-IFN-γ BioXCell Clone XMG1.2 4 – 5 µg/ml 
anti-TGFβ BioXCell Clone 1D11.16.8 10 µg/ml 
anti-CD3 BioXCell Clone 145-2C11 2 µg/ml 
anti-CD28 BioXCell Clone 37.51 2 – 5 µg/ml 
Table 2.2: Cytokines, ER stress modulators and antibodies used for cell culture. 
 Adoptive T cell transfers 
To perform adoptive HEL- or OVA-specific T cell transfers, total lymphocytes were isolated from 
the spleen and peripheral LNs (brachial, axial, superficial cervical, inguinal and mesenteric LNs) 
of TCR7 or OTII transgenic mice, respectively. These mice also expressed ubiquitinGFP+ and/or 
CD45.1+. All cells were stained with CellTrace™ Violet Cell Proliferation Kit (Invitrogen 
#C34557; 1:1000 in PBS) for 15 minutes at 37˚C, followed by two washes with PBS containing 
2 %FBS at 1800 rpm for 5 minutes at 4˚C. The percentage of TCR-transgenic CD4+ CellTrace+ T 
cells was determined by flow cytometry, detecting TCR7 T cells using anti-TCRVb3 antibodies 
and OTII T cells with anti-TCRVa2 antibodies. An equivalent of 1-5 ´ 106 TCR7+ T cells or 5 ´ 105 
OTII T cells was transferred intravenously into C57BL/6, H2+/- or Ifnar1-/- recipient mice in 100 µl 
2 % FBS/PBS. The mice were subsequently immunized subcutaneously into their hind flanks with 
100 µl of 5 µg HEL or 50 µg OVA in Alum. Where indicated, mice were pre-treated 
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intraperitoneally with 500 µg CTLA4-Ig (Orencia® Abatacept) in 100 µl PBS at the time of T cell 
transfer to block CD86 and CD80 co-stimulation. After 2.5 days, the inguinal LNs of each recipient 
mouse were harvested and pooled. They were mashed through 70 µm filters to obtain single cells 
which were then stained for flow cytometry. Antibodies used are listed in Table 2.3. 
 Flow cytometry and Fluorescence-activated cell sorting 
(FACS)  
 Flow cytometry and FACS of in vitro differentiated T helper 
cells 
To assess cytokine production and transcription factor protein levels of in vitro differentiated T 
helper cells, cells were stimulated for 3 hours with 500 g/ml PdBU (Phorbol 12,13-dibutyrate), 
500 ng/ml ionomycin and 10 µg/ml brefeldin A (all from Sigma). Cells were stained with anti-CD4 
and anti-CD25 antibodies and a fixable viability dye (Molecular Probes’ LIVE/DEAD® Fixable 
Near-IR Dead Cell Stain #L10119), followed by fixation using the eBioscience IC Fixation Buffer 
(#00-8222-49). T cells were stained with fluorochrome-coupled anti–IL-17A or anti–IFN-γ 
antibodies. The eBioscience Foxp3/Transcription Factor Staining Buffer set (#00-5323-00) was 
used for intranuclear Foxp3 stains. Total samples were acquired on a LSRFortessa 5 (BD 
Biosciences) to determine absolute cell numbers. FACS was used to sort in vitro-differentiated 
Th17 cells obtained from Rosastop-tdRFPIl17aCre or Rosastop-eYFPIl17aCre mice. After 3 days of culture 
in 24-well plates, T cells were washed once with PBS and stained with APC-coupled anti-CD4 
antibodies and DAPI (4,6-diamidino-2-phenylindole, Molecular Probes #D1306) as a live/dead 
stain. CD4+ DAPI- cells were sorted according to their fluorescent protein (FP) expression levels 
on a BD FACSAria. FP- and FP+ T cells were collected in FBS-coated 15 ml falcon tubes, washed 
in PBS, pelleted and stored at -80˚C for RT-qPCR. Samples for RNA sequencing were stored in 
40 µl RNAlater at -80˚C. Single stained splenocytes served as compensation controls. Data were 
analysed using FlowJo v10 software (Tree Star). Antibodies are listed in Table 2.3. 
 Flow cytometry of PPs and LNs 
A single cell suspension from dissected PPs and LNs was generated by pressing the tissues through 
a 70 µm mesh in 2 %FBS in PBS. Cell numbers and viability were determined using a CASY TT 
Cell Counter (Roche). 1-3 ´ 106 cells were transferred to 96 well plates for subsequent antibody 
staining. To stain for 1W1K-specific CD4 T cells, cell suspensions were first pre-treated with 
Dasatinib (BioVision #1568-100, 1:20,000 in DMEM (Dulbecco’s modified eagle medium, Gibco 
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#41965-039) containing 10 % FBS, 100 U/ml penicillin and 100 µg/ml streptomycin) for 10 
minutes at 37˚C. Then, a PE-conjugated MHC class II tetramer containing the 1W1K peptide (NIH 
Tetramer core facility; PE-coupled “I-A(b) EAWGALANKAVDKA”) was added to each sample 
at a final concentration of 1:100 and incubated for 2 hours at room temperature. Cells were stained 
with LIVE/DEAD® Fixable Blue Dead Cell Stain (Invitrogen #L23105; diluted 1:1000 in PBS) 
and incubated with FcR block for 15 minutes (anti-mouse CD16/32; eBioscience #14-0161-82). 
Surface antibody stains and staining for NP-specific B cells with NP(30)-PE (Biosearch 
Technologies #N-5070-1) were performed for 1 hour at 4˚C in 100 µl Brilliant Stain Buffer (BD 
Biosciences #563794). For intranuclear staining, cells were fixed with the eBioscience 
Foxp3/Transcription Factor Staining Buffer (#00-5323-00). Antibody staining with anti-Foxp3, 
anti-Ki67 and anti-Bcl6 antibodies was performed for 1-2 hours at 4˚C in 1´ Permeabilization 
buffer (eBioscience #00-8333-56). Samples were acquired on a LSRFortessa (BD Biosciences) with 
stained UltraComp eBeads™ Compensation Beads (Invitrogen #01-2222-41) as compensation 
controls. Flow cytometry data were analysed using FlowJo v10 software (Tree Star). The antibodies 
used are listed in Table 2.3. 
 Flow cytometry of faecal bacteria 
To assess IgA-coating of faecal bacteria, we adapted a protocol described previously by Sidonia 
Fagarasan and Mikako Maruya (Kawamoto et al. 2014). Briefly, faecal contents from the ileum and 
colon were collected and weighed, then incubated for 10 minutes on ice in 12 µl sterile-filtered PBS 
per mg of faeces. The samples were vortexed at full speed for 1 minute and spun at 500 g at 4˚C for 
5 minutes to pellet bigger particles. The supernatant containing faecal bacteria was transferred to a 
fresh tube, washed in PBS and spun at 10,000 g at 4˚C for 5 minutes to pellet bacteria. Blocking 
was achieved in 2 % BSA in PBS for 15 minutes, followed by antibody staining of IgA-coated 
bacteria with anti-IgA and anti-Igk antibodies in 2 % BSA/PBS for 45 minutes on ice. After a wash 
step in PBS, bacteria were fixed in 4 % paraformaldehyde (PFA) for 6 hours or overnight at 4˚C. 
Then, samples were stained with DAPI (Invitrogen #D1306; 1:1000 in a staining buffer containing 
0.01 % Tween and 1 mM EDTA) for 30 minutes and AF594-coupled wheat germ agglutinin 
(=WGA; Invitrogen #W11262; 1:100 in 3M KCl solution) for 5 minutes. The samples were 
acquired at 5000 events/sec on a LSRFortessa 5 (BD Biosciences) with the side scatter (SSC) 
threshold set to 200. Single stains served as compensation controls. The antibodies used are listed 
in Table 2.3. 
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 Flow cytometry and FACS of dendritic cells  
For DC analysis, iLNs were harvested and incubated with 10 mg/ml Collagenase D (Roche 
#11088866001), and 30 U/ml DNase I (Roche #04716728001) in plain RPMI medium (Gibco 
#11875093) for 15-30 minutes at 37˚C, followed by gentle pipetting to disrupt the tissue. Cells were 
washed with PBS containing 2 % FBS, before cell numbers were determined using a CASY TT 
Cell Counter (Roche). All isolated cells were subsequently stained for flow cytometry or FACS. 
After a wash in PBS, they were stained with LIVE/DEAD® Fixable Blue Dead Cell Stain 
(Invitrogen #L23105; diluted 1:1000 in PBS) on ice for 10 minutes. After a second wash, they were 
blocked with FcR block (anti-mouse CD16/32; eBioscience #14-0161-82) for 10-15 minutes at 4˚C. 
Surface antibody stains were performed for 45-60 minutes at 4˚C in Brilliant Stain Buffer (BD 
Biosciences #563794). Samples were acquired on a LSRFortessa 5 (BD Biosciences) with stained 
UltraComp eBeads™ Compensation Beads (Invitrogen #01-2222-41) serving as compensation 
controls. Flow data were analysed using FlowJo v10 software (Tree Star). The antibodies used are 
listed in Table 2.3. 
FACS was performed with a BD FACSAria (BD Biosciences). For RT-qPCR, 800-4000 GFP+ 
CD11b+ cDC2 cells from total draining LNs were sorted into PCR tubes containing 20 µl of RLT 
lysis buffer supplied with the RNeasy Micro Kit (Qiagen #74004). For RNA sequencing, Danika 
Hill and Alexandre Bignon sorted 800 cells into PCR tubes containing 8.5 µl of 1´ lysis buffer 
provided with the SMART-Seq v4 Ultra Low Input RNA Kit for Sequencing (Clontech # 634890). 
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Antibody Supplier (Clone) Dilution 
AF647-coupled anti-mouse Foxp3  Biolegend (MF-14) 1:250 
AF647-coupled anti-mouse IL-17A Biolegend (TC11-18H10.1) 1:500 
PE-coupled anti-mouse IL-4 Biolegend (11B11) 1:200 
PB-coupled anti-mouse IFN-γ Biolegend (XMG1.2) 1:500 
APC-coupled anti-mouse CD4 Biolegend (GK1.5) 1:1000 
PE-coupled anti-mouse CD25 Biolegend (PC61) 1:200 
PE-coupled anti-mouse IL-10 Biolegend (JES5-16E3) 1:200 
PE/PE-Cy7-coupled anti-mouse Bcl6  BD Biosciences (K112-91) 1:100 
PE-Cy7-coupled anti-mouse CD95  BD Biosciences (Jo2) 1:200 
BV605-coupled anti-mouse IgG1  BD Biosciences (A85-1) 1:100 
PE-Cy7/BUV395-coupled anti-mouse CD3  BD Biosciences (145-2C11) 1:300 
PE-Cy7/BUV395-coupled anti-mouse CD19  BD Biosciences (1D3) 1:200-300 
PE-Cy7/BUV395-coupled anti-mouse B220  BD Biosciences (RA3-6B2) 1:300 
AF647-coupled anti-mouse CD64  BD Biosciences (X54-5/71) 1:200 
PE-Cf594-coupled anti-mouse CD11b  BD Biosciences (M1/70) 1:200 
BV786-coupled anti-mouse CD103  BD Biosciences (M290) 1:200 
PE/BV510-coupled anti-mouse CD86  BD Biosciences (GL1) 1:300 
APC-AF780-coupled anti-mouse PD1  eBioscience (J43) 1:200 
APC/Foxp3-coupled anti-mouse Foxp3  eBioscience (FJK-16S) 1:100-1:200 
AF488/AF700-coupled anti-mouse Ki67  eBioscience (SolA15) 1:100 
Biotin-coupled anti-mouse Gr1  eBioscience (RB6-8C5) 1:200 
eF450-coupled anti-mouse CD38  eBioscience (90) 1:400 
PerCp-Cy5.5-coupled anti-mouse CD172a  eBioscience (P84) 1:200 
eF450-coupled anti-mouse CD24  eBioscience (M1/69) 1:500 
APC-AF870-coupled anti-mouse CD11c  eBioscience (N418) 1:200 
PE-Cy5/APC-coupled anti-mouse CD80  eBioscience (16-10A1) 1:300 
PerCp-Cy5.5-coupled anti-mouse CD45.2  eBioscience (104) 1:200 
AF700-coupled anti-mouse MHC-II  eBioscience (M5/114.12.2) 1:400 
BV421-coupled anti-mouse CXCR5  Biolegend (L138D7) 1:100 
V500/PE/BV605-coupled anti-mouse CD4 Biolegend (RM4-5) 1:400-1:800 
BV510/BV785-coupled anti-mouse B220  Biolegend (RA3-6B2) 1:200-1:400 
PerCp-Cy5.5-coupled anti-mouse CD44  Biolegend (IM7) 1:200 
AF488-coupled anti-mouse GL7  Biolegend (GL7) 1:100 
BV605-coupled anti-mouse F4/80  Biolegend (BM8) 1:200 
BV650-coupled anti-mouse XCR1 BV650  Biolegend (ZET) 1:200 
PE-Cy7-coupled anti-mouse CD40 Biolegend (3/23) 1:300 
AF700-coupled anti-mouse CD45.1 Biolegend (A20) 1:200 
AF674/FITC-coupled anti-mouse IgA Southern Biotech (1040-02/-31) 1:100 
PerCp-Cy5.5-coupled anti-mouse PDCA-1  Biolegend (927) 1:100 
PE/Cy7/APC-Cy-7-coupled anti-mouse Igk  BD Biosciences (187.1) 1:100 
PE-coupled anti-mouse TCR Vb3 BD Biosciences (KJ25) 1:100 
APC-coupled anti-mouse TCR Va2 eBioscience (B20.1) 1:100 
APC/PE/BV421/BV510-coupled Streptavidin  Biolegend, eBioscience 1:600 
Biotin-coupled anti-mouse Ea 52-68 peptide  eBioscience (eBioY-Ae) 1:200 
NP(30)-PE  Biosearch Tech. (N-5070-1) 1:200 
PE-coupled 1W1K-IAb tetramer NIH Tetramer core facility 1:100 
Table 2.3: Antibodies and conjugated probes used for flow cytometry and FACS 
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 Confocal imaging of germinal centres 
Draining inguinal LNs or PPs were fixed in periodate-lysine-paraformaldehyde (PLP) containing 
1 % (v/v) PFA (Sigma #P6148), 0.075 M L-Lysine (Sigma #L5501), 0.37 M Na3PO4 (pH 7.4) 
(Sigma #342483) and 0.01 M NaIO4 (Sigma #210048), for 4 hours at 4˚C. After fixation, the 
samples were dehydrated in 30 % sucrose (Sigma #S0389) overnight, embedded in Optimum 
Cutting Temperature (OCT) medium (VWR #25608-930) on dry ice and stored at -80˚C. The frozen 
tissues were cut into 10 µm sections using a cryostat (Leica Biosystems) at -20˚C and again stored 
at -80 °C. For antibody stains, the slides were first air-dried and then hydrated in 0.5 % Tween 20 
in PBS (PBS-T). Slides were blocked in 200 µl blocking buffer (PBS containing 2 % BSA and 10 % 
goat serum), then permeabilised with 200 µl PBS containing 2 % Triton X (Sigma #X100). After 
three wash steps in PBS-T, the slides were incubated with 200 µl of a primary antibody mix in PBS-
T containing 1 % BSA at 4˚C overnight. Sections were stained with eF450-conjugated rat anti-
mouse Foxp3 (clone FJK16S, Thermo Fisher Scientific; 1:50), hamster anti-mouse CD3ε (clone 
500A2, Thermo Fisher Scientific; 1:200), rabbit anti-mouse Ki67 (#15580, Abcam; 1:100) and 
AF647-conjugated rat anti-mouse IgD (clone 11-26c.2a, Biolegend; 1:100). The next day, the slides 
were washed in PBS-T three times, then they were incubated with secondary antibodies in 200 µl 
PBS-T containing 2 % goat serum for 2 hours at room temperature. The secondary antibodies used 
were AF568-conjugated goat anti-hamster IgG (#A-21112, Life Technologies; 1:500) and AF488-
conjugated goat anti-rabbit (#150077, Abcam; 1:400). Hydromount mounting medium (National 
diagnostics #HS-106) was used to mount slides and coverslips were gently placed on top of the 
slides to avoid the formation of air bubbles. Slides were dried overnight for the mounting medium 
to set. Images were acquired using a Zeiss 780 microscope using 10´, 20´ and 40´ objectives. 
Image analysis was performed using ImageJ.  
 Enzyme-linked immunosorbent assay (ELISA)  
 Quantitation of antigen-specific immunoglobulins 
ELISA plates (Thermo Fisher Scientific 96F Maxisorp #456537) were coated overnight at 4˚C with 
10 µg/ml NP20-BSA (Biosearch Technologies #N-5050H-100), 2.5 µg/ml NP2-BSA (Biosearch 
Technologies #N-5050L-100) or 1 µg/ml CTx in PBS. The next day, plates were washed 4 times in 
wash buffer containing 0.05 % Tween 20 in PBS and blocked with 1 % BSA in PBS for 1 hour at 
room temperature. After an additional wash step, sera or free IgA-containing ileal supernatants from 
oral immunisation experiments were loaded onto the plates. The starting dilution for sera was 1:100-
200 in 1 % BSA/PBS, ileal supernatants were loaded at 10-20 mg/ml faecal input (1:5-10 dilution 
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of frozen supernatants) in 1 % BSA/PBS. This initial dilution was titrated down the plate at a 1:4 
ratio. The pooled serum/ileal supernatants of previously immunised mice served as positive controls, 
the serum/ileal supernatant of unimmunized mice as negative controls on each ELISA plate. The 
plates were incubated for 2 hours at room temperature and after another wash step the plates were 
incubated with 50 µl of polyclonal goat anti-mouse IgG1 HRP-conjugated antibodies (Abcam 
#ab97240; 1:10,000 in PBS) or polyclonal goat anti-mouse IgA HRP-conjugated antibodies (Bethyl 
#A90-103P; 1:25,000 in PBS) for 2 hours at room temperature. After a last wash step, the plates 
were developed with 100 µl/well TMB (Biolegend #421101) for up to 20 minutes, when the 
reaction was stopped with 50 µl/well 0.5M H2SO4. A PHERAstar FS microplate reader (BMG 
Labtech) was used to measure absorption at 450 nm. Absorbance values from serially diluted 
samples were plotted and values which fell into the linear range of the curve were selected to 
calculate endpoint titres. 
 Quantitation of total free IgA 
ELISA plates (Thermo Fisher Scientific 96F Maxisorp #456537) were coated overnight at 4˚C with 
1 µg/ml goat anti-mouse IgA (Bethyl Mouse IgA ELISA Quantitation Set #E90-103). The next day, 
plates were washed 4 times in wash buffer containing 0.05 % Tween 20 in PBS and blocked with 
1 % BSA in PBS for 1 hour at room temperature. After an additional wash step, free IgA-containing 
faecal supernatants were loaded onto the plates in duplicates. The starting concentration was 0.1-
0.5 mg/ml for ileal supernatants and 5-8.5 mg/ml for colonic supernatants. The plates were 
incubated for 2 hours at room temperature. After another wash step, the plates were incubated with 
50 µl of polyclonal goat anti-mouse IgA HRP-conjugated antibodies (Bethyl #A90-103P) for 2 
hours at room temperature. After a final wash step, the plates were developed with 100 µl/well 
TMB (Biolegend #421101) for up to 20 minutes, when the reaction was stopped with 50 µl/well 
0.5 M H2SO4. A PHERAstar FS microplate reader (BMG Labtech) was used to measure absorbance 
at 450 nm. A standard dilution of mouse reference serum (Bethyl Mouse IgA ELISA Quantitation 
Set #E90-103) was used for the quantitation of free IgA in faecal supernatants using a 4-parameter-
fitted curve within the MARS data analysis software (BMG Labtech).  
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 Real-Time qPCR (RT-qPCR) 
 RNA isolation & cDNA synthesis from in vitro differentiated 
T cells and ex vivo cells 
RNA isolation from in vitro differentiated Th17 cells and ex vivo isolated cells was performed using 
Qiagen’s RNeasy Mini or Micro Kit (#74104 and #74004) following the manufacturer’s 
instructions. Homogenisation of the samples achieved by vortexing for 1 minute or by using 
QIAshredders (Qiagen #79654). RNA concentrations obtained from the RNA isolation were 
measured using the NanoDrop system (Thermo Fisher Scientific). RNA samples were used for 
cDNA synthesis right away or stored at -80˚C. cDNA was synthesised from 100-1000 ng RNA 
using a combination of oligo-dT and random primers using Qiagen’s cDNA synthesis kit containing 
Quantitect Reverse Transcriptase (#205311) following the manufacturer’s instructions. cDNA 
samples were diluted 1:10 in DNase-free water for RT-qPCR and stored at -20˚C. 
 RNA isolation from lymph nodes 
RNA isolation from whole inguinal LNs was achieved using Tri Reagent (Invitrogen #AM9738). 
Inguinal LNs were stored in RNAlater (Sigma #R0901) at -20˚C until RNA isolation, when they 
were transferred into 1 ml TRI Reagent and homogenised using a bounce homogeniser at full speed 
for 40 seconds. RNA precipitation in isopropanol was performed for 1 hour on ice to maximise 
RNA yields. An additional ethanol wash step was included in the protocol to improve RNA purity. 
RNA concentrations were determined using the NanoDrop system (Thermo Fisher Scientific). RNA 
samples were stored at -80°C until use.  
 RT-qPCR of in vitro differentiated T helper cells 
RT-qPCR of cultured cells was performed using Life Technologies’ TaqMan Gene Expression 
Assays (#4331182) combined with a TaqMan Universal PCR Master Mix (Applied Biosystems 
#4304437). PCR protocols and TaqMan Gene Expression Assays used are listed in Tables 2.4 and 
2.5. All RT-qPCR reactions were assembled from 1 µl of a TaqMan Gene Expression Assay, 10 µl 
of the universal PCR master mix as well as 1 µl of PCR-grade water. 12 µl of the mix was 
transferred to each well of a PCR 96-well plate (Bio-Rad #MLL9601), then 8 µl of template cDNA, 
equivalent to 10-20ng input RNA per reaction, was added to the wells in duplicates. All plates were 
run on a BioRad CFX96 Real-Time System. Only duplicates with a standard deviation lower than 
0.5 were considered for down-stream analysis.  
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The 2-ΔΔCt -method - also known as comparative CT method - was applied for relative quantification 
of mRNA levels. Using this 2-ΔΔCt -method, the data are presented as the fold change in expression 
normalised to an internal control gene, relative to a control sample called calibrator (Livak & 
Schmittgen 2001). Expression levels were normalised to Hprt which was found to be stably 
expressed under all tested experimental conditions. When Th17 cells were sorted according to their 
FP expression, the FP--fractions of c-Th17 cells were used as calibrators. Cq values were exported 
from the CFX Manager software (Bio-rad) and calculations were performed in Microsoft Excel. 
GraphPad Prism 6 was used to create graphics and perform statistical analysis.  
RT-qPCR programme for TaqMan Universal PCR Master Mix 
Step 1 50°C 2 min 
Step 2 95°C 10 min 
Step 3 95°C 15 sec 
Step 4 60°C 1 min 
         repeat Steps 3 & 4 40-45 times 
RT-qPCR programme for TaqMan™ RNA-to-CT™ 1-Step Kit 
RT-qPCR program for TaqMan RNA-to-CT 1-Step Kit Step 1 48°C 15 min 
Step 2 95°C 10 min 
Step 3 95°C 15 sec 
Step 4 60°C 1 min 
         repeat Steps 3 & 4 48 times 
Table 2.4: Overview of the RT-qPCR programmes. 
 One-step RT-qPCR of LNs and ex vivo isolated cells 
RT-qPCR was performed directly on RNA using Thermo Fisher Scientific’s TaqMan™ RNA-to-
CT™ 1-Step Kit (#4392656) combined with TaqMan Gene Expression Assays. The PCR protocol 
and TaqMan Gene Expression Assays used are listed in Tables 2.4 and 2.5. All RT-qPCR reactions 
were assembled in PCR 384-well plates (Bio-Rad #HSP3805), adding 2 µl of template RNA (10-
20ng RNA per reaction) to 8 µl of a master mix containing the appropriate TaqMan Gene 
Expression Assay in duplicates or triplicates. All plates were run on a BioRad CFX384 Real-Time 
System. Only duplicates/triplicates with a standard deviation lower than 0.5 were considered for 
down-stream analysis. The 2-ΔΔCt-method was applied for relative quantification of mRNA levels. 
Expression levels were normalised to Hprt or Gapdh which were found to be stably expressed under 
all experimental conditions. Samples from young, unimmunised or immunised mice were used as 
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calibrators. As above, Cq values were exported from the CFX Manager software (Bio-rad) and 
calculations were performed in Microsoft Excel. GraphPad Prism 6 was used to create graphics and 
perform statistical analysis. 
TaqMan Gene Expression Assays (Thermo Fisher Scientific #4331182) 
Ahr Mm00478930 m1 
Hif1a Mm00468869_m1 
Hprt Mm03024075_m1 
IFNg Mm99999071 m1 
Il10 Mm00439614 m1 
Il17a Mm00439618 m1 
Il17f Mm00521423 m1 
Rora Mm00443103 m1 
Rorc Mm01261019 g1 
Tbx21 Mm00450960 m1 
Tnf Mm00443260 g1 
Mx1 Mm00487796_m1 
Ifit1 Mm00515153_m1 
Gapdh Mm99999915_g1 
Ifnb1 Mm00439552_s1  
Table 2.5: Overview of TaqMan Gene Expression Assays used for RT-qPCR. 
 RNA sequencing  
 Th17 cells: RNA library preparation and sequencing 
Samples for RNA sequencing were obtained from FACS sorts of 5 different experiments. RNA 
isolation was performed using Qiagen’s RNeasy Mini Plus Kit (#74104) following the 
manufacturer’s instructions, using Qiagen’s QIAshredders (#79654) to homogenise the samples. 
The RNA Integrity Number (RIN) was determined by the Babraham Sequencing facility using 
Agilent Bioanalyser RNA Pico Chips (#5067-1513). The RNA content was determined on a 
NanoDrop spectrometer and ranged from 0.9 – 11.1 µg RNA per sample. Two samples per 
experiment were chosen for sequencing based on their RIN (Table 2.6).  
An input of 250 ng RNA per sample was used for the subsequent generation of non-directional 
RNA libraries using the NEBNext® Ultra™ RNA Library Prep Kit for Illumina (#E7530S), 
following the manufacturer’s instructions. Succeeding an rRNA depletion step performed with the 
NEBNext® rRNA Depletion Kit (#E6310), we fragmented the RNA for 15 minutes at 94°C to 
obtain RNA fragments about 200 bp in size. After adapter ligation, we used NEBNext Multiplex 
 2.Material and Methods: RNA sequencing 
 
53 
Oligos for Illumina (Set 1, NEB #E7335) to generate barcoded samples for multiplexing. PCR 
library enrichment was performed for 13 cycles. The quality of RNA libraries was assessed on 
Agilent Bioanalyser High Sensitivity DNA Chips (#5067-4626; Table 2.6 “% 200-1000 bp” and 
“RIN”). Library quantification was achieved using the KAPA Library Quantification Kits for NGS 
(#KK4824). All samples were pooled onto one NextSeq 500 sequencing lane and sequenced as 
75 bp paired-end (PE) reads. This resulted in a total of more than 800 million reads, corresponding 
to 50 million reads per sample. 
 Th17 cells: RNA sequencing data analysis 
The NextSeq 500 sequencer used the NextSeq Control Software 2.0.2. and Real Time Analysis 
software 2.4.11 for primary on-machine analysis, creating three *.bcl-output files: two files 
containing the PE reads and a separate files containing the barcode reads. These files were converted 
to *.fastq files with the Bcl2fastq2 software. FastQC was used for the initial assessment of read 
quality. Then, the barcodes were merged with the forward read using the bash command “paste” to 
concatenate the *.fastq files line by line. The resulting *.fastq file was imported into Qiagen’s 
Genomics Workbench 9.5.2 (GxWB) together with the reverse read as PE data. The “Demultiplex” 
tool was used to split the reads according to their barcode sequence, followed by the removal of the 
6 bp barcode and a 1 bp linker from the sequence. This gave rise to 8 separate read files, each of 
which contained 8-13 % of the total reads. Next, the demultiplexed reads were subjected to an 
adaptor and quality trimming step of reads which did not meet the quality limit of 0.05 and/or 
contained more than two ambiguous nucleotides. In addition, NEBNext adaptor sequences at the 3’ 
ends were trimmed off. In the process, a total of 12 million reads were trimmed. After trimming, 
FastQC quality control was used to confirm the absence of adaptor contaminations from all reads. 
Demultiplexed raw reads are publicly available on ArrayExpress: E-MTAB-5692. 
As a next step, all remaining 799 million reads were mapped to a reference genome using Qiagen’s 
Biomedical Workbench 3.5.2 (BmWB). For this purpose, the “RNA-Seq Analysis” tool of the 
Advanced RNA-Seq Plugin was used. We used the mouse reference data library “GRCm38.p4” 
provided by the Genome Reference Consortium and mapped our reads against both the gene and 
mRNA tracks (Ashburner et al. 2000; The Gene Ontology Consortium 2019). In addition, we 
mapped them against inter-genic regions, applying the following alignment score: Mismatch cost = 
2, Insertion cost = 3, Deletion cost = 3, Length fraction = 0.8, Similarity fraction = 0.8. The 
maximum number of hits per read was set to 10 and expression values were expressed as the number 
of total counts for downstream analysis. The expectation-maximization estimation algorithm was 
enabled to improve the estimation of expression levels in cases where reads map equally well to 
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several reference genes or transcripts. The quality of read mapping was assessed by inspecting the 
mapping report and the graphical output of the BmWB genome browser view. PE read distances 
were about 150 bp in average. 76.72 % of reads mapped to the reference in pairs, with a total of 
65 % uniquely mapping to a specific reference sequence. 7.71 % of reads could not be mapped to 
the reference sequence, indicating a high overall mapping efficiency. 2.64 % of PE reads mapped 
to intergenic regions, indicating limited genomic DNA contamination.  
Exp 
ID 
Barcode  Name Mouse ID Gender Age 
 
(weeks
) 
Treatment RIN % 200-1000 bp 
Exp 2 Index 3 TGF 1 IL-17ACre RosaRFP 1 Male 9 IL-6+TGFβ 10 99 
Exp 2 Index 4 CPA 1 IL-6+CPA 10 98 
Exp 3 Index 5 TGF 2 IL-17ACre RosaRFP 2 Male 20 IL-6+TGFβ 10 99 
Exp 3 Index 6 CPA 2 IL-6+CPA 9.6 99 
Exp 4 Index 7 TGF 3 IL-17ACre RosaRFP 3 Male 18 IL-6+TGFβ 10 97 
Exp 4 Index 8 CPA 3 IL-6+CPA 9.3 90 
Exp 5 Index 9 TGF 4 IL-17ACre RosaRFP 4 Male 22 IL-6+TGFβ 10 93 
Exp 5 Index 12 CPA 4 IL-6+CPA 10 99 
Table 2.6: Metadata table of RNA sequencing libraries used for sequencing. This table shows 
the metadata used for RNA sequencing data analysis. This includes the Experiment ID 
corresponding to each samples as well as sample names, RINs and the proportion of library 
fragments falling into the 200-1000 bp range as determined by the Agilent Bioanalyser. In addition, 
multiplexing barcodes associated with each sample are displayed. The table also includes 
information about mice such as their ID, gender and age in weeks. 
Following the read mapping, inter-sample variation was assessed by principal component analysis 
(PCA) and box plot representations of each sample’s expression level distribution using the 
“Quality Control” tool of the BmWB’s “Advanced RNA-seq” plugin. Then differential gene 
expression (DGE) analysis was performed. The BmWB’s “Differential Expression for RNA-Seq” 
tool was supplied with the metadata listed in Table 2.6 and set to compare all group pairs using the 
Wald test (Chen et al. 2011). Heat maps were calculated based on Euclidean distance and complete 
linkage, forming hierarchical trees by joining clusters of genes if the distance between the furthest 
genes in the clusters is smallest. Only genes with a minimal total count of 10 were included. The 
heat maps were set to display the 20 top hits. A gene expression browser listing all gene or transcript 
expression values as well as gene ontology annotations was created using MGI’s Mus musculus 
gene ontology annotations “gene_association.mgi.gz” supplied online by the Gene Ontology 
Consortium (Ashburner et al. 2000; The Gene Ontology Consortium 2019). For functional analysis, 
we used the BmWB’s “Ingenuity Pathway Analysis (IPA)” plugin. This software tool uses its richly 
annotated Ingenuity Knowledge Base to query the significance of sequencing data in the context of 
biological systems, predicting affected signalling pathways, regulatory networks as well as disease 
functions (QIAGEN Inc. 2016). To probe our data, we uploaded different subsets of our DGE data 
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to IPA using the settings described in Table 2.7. Briefly, only features with a FDR p-value ≤ 0.05 
and a fold change of ≥ 1.0 or 1.5 were uploaded to IPA. In addition, features with a maximum group 
mean (MGM = maximum of the average reads per kilobase per million mapped reads) ≤ 3 or 10 
were excluded from the analysis. In case of duplicates, only the entry with the maximal exponential 
log ratio was taken into account. IPA application preferences were changed to consider only 
molecules and/or relationships from mouse with a high confidence, either based on prediction or 
experimental observations. To restrict the analysis to networks and diseases relevant to T cell 
biology, the analysis was repeated with the settings changed to consider only genes and 
relationships related to murine T cells. The IPA results from all different settings were analysed and 
compared using the installed Ingenuity IPA version 28820210. Only pathways and networks 
consistently scoring high in all analyses are discussed in this report. 
 Abs. Fold Change (≥) FDR p-value (≤) MGM (≥) No. of uploaded genes 
Set 0 1.0 0.05 3 3550 
Set 1 1.5 0.05 3 1407 
Set 2 1.0 0.05 10 1796 
Set 3 1.5 0.05 10 724 
Table 2.7: Subsets of differentially-expressed genes uploaded to IPA. Different subsets of our 
DGE data were created for IPA by adjusting the minimally-required absolute fold change and 
maximal group mean (MGM) values (all of which were obtained from the BmWB’s DGE analysis). 
This resulted in gene sets of different sizes. Sets are ranked according to their statistical stringency. 
 cDC2 cells: RNA library preparation and sequencing 
Samples for RNA sequencing were obtained from 16 mice in one FACS sort performed by 
Alexandre Bignon. cDNA was prepared by Danika Hill from sorted cells using the SMART-Seq 
v4 Ultra Low Input RNA Kit for Sequencing (Clontech # 634890) on the day of the sort following 
the manufacturer’s protocol. cDNA enrichment was performed for 13 cycles. cDNA quality was 
assessed on Agilent Bioanalyser High Sensitivity DNA Chips (#5067-4626). 400 pg of cDNA per 
sample were used as input by Danika Hill for the preparation of sequencing libraries with the 
Illumina Nextera XT kit (#FC-131-1096) following the manufacturer’s instructions. The quality of 
the libraries was again assessed using Agilent Bioanalyser High Sensitivity DNA Chips (#5067-
4626). Library quantification was achieved using the Qubit dsDNA High Sensitivity Assay Kit 
(Invitrogen #Q32854) on a Qubit 4 Fluorometer (Invitrogen). Six samples from young mice and six 
samples from aged mice passed all quality controls, were pooled onto two HiSeq sequencing lanes 
and sequenced as 100 bp single-end reads. 
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 cDC2 cells: RNA sequencing data analysis 
RNA sequencing analysis was performed in SeqMonk by Edward Carr, Michelle Linterman and 
Christel Krueger using the SeqMonk software package (Babraham Institute, 
https://www.bioinformatics.babraham.ac.uk/projects/seqmonk/) after trimming (Trim Galore 
v0.4.2) and alignment of reads to the reference mouse genome GRCm38 using HISAT2 (Kim et al. 
2015a) Reads were quantitated over exons and library size was standardized to 1 million reads, and 
then read counts were log2 transformed. Differentially expressed genes were determined by 
DESeq2 analysis using raw counts (adjusted p-value cut-off p ≤ 0.05) (Love et al. 2014). Principal 
component analysis was performed using 1000 genes with the largest variances, after normalisation 
for batch effects with RUVSeq (Risso et al. 2014). 
Pathway enrichment analysis was performed by Christel Krueger who filtered a publicly available 
list of gene sets for categories containing less than 20 or more than 500 genes (Bader Lab 
EM_Genesets, Mouse_GO_AllPathways_with_GO_iea_December_24_2014_symbol.gmt.txt) 
(Merico et al. 2010). Remaining gene sets were tested for differential expression between young 
and aged samples using Seqmonk Subgroup Statistics (t-test, p<0.05, average absolute z-score > 
0.5, multiple testing correction). Genes in the Responsiveness to IFN-I pathway: Stat1, Aim2, 
Pyhin1, Ifi204, Ifi203, Ifi202b, Ifi205, Gbp3, Gbp2, Ifnb1, Gbp6, Htra2, Ndufa13, Trex1, Pnpt1, 
Tgtp1, Irf1, Igtp, Ddx41, Irg1, Tmem173, Gm4951, Iigp1, Ifit3, Ifit1. Principal component analysis 
was performed using the most variable genes.  
 16S rDNA sequencing of faecal bacteria 
 DNA isolation  
Bacterial DNA isolation from faecal matter was performed using the QIAamp PowerFecal DNA 
Kit (Qiagen #12830-50) following the manufacturer’s instructions. First, samples were 
homogenised by bead beating using a FastPrep24 (MP Biomedicals) machine at 5 m/s for 50 sec. 
Total genomic DNA was captured on a silica membrane and the QIAmp Inhibitor Removal 
Technology was used to remove common substances that can interfere with downstream 
applications. In the final step, purified DNA was eluted in 70 µl of Solution C6. DNA 
concentrations were determined using the Qubit dsDNA High Sensitivity Assay Kit (Invitrogen 
#Q32854) on a Qubit 4 Fluorometer (Invitrogen). 
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 16S rDNA sequencing library preparation and sequencing 
High-throughput sequencing of the V3-V4 hypervariable region of the bacterial 16S rRNA gene 
was performed by the Beijing Genomics Institute (ageing studies) or Eurofins (Bcl6fl/flCd4cre/+ 
analysis) on an Illumina MiSeq platform. The resulting sequencing reads were supplied as 
demultiplexed fasta files for downstream analysis.  
At Eurofins, the V3-V4 region was PCR-amplified using universal primers that contained the 
adapter overhang nucleotide sequences for forward (TACGGGAGGCAGCAG) and reverse 
primers (CCAGGGTATCTAATCC). DNA was used at a concentration of 1-10 ng/ml. Amplicons 
were purified using AMPure XP beads (Beckman Coulter) and set up for index PCR with Nextera 
XT index primers (Illumina). The indexed samples were purified using AMPure XP 
beads (Beckman Coulter) and quantified using the Fragment Analyzer Standard Sensitivity NGS 
Fragment Analysis Kit (Advanced Analytical). Equal quantities from each sample were pooled. The 
pooled library was quantified using the Agilent DNA 7500 Kit (Agilent), and sequenced using v3 
chemistry (2x300 bp paired-end reads, Illumina).  
At the Beijing Genomics Institute, DNA integrity was assessed by agarose gel electrophoresis. After 
DNA quantification by Qubit Fluorometer, 30 ng DNA per sample were utilised to PCR-amplify 
the V3-V4 region using 341F forward (ACTCCTACGGGAGGCAGCAG) and 806R reverse fusion 
primers (GGACTACHVGGGTWTCTAAT). The PCR products were purified using Agencourt 
AMPure XP beads (Beckman Coulter) for library validation using an Agilent 2100 bioanalyzer 
instrument (Agilent DNA 1000 Reagents). All libraries passed the quality control and were 
sequenced on an Illumina MiSeq Platform using the MiSeq reagent kit (2x300 bp paired-end reads, 
Illumina). The demultiplexed raw reads are available on ArrayExpress upon request: E-MTAB-
7750. 
 16S rDNA sequencing data analysis 
16S rDNA sequencing analysis was performed using QIIME2 (Caporaso et al. 2010). Successfully 
merged reads were quality filtered in QIIME2 using default settings. Sequences were clustered into 
operational taxonomic units (OTUs) based on similarity to the annotated bacterial sequences 
provided by Silva (v132 SSU; https://www.arb-silva.de/ (Quast et al. 2012); 99 % sequence 
similarity cut-off). For this, classifiers were trained in QIIME2 based on the Silva database and the 
V3-V4 primers used for library preparation. Taxa bar plots were generated using QIIME2. 
Statistical analysis was performed with the Calypso software (v8.48-84; cgenome.net/calypso/ 
(Zakrzewski et al. 2017)) applying default parameters. Cumulative-sum scaling (CSS) was applied, 
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followed by log2 transformation to account for the non-normal distribution of taxonomic counts 
data. Calypso was also used to generate Bray-Curtis Principal Coordinates Analysis (PCoA) based 
on OTUs and KRONA plots (Ondov et al. 2011). Bacterial families whose abundance was 
statistically significantly different between groups were determined in Calypso by ANOVA, using 
FDR adjusted p-values ≤ 0.05 as the cut-off. Venn Diagrams were generated using the Metachart 
App (https://www.meta-chart.com/venn#/display). 
 Statistics 
All experiments were repeated at least two times with 4-10 mice per group. Differences between 
experimental groups, as determined by flow cytometry, were assessed using the non-parametric 
Mann–Whitney or Kruskal-Wallis test (with Dunn’s multiple testing correction) within the Prism 6 
software (GraphPad). P-values ≤ 0.05 were considered statistically significant. Statistical 
differences between bacterial families based on 16S rDNA sequencing data were determined by 
ANOVA, using FDR adjusted p-values ≤ 0.05 as the cut-off. Statistical differences in gene 
expression based on RNA sequencing were determined by BmWB’s DEG or DESeq2, with FDR 
p-values ≤ 0.05, fold changes ≥ 1.5 and, for Th17 cell RNA sequencing, MGM ≥ 3 as cut-offs. 
Statistical differences of clinical EAE scores between groups was performed using group 
comparisons by Mann-Whitney tests of the area under the curve (AUC) calculated for each mouse 
within the Prism 6 software (GraphPad) as suggested by Fleming et al. (Fleming et al. 2005). 
Significant differences between atypical EAE symptoms were assessed by Mantle-Cox tests in 
Prism 6 (GraphPad). 
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 ER STRESS SUPPORTS TGFb-
INDEPENDENT T HELPER 17 
DIFFERENTIATION  
 Abstract 
T helper 17 (Th17) cells are important for immune protection at epithelial barrier sites, but they 
have also been implicated in the pathology of many autoimmune disorders. Sites of inflammation 
in autoimmune diseases are often characterised by low metabolite availability and/or hypoxia - 
conditions which are potent inducers of the endoplasmic reticulum (ER) stress response. Classically, 
Th17 cell differentiation has been thought to depend upon IL-6 and TGFβ. In this study, I 
demonstrate that sustained ER stress can drive mouse Th17 cell differentiation even in the absence 
of TGFβ. ER stress-generated Th17 cells exhibit increased Th1-associated features, express many 
genes associated with Th17 cell-mediated pathogenicity and cause atypical symptoms of 
experimental autoimmune encephalitis (EAE), a Th17 cell-mediated autoimmune disease, in vivo. 
The data presented here link the ER stress response with Th17 cell-mediated immune pathologies, 
which may inform the development of new therapies against autoimmune disorders. 
 Background 
Th17 cells are a distinct T helper cell subset, which is most abundant at epithelial barrier sites, 
where they provide immunity against extracellular bacteria and fungi (Weaver et al. 2013). This is 
mediated by their production of IL-17A and IL-17F, pro-inflammatory cytokines which help to 
attract other immune cells to sites of infection. While they are crucial for immune protection, Th17 
cells can also be involved in pathology (Stockinger & Omenetti 2017) and autoimmune diseases 
(Maddur et al. 2012). They are enriched at sites of inflammation and have been directly implicated 
in the immunopathology of rheumatoid arthritis, psoriasis, and multiple sclerosis (MS), an 
autoimmune disorder associated with axon demyelination in the central nervous system followed 
by progressive neurological deterioration (Bedoya et al. 2013; Jadidi-Niaragh & Mirshafiey 2011; 
Sie et al. 2014).  
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In mice, Th17 cell differentiation from naïve CD4 T cells is well characterised to be driven by IL-
6 and TGFβ (Mangan et al. 2006; McGeachy et al. 2007; Veldhoen et al. 2006a). These cytokines 
induce the STAT3-mediated expression of the Th17 lineage-specific transcription factors RORγt 
and RORα of the retinoic acid receptor-related orphan receptors (ROR) family, as well as the 
activation of the transcription factors aryl hydrocarbon receptor (AhR), hypoxia-inducible factor 1 
alpha (HIF1a), basic leucine zipper (bZIP) transcription factor ATF-like (BATF) and the interferon 
regulatory factor 4 (IRF4) (Brüstle et al. 2007; Dang et al. 2011; Huber et al. 2008; Schraml et al. 
2009; Veldhoen et al. 2008a). While cytokines are important to guide immune cell differentiation, 
other environmental cues such as low local metabolite availability (Kominsky et al. 2010), high salt 
concentrations (Kleinewietfeld et al. 2013; Wu et al. 2013) and hypoxia (McNamee et al. 2013) 
can also influence Th cell differentiation. These conditions are potent inducers of the ER stress 
response pathway and often occur at sites of active immune responses and inflammation. These 
observations suggest that immune cell function and the ER stress response are functionally 
associated (Bettigole & Glimcher 2015).  
The ER stress response, also known as unfolded protein response (UPR), is an essential cellular 
response to tissue stress and pathogen infection, but chronic ER stress can also contribute to the 
pathology of inflammatory diseases (Bettigole & Glimcher 2015). The ER stress response was 
found to be highly active in active lesions of MS patients (Mháille et al. 2008) as well as in EAE, 
the mouse model of this disease, and to promote astrocyte-dependent inflammation and pathology 
(Deslauriers et al. 2011; Meares et al. 2014; Mháille et al. 2008). EAE can be induced directly by 
immunisation with myelin oligodendrocyte glycoprotein (MOG) or by adoptive-transfers of MOG-
specific T cells into wild-type mice (Stromnes & Goverman 2006a; 2006b). This leads to Th17 cell-
mediated damage of the myelin sheath around neurons and brain inflammation, resulting in 
progressive neuronal loss typically manifesting itself in ascending paralysis (Cua et al. 2003; 
Rostami & Ciric 2013; Stromnes & Goverman 2006a). Excessive brain inflammation caused by 
pathogenic Th17 cells additionally triggers atypical forms of EAE characterised by a variety of 
other clinical symptoms, such as ataxia and unilateral paralysis (Domingues et al. 2010; Stromnes 
et al. 2008). Lin et al. demonstrated that the Protein Kinase RNA-like Endoplasmic Reticulum 
Kinase (PERK)-mediated ER stress response can be both protective or detrimental in EAE 
experiments, depending on the time of its activation (Lin et al. 2006; 2007). Furthermore, Kim et 
al. associated aggravated LPS-induced lung injury in mice treated with the ER stress-inducer 
Thapsigargin with increased levels of IL-17 (Kim et al. 2015b). These data suggest a link between 
ER stress and Th17-mediated pathology. 
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We hypothesised a potential role of ER stress in autoimmune disorders by driving Th17 cell 
differentiation and pathogenicity. To test this hypothesis, we treated murine CD4 T cells with IL-6 
and the sarcoplasmic reticulum Calcium-ATPase (SERCA) inhibitor cyclopiazonic acid (CPA), 
which induces a strong ER stress response (Mason et al. 1991). This resulted in the robust 
generation of Th17 cells even in the absence of TGFβ. To determine whether these ER stress-
generated Th17 cells (e-Th17 cells) differ in their pathogenic potential from conventional Th17 (c-
Th17) cells generated by a combined treatment with IL-6 and TGFβ, I generated RNA sequencing 
data from sorted e- and c-Th17 cells. RNA sequencing analysis revealed that e-Th17 cells exhibit a 
unique gene expression profile characterised by a pronounced increase in “pathogenicity-associated” 
genes (Lee et al. 2012). This was linked with a high potential of these cells to trigger Th17 cell-
mediated pathology in adoptive-transfer EAE experiments. This suggests that e-Th17 cells may 
play a role in the pathology associated with Th17-mediated autoimmune diseases. 
 Results  
 ER stress increases Th17 cell differentiation  
To determine the impact of ER stress on the differentiation of different T helper subsets, I purified 
naïve CD4+ T cells by magnetic cell separation (MACS) from the spleens of C57BL/6 mice and in 
vitro differentiated them into Th17, Th1 and Treg cells in the presence of increasing concentrations 
of two ER stress inducers: the SERCA inhibitor CPA (Figure 3.1A-C) and the pyruvate analogue 
3-bromopyruvate (BrPA) (Figure 3.1D-F) (Ganapathy-Kanniappan et al. 2010; Mason et al. 1991). 
Both compounds specifically enhanced Th17 cell differentiation, with some negative effects on the 
differentiation of Th1 and Treg cells at high concentrations (Figure 3.1A-F). This reveals a general 
role for the ER stress response as a specific enhancer of in vitro Th17 cell differentiation. 
 
To further characterise the impact of ER stress on Th17 cell differentiation, we generated Th17 
cells with IL-6 and α-IFNg antibodies in the additional presence or absence of CPA and/or TGFβ 
(Figure 3.2A). As expected, a combined treatment of naïve CD4 T cells with IL-6 and TGFβ 
induced conventional Th17 (“c-Th17”) cell differentiation. The addition of the ER stress inducer 
CPA clearly increased Th17 cell differentiation efficiency by two-fold, albeit this was not detected 
as significant by the Kruskal-Wallis test due to the limitation of sample ranking. Even in the absence 
of TGFβ, a mix of CPA with IL-6 only (“e-Th17”) induced Th17 cells in a dose-dependent manner 
(Figure 3.2A, C). To exclude an effect of endogenous TGFβ present in foetal bovine serum (FBS) 
(Oida & Weiner 2010)) on e-Th17 cell differentiation, “IL-6+CPA+α-TGFβ” samples were 
additionally treated with anti-TGFβ neutralising antibodies. This reduced the proportion of Th17 
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cells formed in vitro, confirming that, while TGFβ is not essential for Th17 cell differentiation, it 
enhances the generation of these cells under both conventional and ER stress conditions (Figure 
3.2A). This demonstrates that ER stress induces the generation of Th17 cells even in the absence of 
an exogenous source of TGFβ.  
 
   
 
Figure 3.1: ER stress enhances the differentiation efficiency of Th17 cells, but not Th1 or Treg 
cells. Naïve CD4+CD62L+ T cells were isolated from the spleens of C57BL/6 mice and 
differentiated into Th17, Th1 and Treg cells. Cells were co-cultured with indicated concentrations 
of the ER stress inducers CPA or BrPa for three days. On day 3, cells were stimulated for 3 hours 
with 500 g/ml PdBU, 500 ng/ml ionomycin and 10 µg/ml brefeldin A, then the percentage of 
IL17A+ cells (=Th17; A, D), IFN-γ+ cells (=Th1; B, E), and Foxp3+ cells (=Treg; C, F) was 
determined by flow cytometry. Data were collected in 2-3 independent experiments performed for 
biological duplicates or triplicates (n=4-6). Bar heights correspond to mean percentages with error 
bars representing standard deviations. Dots represent the proportion of IL-17A+/ IFN-γ+/Foxp3+ 
cells generated from individual mice. P-values are based on Kruskal-Wallis tests without multiple 
testing in GraphPad Prism 6. 
CPA titration experiments revealed a CPA dose-dependent increase in Th17 cell numbers up to a 
concentration of 2 µM CPA, where cell numbers plateaued in the presence or absence of TGFβ 
(Figure 3.1A, Figure 3.2B, C). In these experiments, in vitro Th17 cell differentiation efficiency 
was positively correlated with the duration of CPA treatment (Figure 3.2D, E): the number of IL-
17A+ Th17 cells increased with prolonged exposure to CPA. This demonstrates that extended 
periods of CPA treatment are required for enhanced Th17 cell differentiation. The UPR inhibitor 
TUDCA (tauroursodeoxycholic acid) reduced the frequency of Th17 cells formed in vitro under 
conventional Th17 cell culture conditions (“IL-6+TGFβ”) (Figure 3.2A) (Xie et al. 2002). This 
suggests that the ER stress response is an integral part of the Th17 cell differentiation pathway, 
even in the absence of a dedicated ER stress inducer. 
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To characterise ER stress-generated Th17 (e-Th17) cells more thoroughly, I purified in vitro-
generated Th17 cells to analyse their gene expression profile by RT-qPCR (Figure 3.3). I generated 
Th17 cells from Rosastop-tdRFPIl17acre or Rosastop-eYFPIl17acre reporter mice (both of which will from 
now on be referred to as “Il17aFP” mice), which fate-map IL-17A-expressing cells by their 
fluorescent protein (FP) expression, and sorted them into FP- and FP+ fractions by fluorescence-
activated cell sorting (FACS) (gating strategy shown in Figure 3.3). This allowed us to compare the 
gene expression profiles of c-Th17 and e-Th17 cells by RT-qPCR, with the “non-Th17 cell” FP- 
fraction as an internal control. It is important to note that the FP+ fraction also includes a fraction 
of FP+IL-17A- ex-Th17 cells (Figure 3.3A-C). RT-qPCR revealed that the Th17 lineage-specific 
markers Rora, Rorc, Il17a and Il17f were expressed in the FP+ fraction of all tested conditions 
(Figure 3.4A-D). RT-qPCR of e-Th17 cells generated in the presence of TGFβ blocking antibodies 
showed that, although fewer Th17 cells are formed under these conditions (Figure 3.2A, Figure 
3.3C), the cells formed in the complete absence of TGFβ are bona fide Th17 cells which express 
all Th17 cell lineage markers (Figure 3.4A-D). This confirms that ER stress drives the formation of 
Th17 cells which express the relevant transcripts associated with this subset, even in the absence of 
TGFβ. 
The FP- fraction also expressed some of the Th17 lineage markers. This may be due to the presence 
of early Th17 cells in the FP- fraction, which already express RORgt and IL-17A, but do not yet 
express the FP (Figure 3.3A-C). Consistent with this hypothesis, fewer FP-expressing cells were 
detected by flow cytometry than IL-17A+ cells as determined by intracellular antibody staining 
(Figure 3.4E, F). This points towards the presence of a population of Th17 cells which express IL-
17A but not the FP, consistent with observations by Hirota et al., who also observed early 
commitment of Th17 cells to IL-17A production without FP expression upon PdBu/Ionomycin 
treatment using the same mice (Hirota et al. 2011).  
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Figure 3.2: CPA enhances Th17 cell differentiation. (A-E) Naïve CD4+ CD62L+ T cells were 
MACS-purified from the spleens of Rosastop-tdRFPIl17aCre or Rosastop-eYFPIl17aCre reporter mice and 
differentiated into Th17 cells in the presence of TGFβ (“IL-6+TGFβ”; A-B, D-E) and/or 2 µM CPA 
(“IL-6+TGF+CPA” and “IL-6+CPA”; “IL-6 only”). In A, some cells were additionally treated with 
10 µg/ml anti-TGFβ blocking antibodies (“IL-6+CPA+aTGF”) or 0.5 mM TUDCA to block the 
UPR (“IL-6+TUDCA”). On day three, cells were stimulated for 3 hours with 500 g/ml PdBU, 
500 ng/ml ionomycin and 10 µg/ml brefeldin A, then the percentage of IL-17A+ cells was 
determined by flow cytometry. (B, C) In CPA titration experiments, cells were cultured with 0.5-
10 µM CPA. Data in A-C were collected in 4-6 experiments performed for biological duplicates or 
triplicates (n=9-12). (D) For CPA time-courses, 2 µM CPA was added to the cultures 0 h, 4 h, 24 h 
or 48 h after cell culture set-up. (E) For washout experiments, cells were treated with 2 µM CPA at 
the start of the cell culture. At 2 h, 4 h, 24 h or 48 h CPA-containing media was removed and 
replaced by standard differentiation medium. Data were collected from 2 (time-course) or 6 
(washout) experiments performed with biological duplicates or triplicates (n = 5-12). Bar heights 
correspond to mean percentages with error bars representing standard deviations. Dots represent 
the proportion of IL-17A+ cells observed in individual samples. P-values are based on Kruskal-
Wallis tests (in A with Dunn’s correction for multiple testing) in GraphPad Prism 6. 
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Figure 3.3: Gating strategy for sorting FP+ and FP- T cells from Il17aFP reporter mice. Naïve 
CD4+ CD62L+ T cells were isolated from the spleens of Il17aFP reporter mice and differentiated 
into c-Th17 cells (“IL-6+TGFb”; A) and e-Th17 cells (“IL-6+CPA”, B). Alternatively, they were 
treated with a combination of IL-6, CPA and α-TGFβ antibodies (“IL-6+CPA+αTGFb”; C). On 
day three, cells were optionally stimulated for 3 hours with 500 g/ml PdBU, 500 ng/ml ionomycin 
and 10 µg/ml brefeldin A for intracellular IL-17A staining, then cells were stained for flow 
cytometry and sorted into FP- (populations left of horizontal gate) and FP+ (populations right of 
horizontal gate) fractions as shown above. (A-C) Representative flow plots for Th17 cells generated 
in vitro by treatment with IL-6+TGFb, IL-6+CPA or IL-6+CPA+ αTGFb.   
A. 
C. 
B. 
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Figure 3.4: ER stress induces the expression of Th17 cell-associated genes in the absence of 
TGFβ. (A-D) Naïve CD4+ CD62L+ T cells were isolated from the spleens of Il17aFP reporter mice 
and differentiated into c-Th17 cells (“IL-6+TGFβ”) and e-Th17 cells (“IL-6+CPA”). Alternatively, 
they were treated with a combination of IL-6, CPA and α-TGFβ antibodies (“IL-6+CPA+αTGF”). 
On day three, cells were sorted into FP- (“-“) and FP+ (“+”) fractions for RT-qPCR. Data were 
collected as biological duplicates in 2-7 independent experiments (n = 4-14). (A-D) RT-qPCR 
analysis of Th17 cell-associated gene expression in sorted cells. Dots represent relative gene 
expression levels of individual samples normalised to Hprt and relative to the c-Th17 FP- fraction 
as determined by the 2-ΔΔCt method. Bar heights correspond to mean expression level with error bars 
representing standard deviations. P-values are based on Kruskal-Wallis tests with Dunn’s multiple 
comparison corrections in GraphPad Prism 6. (E, F) Cells were cultured with a combination of IL-
6, TGFβ and different concentration of CPA. The proportion of Th17 cells was assessed by flow 
cytometry after 3 hours of stimulation with 500 g/ml PdBU, 500 ng/ml ionomycin and 10 µg/ml 
brefeldin A, based on intracellular antibody staining for IL-17A (E) or their YFP expression (F) in 
4 independent experimental repeats for biological duplicates (n = 8).  
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 Increased expression of Th1 cell-associated genes in ER 
stress-generated Th17 cells  
Next, I generated transcriptomic data from sorted c- and e-Th17 cells to investigate global gene 
expression differences between these cells. Principal component analysis and data clustering based 
on Euclidian distances revealed separate clustering of c-Th17 and e-Th17 cells, thus confirming 
global differences between these treatment groups (Figure 3.5A, B). Statistical comparison of e-
Th17 and c-Th17 cells by differential gene expression (DGE) analysis in Qiagen’s Biomedical 
Workbench (BmWB) generated a list of 3301 differentially-expressed genes with a false discovery 
rate (FDR) p-value ≤ 0.05 and absolute fold change ≥ 1.5. Many of these genes were involved in T 
cell development, activation and functions (Table 3.1). Notably, DGE revealed that the expression 
of Tbx21 and Ifng, lineage marker genes associated with the T helper 1 (Th1) cell subset, was 
significantly upregulated in e-Th17 cells (Table 3.1, Figure 3.6A). The canonical Th17 transcripts 
Il17f and Ahr were reduced in e-Th17 cells, as was the expression of the anti-inflammatory cytokine 
Il10. These findings were confirmed by RT-qPCR (Figure 3.6B-H) and suggest there may be an 
increased Th17-to-Th1 plasticity of e-Th17 cells (Figure 3.6G, H). ex-Th17 Th1 cells have been 
described as potent drivers of EAE pathology, providing a potential link between ER stress and 
Th17 cell pathogenicity (Hirota et al. 2011; Stockinger & Omenetti 2017). The transcriptional 
signature of e-Th17 cells, characterised by high expression levels of Tbx21 and low levels of Ahr 
and Il10, also highly resembles the pathogenic Th17 cell signature proposed by Lee et al (Lee et al. 
2012). e-Th17 cells also express increased levels of secreted phosphoprotein 1 (Spp1), which has 
been implicated in the pathology of EAE (Chabas et al. 2001; Hur et al. 2007). This indicates that 
ER stress-generated Th17 cells exhibit increased EAE pathogenicity compared to c-Th17 cells. 
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Figure 3.5: CPA treatment induces global gene expression changes in Th17 cells. (A) Principal 
component analysis reveals clustering of samples according to their respective treatment. c-Th17 
(TGF) samples are coloured in green, CPA-treated e-Th17 cells in blue. Samples obtained from the 
same experiment share the same node shape. (B) This hierachical tree was generated using Qiagen’s 
BmWB based on Euclidean distances and complete linkage, by joining clusters of genes if the 
distance between the furthest genes in the clusters is smallest. Only genes with a total count of 10 of 
greater were taken into account.  
  
A. 
B. 
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Rank Symbol Entrez Gene Name Fold Change Log2 FC 
1 NKG7 natural killer cell granule protein 7 304.10 8.24 
2 GLP1R glucagon-like peptide-1 receptor 291.25 8.19 
3 SIGLEC-F sialic acid binding Ig like lectin 8 278.59 8.12 
4 ARL4D ADP ribosylation factor like GTPase 4D 170.20 7.41 
5 NRGN neurogranin 142.83 7.16 
6 MPZL2 myelin protein zero like 2 81.67 6.35 
7 GPRIN2 G protein regulated inducer of neurite outgrowth 2 70.50 6.14 
8 AJUBA ajuba LIM protein 49.32 5.62 
9 IFNG Interferon gamma 45.27 5.50 
10 TBX21 T-box protein 21 43.48 5.44 
22 SPP1 secreted phosphoprotein 1 17.37 4.12 
12 IL-22 interleukin 22 -19.44 -4.28 
9 CRISPLD2 cysteine rich secretory protein 2 -34.27 -5.10 
8 TNFRSF8 TNF receptor superfamily member 8 -34.50 -5.11 
7 TIMP1 TIMP metallopeptidase inhibitor 1 -37.19 -5.22 
6 GCNT2 N-acetyllactosaminide beta-1,6-N-
acetylglucosaminyl-transferase 
-47.33 -5.56 
5 DNTT DNA nucleotidylexotransferase -49.41 -5.63 
4 Ctla2a cytotoxic T lymph-associated protein 2 α -75.49 -6.24 
3 Ctla2b cytotoxic T lymph-associated protein 2 β -101.38 -6.66 
2 IL-24 interleukin 24 -474.82 -8.89 
1 Ly6a  lymphocyte antigen 6 complex, locus A -490.2 -8.94 
Table 3.1: Top differentially-expressed genes between c-Th17 and e-Th17 cells. The list was 
obtained from a gene expression (DGE) analysis between treatment groups (CPA versus TGF) 
while controlling for variation between experimental repeats. It contains the top differentially-
expressed genes with false-discovery rate (FDR) p-values ≤ 0.05 and maximal group means 
(MGMs) ≥ 3. The false-discovery rate (FDR) p-value accounts for the increased false-discovery 
rate in multiple testing, while the maximum group mean (MGM) describes the maximum average 
group RPKM (Reads Per Kilobase per Million mapped reads) values among all samples of a 
treatment group. Genes are ranked by their fold change, with rank 1 having the highest fold change, 
i.e. the highest or lowest expression in e-Th17 cells compared to c-Th17 cells. Genes upregulated 
in e-Th17 cells are marked in red, downregulated genes are highlighted in blue. 
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Gene RNA-seq 
 MGM Fold change FDR p-value 
Ifng 3.3 45.27 0.00 
Tbx21 21.8 43.48 0.00 
Rorc 33.7 1.45 2.94E-08 
Tnf 28.6 1.37 1.29E-05 
Hif1a 152.5 1.15 0.15 
Il17f 485.8 -1.92 0.00 
Ahr 18.1 -2.84 1.57E-13 
Il10 14.6 -5.94 0.00 
 
 
 
Figure 3.6: Distinct Th17 and Th1 cell type-specific mRNA expression by e-Th17 cells. (A) 
Table showing the fold change in gene expression of canonical Th17 and Th1 cell-associated genes 
as measured by DGE analysis of e-Th17 cells compared to c-Th17 cells. The false-discovery rate 
(FDR) p-value accounts for the increased false-discovery rate in multiple testing, while the 
maximum group mean (MGM) describes the maximum average group RPKM (Reads Per Kilobase 
per Million mapped reads) values among all samples of a treatment group. (B-H) Naïve CD4+ 
CD62L+ T cells were isolated from the spleens of Il17aFP reporter mice and differentiated into c-
Th17 cells (IL-6+TGFβ) and e-Th17 cells (IL-6+CPA). Alternatively, they were treated with a 
combination of IL-6, CPA and TGFβ (“e-Th17 + TGF”). On day three, cells were sorted into FP- 
and FP+ fractions and the FP+ factions were subsequently analysed by RT-qPCR for Il17f, Rorc, 
Ahr, Hif1a or Il10 (C). Data were collected in 2-7 independent experiments performed for biological 
duplicates (n = 5-14). Dots represent gene expression levels of biological replicates normalised to 
Hprt and relative to the c-Th17 FP- fraction as determined by the 2-ΔΔCt-method. Bar heights 
correspond to the mean expression level with error bars representing the standard deviation. P-
values are based on Mann-Whitney (B-F) or Kruskal-Wallis tests with Dunn’s multiple comparison 
corrections (G, H) calculated in GraphPad Prism v6. 
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 Potential effects of ER stress on T cell receptor signalling in 
Th17 cells  
Ingenuity Pathway Analysis (IPA; QIAGEN Inc. 2016) confirmed activation of the UPR in e-Th17 
cells (Table 3.2) and revealed the reduced expression of EIF2 signalling pathway genes in e-Th17 
cells, which is indicative of ER stress-induced translational repression by PERK. Another pathway 
identified as being underrepresented in e-Th17 cells compared to c-Th17 cells was mTOR 
signalling, a pathway often linked with ER stress (Appenzeller-Herzog & Hall 2012; Malhotra & 
Kaufman 2011). This confirms that the SERCA inhibitor CPA is indeed an inducer of the ER stress 
response. 
IPA also confirmed differences in the expression of T cell differentiation-associated genes between 
e-Th17 and c-Th17 cells and revealed changes in gene expression associated with TCR-dependent 
T cell activation (Table 3.2, Figure 3.7, Figure 3.8): the genes encoding the TCR signalling-
associated transmembrane receptors Cd3, Cd28 and Cd4 and the downstream signalling proteins 
Zap70, Fyn and Lck were found to be upregulated in e-Th17 compared to c-Th17 cells. This was 
associated with the increased expression of genes encoding Erk, Nfatc1 and Nfatc3 in these cells, 
while the expression of Nfat2c was decreased (Figure 3.8). This suggests that CPA treatment affects 
the signalling events downstream of the TCR, with possible implications for T cell activation and 
differentiation. Further experiments are required to determine whether this is due to downstream 
effects of the ER stress response or more directly caused by a CPA-induced increase in intracellular 
calcium signalling. 
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Table 3.2: The top canonical IPA pathways are linked with ER stress or T cell differentiation 
and activation. This table lists the top IPA canonical pathways correlated with e-Th17 cell gene 
expression (abs. fold change ≥ 1.0, MGM ≥ 10). The pathways are ranked according to their IPA 
overlap p-values (shown as log-transformed values), which describe the correlation of the gene set 
with individual pathways. z-scores indicate whether the genes involved in a pathway are activated 
(z score > 0; orange), inhibited (z score < 0; blue) or neutral (z score ~ 0; grey). The top pathways 
can be loosely divided into two groups: ER stress-linked (upper section) as well as T cell 
differentiation and activation pathways (lower section). 
  
  
Rank ER stress-linked Pathways -log(p-value) z score 
1 EIF2 Signalling 57.6 -5.528 
3 mTOR Signalling 22.7 -1 
7 Mitochondrial Dysfunction 9.38 0 
26 Unfolded protein response 6.1 0 
2 Regulation of eIF4 and p70S6K Signalling 28.4 1.604 
 T cell differentiation/activation Pathways   
4 T Cell Receptor Signalling 10.6 0 
5 Regulation of IL-2 in Activated and Anergic T Cells 10.5 0 
6 T Helper Cell Differentiation 10 0 
10 Phospholipase C Signalling 7.63 0.209 
8 Role of NFAT in Regulation of the Immune Response 8.02 1.859 
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Figure 3.7: CPA treatment affects T cell differentiation. This graphical representation of the 
IPA “T cell differentiation” pathway depicts genes involved in Th subset differentiation and identity. 
The expression status of all involved genes in e-Th17 versus c-Th17 cells is colour-coded 
(upregulation=red; downregulation=green).  
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Figure 3.8: CPA treatment affects T cell activation. This graphical representation of the IPA “T 
cell receptor signalling” pathway shows the main genes involved in TCR signalling. The expression 
status of all involved genes in e-Th17 versus c-Th17 cells is colour-coded (upregulation=red; 
downregulation=green).  
 ER stress promotes EAE pathology 
Downstream effects analysis (DEA) by IPA revealed that the gene expression pattern of e-Th17 
cells was closely linked with several Th17-linked autoimmune disease pathways: DEA associated 
e-Th17 cells with systemic autoimmune syndrome (z score=1.45; log-transformed IPA overlap p-
value=25), rheumatoid arthritis (z score=1.8; p=6.5) and EAE (z score=1.56; p=17.6).  
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To test whether these IPA predictions were correct, the impact of ER stress on Th17 cell-mediated 
EAE pathology in vivo was determined. For this, Verena Brucklacher-Waldert and Marc Veldhoen 
induced direct EAE in C57BL/6 mice by immunising them with myelin oligodendrocyte 
glycoprotein (MOG) in complete Freund’s adjuvant (CFA). This triggers an immune response 
towards myelin, resulting in progressive neuronal loss and paralysis (Stromnes & Goverman 2006b). 
Daily dosing of MOG-immunised mice with the ER stress inhibitor TUDCA significantly delayed 
the onset of EAE compared to controls, strengthening the link between ER stress and EAE 
pathology (Figure 3.9A).  
To determine whether TUDCA delayed the onset of EAE by blocking the ER stress response in T 
cells or other cell types, we made use of Xbp1fl/flRag1cre/+ mice. These mice delete Xbp1 specifically 
from lymphocytes. The conditional excision of Xbp1, and its downstream ER stress response 
pathway, in lymphocytes again delayed the onset of EAE and reduced clinical EAE scores 
compared to wild-type and Xbp1fl/flRag1+/+ control mice (Figure 3.9B). This confirms that blockade 
of the ER stress response pathway in lymphocytes can ameliorate EAE pathology. 
 
 
 
 
Figure 3.9: Blockade of the ER stress response ameliorates EAE disease severity. (A) Clinical 
scores of EAE induced by administration of MOG/CFA and daily dosing of PBS (Ctrl; closed 
circles) or 250 mg/kg TUDCA (open circles). P-values were calculated based on a Mann-Whitney 
test comparing the area under the curve (AUC) of each mouse as suggested by Fleming et al. 
(Fleming et al. 2005). (B) Clinical EAE scores from control C57BL/6 (closed circles), 
Xbp1fl/flRag1+/+ (open squares), and Xbp1fl/flRag1cre/+ (open circles) mice upon administration of 
MOG/CFA. P-values were calculated based on a Kruskal-Wallis test with Dunn’s multiple testing 
correction comparing the AUC of Xbp1fl/flRag1cre/+ mice with the AUC of Xbp1fl/flRag1+/+ controls. 
Lines represent the mean, error bars the standard deviation of pooled data from 3 experiments with 
n = 19 mice per group (A) or two experiment with a total of n = 7-8 mice per group (B). The data 
depicted here were generated by Verena Brucklacher-Waldert and Marc Veldhoen. 
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Figure 3.10: e-Th17 cells induce atypical symptoms in adoptive-transfer EAE experiments. 
(A) Schematic overview of the adoptive-transfer EAE protocol. (B, C) Adoptive-transfer EAE was 
induced by injecting mice with MOG-re-stimulated cell populations, which were isolated from 
MOG-immunised 2D2 mice and exposed to different Th17 cell differentiation conditions in vitro 
for 4 days. EAE progression was monitored over 22 days. Data were obtained from two experiments 
with a total of n = 9 mice per group. (B) Mean clinical EAE scores of mice injected with ER stress-
generated e-Th17 (CPA) or c-Th17 (Ctrl) cells. Mean group scores of the “IL-6+CPA” treatment 
group are shown as open circles, the “IL-6+TGFβ” group as closed circles, error bars represent the 
standard deviation. P-values were calculated in GraphPad Prism6 and are based on Mann-Whitney 
tests comparing the area under the curve (AUC) of each mouse in the two different groups as 
suggested by Fleming et al. (Fleming et al. 2005). (C) Percentage of mice who developed atypical 
EAE symptoms during adoptive-transfer EAE experiments. The “CPA” treatment group is shown 
as open circles, the “Ctrl” group as closed circles. The lines represent the mean, error bars represent 
the standard deviation. The p-value is based on a Mantel-Cox curve comparison calculated in 
GraphPad Prism6. I performed the pilot experiment for this data set, but both repeats shown here 
were performed by Marc Veldhoen. 
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To further study the link between ER stress and T cell-mediated pathology of EAE, Marc Veldhoen 
and I conducted adoptive-transfer EAE experiments (Figure 3.10A). For this, we isolated total cells 
from the LNs and spleens of MOG-immunised 2D2 mice, whose T cells carry a transgenic TCR 
that is specific for a peptide of the MOG protein. These cells were expanded in vitro in the presence 
of MOG and a combination of either IL-6 plus TGFβ to generate c-Th17 cells, or a combination of 
IL-6 and CPA to promote the formation of e-Th17 cells. After four days, these cells were injected 
into sub-lethally irradiated C57BL/6 mice. These mice developed clinical signs of adoptive-transfer 
EAE within 8-18 days. While the “IL-6+TGFβ” group started showing clinical signs of EAE 
pathology on days 8-12 after T cell transfer, “IL-6+CPA” mice showed a delayed and reduced onset 
of classical EAE (Figure 3.10B). In contrast, they developed symptoms of atypical EAE such as 
ataxia (Figure 3.10C). This is indicative of Th17 cell-mediated brain inflammation as described by 
Stromnes et al (Stromnes et al. 2008). Taken together, these data provide evidence for a link 
between ER stress and EAE pathology and suggest that TUDCA, an FDA-approved drug, could 
potentially be used for the treatment of MS patients. 
 Discussion  
It was long thought that the generation of Th17 cells requires a combination of both IL-6 and TGFβ 
signalling (Mangan et al. 2006; Veldhoen et al. 2006a). However, Ghoreschi et al. reported on the 
formation of Th17 cells in the absence of TGFβ when cultured with a combination of IL-6, IL-1b 
and IL-23 (Ghoreschi et al. 2010). The data presented here demonstrate that TGFβ-independent 
generation of Th17 cells can also occur in the presence of IL-6 and the ER stress inducers CPA and 
BrPA. This ER stress-generated Th17 cell population has a distinct gene expression profile, 
characterised by increased Th1 cell-associated gene expression and the expression of genes 
correlated with inflammation and autoimmune diseases such as rheumatoid arthritis and EAE. In 
line with this, we found that e-Th17 cells evoked Th17 cell-linked, atypical pathology in adoptive-
transfer EAE experiments.  
This study challenges the original theory that TGFβ is required for the formation of Th17 cells. 
TGFβ is thought to facilitate Th17 cell differentiation by relieving the SOCS3-dependent inhibition 
of STAT3 and repressing STAT4 and GATA3 expression (Das et al. 2009; Qin et al. 2009). 
Accordingly, mice with a dominant negative mutation in the TGFβ receptor II have reduced 
proportions of Th17 cells in their lamina propria and are protected from EAE (Ghoreschi et al. 
2010; Qin et al. 2009; Veldhoen et al. 2006b). Ghoreschi et al. have recently described the TGFβ-
independent generation of pathogenic Th17 cells under the influence of IL-6, IL-1β and IL-23 
(Ghoreschi et al. 2010), however, and we have now established that a similar Th17 cell population 
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can be obtained under ER stress conditions in vitro. There is a high correlation between the gene 
expression changes we observed between c- and e-Th17 cells and the differentially expressed genes 
described by Ghoreschi et al. (Ghoreschi et al. 2010). Ghoreschi et al. compared microarray data 
from conventional Th17 cells (treated with IL-6 + IL-1β + TGFβ) with data obtained Th17 cells 
generated without TGFβ (Ghoreschi et al. 2010). Both in their, as well as in our transcriptomics 
data, the absence of TGFβ was correlated with the reduced expression of Il10 and Ahr and increased 
expression levels of Tbx21. This indicates that, while TGFβ is not required for the generation of 
Th17 cells, it is important to shape the gene expression profile of Th17 cells. As a result, Th17 cells 
generated in the absence of TGFβ express higher levels of classical Th1 cell marker genes which 
has been linked with increased pathogenicity in autoimmune diseases (Lee et al. 2012). 
In contrast to Ghoreschi et al.’s data, our transcriptomics data additionally revealed the CPA-
associated upregulation of many genes associated with TCR signalling. Similar to CPA treatment, 
T cell activation culminates in the release of Ca2+ from the ER and drives NFAT-dependent 
transcription programmes, but can also induce the UPR (Feske 2007; Leitenberg & Bottomly 1999; 
Pino et al. 2008). Thus, the ER stress response and T helper cell activation are potentially closely 
associated. We cannot rule out, however, that the proposed ER stress-mediated effect on TCR 
signalling is caused by CPA-induced changes in calcium signalling rather than downstream effects 
of the UPR. 
We observed potent Th17 cell differentiation not only under the influence of CPA, but also of the 
ER stress inducer BrPA. This indicates that CPA-driven Th17 cell differentiation is not due to CPA-
specific effects on calcium signalling or unknown off-target effects, but that the generation of Th17 
cells is promoted by a variety of conditions inducing ER stress. It would be interesting to perform 
RNA sequencing on Th17 cells differentiated under other stress conditions to further elucidate the 
molecular basis for stress-mediated Th17 cell differentiation. 
Downstream analysis of our RNA sequencing data predicted an elevated potential of e-Th17 to 
cause pathology of EAE and arthritis. In accordance with this, mice dosed with the ER stress 
inhibitor TUDCA during active EAE induction exhibit a delayed onset of disease. As described 
above, e-Th17 cells have a lot in common with the Th17 cells generated by Ghoreschi et al., which 
were also differentiated in the absence of TGFβ and were highly pathogenic in adoptive-transfer 
EAE experiments (Ghoreschi et al. 2010). Instead in our adoptive-transfer EAE model, mice 
injected with CPA-treated cells showed a delayed onset of classical disease symptoms. This could 
be linked with the increased expression of IFN-γ by e-Th17 cells, as IFN-γ-induced ER stress can 
have protective functions during EAE induction (Lin et al. 2007). While disease onset triggered by 
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e-Th17 cells was delayed, we did observe the emergence of atypical EAE symptoms in mice 
injected with CPA-treated cells. These symptoms had previously been associated with Th17 cell-
mediated brain inflammation (Domingues et al. 2010; Stromnes et al. 2008). Further studies are 
required to confirm whether this phenotype is linked with an ER stress-related increase in Th17 cell 
numbers, or maybe an increase in Th17-to-Th1 plasticity of e-Th17 cells. It is important to note that 
in our adoptive-transfer EAE experiments, we injected recipient mice with a complex population 
of cells, all of which respond to ER stress and have the potential to influence disease progression. 
Unfortunately, MACS-sorted MOG-re-stimulated CD4 T cells did not induce adoptive-transfer 
EAE in our hands. Thus, it is not possible to rule out that non-Th17 cells are involved in directing 
EAE disease progression in this experimental system.  
Nevertheless, our study provides compelling evidence for the ER stress response as a strong driver 
of Th17 cell differentiation into Th17 cells with a pathogenic gene expression signature. In 
adoptive-transfer EAE studies, these cells evoke atypical symptoms linked with Th17 cell-mediated 
brain inflammation. Thus, ER stress clearly affects the onset and progression of EAE. We do not 
yet fully understand the ER stress-mediated effect on e-Th17 cell pathogenicity, however. 
Additional T cell transfer and tracking studies could help to further dissect the plasticity, migration 
and pathogenic potential of e-Th17 cells. This would improve our understanding of the behaviour 
of ER stress-generated Th17 cells in vivo and could strengthen the novel link between ER stress 
and the pathology of Th17 cell-mediated autoimmune diseases proposed in this study. 
Note: 
This project was published in 2017 as part of a publication in Cell Reports: Brucklacher-Waldert 
V, Ferreira C, Stebegg M, Fesneau O, Innocentin S, Marie JC, Veldhoen M. 2017. Cellular Stress 
in the Context of an Inflammatory Environment Supports TGF-β-Independent T Helper-17 
Differentiation, Cell Reports 19(11), 2357-2370 (Brucklacher-Waldert et al. 2017). No follow-up 
studies were performed, as I took on a new project in Michelle Linterman’s group in January 2017. 
This was in consequence of Marc Veldhoen’s move to Lisbon during the 1st year of my PhD and 
my wish to stay in Cambridge
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 HETEROCHRONIC FAECAL 
TRANSPLANTATION BOOSTS THE GUT 
GERMINAL CENTRE REACTION 
 Abstract  
Ageing is a complex multifactorial process associated with a plethora of disorders which contribute 
to significant morbidity worldwide. One of the organs significantly affected by age is the gut. Age-
dependent changes of the gut-associated microbiome have been linked to increased frailty and 
systemic inflammation. This change in microbial composition with age occurs in parallel with a 
decline in function of the gut immune system, however it is not clear if there is a causal link between 
the two. Here, we establish that the defective germinal centre (GC) reaction in Peyer’s patches (PPs) 
of aged mice can be rescued by co-housing of adult and aged mice, and via faecal transfers from 
younger adults into aged mice. This demonstrates that the poor GC reaction in aged animals is not 
irreversible, and that it is possible to enhance this response in older individuals by replenishing the 
gut microbiome.  
 Background 
One of the major achievements of human endeavour is the extension of lifespan through 
improvements in medical care, nutrition, sanitation and access to clean water. The consequent 
upward demographic shift in human age creates a challenge for medical science: how to enable 
people to age in good health. One of the organs that is significantly affected by age is the 
gastrointestinal tract and the gut-associated microbiome. The gut microbiota comprises hundreds 
of different commensal bacterial species, as well as fungi, protozoa and viruses. These commensal 
microorganisms are essential for health, affecting the functions of multiple bodily systems, such as 
host metabolism, brain functions and the immune response (Wang et al. 2017). Older individuals 
have age-related alterations in gut microbial composition (Buford 2017; Claesson et al. 2011; 2012; 
Maffei et al. 2017), which have been associated with increased frailty (Claesson et al. 2012; Maffei 
et al. 2017), reduced cognitive performance (Cattaneo et al. 2017) and an increased susceptibility 
to intestinal disorders (Kolling et al. 2012).  
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What drives these age-associated changes in the gut microflora remains unknown. The microbiome 
is shaped by many factors including host genetics, early life events, diet, and the gut immune system 
(Belkaid & Hand 2014; Kurilshikov et al. 2017; Power et al. 2014). While some of these factors 
remain relatively constant throughout life, the function of the immune system is known to 
deteriorate with age (Nikolich-Žugich 2018). This prompts the hypothesis that dysbiosis of the 
intestinal microbiome in older individuals may be driven by altered cross-talk between the host 
immune system and the microbiota. The gut immune system can regulate the composition of the 
microbiome by the production of IgA antibodies that coat commensal bacteria (Macpherson et al. 
2018). Gut IgAs bind to a wide variety of bacteria in the gut lumen and alter the composition of the 
microbiome through several mechanisms, e.g. by blocking antigen interactions of gut microbes with 
the host, or trapping bacteria in the intestinal mucus (Macpherson et al. 2012). Animals that lack 
IgA production have aberrant expansion of anaerobic gut commensals and extensive immune 
hyperplasia (Fagarasan et al. 2002; Suzuki et al. 2004). In line with this, patients with selective IgA 
deficiency have an altered composition of the gut microbiome, associated with increased Th17 cell-
associated inflammation (Fadlallah et al. 2018) and an increased susceptibility to recurrent 
infections, celiac disease and autoimmunity (Cunningham-Rundles 2001). This demonstrates an 
important role of IgA for gut health. 
In the gastrointestinal tract, IgA antibodies are either produced by short-lived plasma cells in the 
lamina propria or from plasma cells that derive from GC reactions in PPs (Bunker & Bendelac 
2018; Ost & Round 2018). In the lamina propria, plasma cells can be generated with or without T 
cell help, and typically secrete IgA antibodies that are encoded by germline immunoglobulin genes. 
In GCs, B cells proliferate and undergo somatic mutation of their immunoglobulin genes. GC B 
cells, which are able to bind antigen with improved affinity after somatic mutation, receive positive 
selection signals from T follicular helper (Tfh) cells and follicular dendritic cells (FDCs) that 
facilitate their differentiation into long-lived antibody secreting plasma cells that secrete high-
affinity IgA (Bunker & Bendelac 2018; Mesin et al. 2016; Ost & Round 2018). Negative regulation 
of the GC reaction is mediated by suppressive T follicular regulatory (Tfr) cells that limit the output 
of the GC (Vanderleyden et al. 2014). Deregulation of Tfh or Tfr cell-mediated control or the 
absence of somatic hypermutation in GC B cells results in changes in the gut IgA repertoire which 
alter the composition of the gut microbiome (Kawamoto et al. 2012; 2014; Wei et al. 2011). This 
suggests that GC-derived IgA antibodies can regulate the commensal microbiome.  
The studies described above have established the existence of a relationship between GC reactions 
and the microbiome and indicate clearly that the microbiome is causally influenced by the GC 
reaction. In the case of the gut-associated defects seen with advancing age in the GC reaction and 
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gut microbiota, however, the direction of causation is unclear. Here we report that the defective GC 
reaction in aged mice could be reversed by co-housing with younger animals or by direct faecal 
transplantation from adult donors. This demonstrates that the age-dependent defect in the gut GC 
reaction is not irreversible, but can be corrected by appropriate external stimuli.  
 Results  
 The GC reaction is diminished in aged PPs  
To assess the impact of ageing on PPs, we compared the GC reaction at this site in 22-month-old 
“aged” mice with 3-month-old “adult” C57BL/6 and BALB/c mice by flow cytometry (gating 
strategy in Figure 4.1). Aged mice of both strains showed a reduction in frequency and number of 
Bcl6+Ki67+B220+ GC B cells (Figure 4.2A-E). This was specific to the PPs, as there was no 
reduction in the proportion of GC B cells in the gut-draining mesenteric lymph nodes (LNs) in the 
same mice (Figure 4.3A-E). GC size depends on interactions with T cells: GC B cells receive 
positive signals from Tfh cells, while Tfr cells negatively regulate the response. The frequency of 
Tfh cells was not affected by age in the PPs (Figure 4.2F-J) in either strain, demonstrating that a 
reduction of Tfh cell number is not the cause of the diminished GC reaction in the PPs of aged mice. 
In mesenteric LNs, there was an increase in the number and frequency of Tfh cells in aged mice 
(Figure 4.3F-J). In the PPs of 22-month-old mice, Tfr cell frequency was not changed in BALB/c 
mice (Figure 4.2K-M) and was slightly decreased in C57BL/6 mice (Figure 4.2N, O), indicating 
that an increase in the proportion of Tfr cells does not contribute to the decreased magnitude of the 
GC reaction in the PPs of aged mice. There was an increase in Tfr cell numbers in mesenteric LNs 
from aged mice in both strains, consistent with previous observations (Sage et al. 2015) (Figure 
4.3K-O). These data show that there is a decrease in the magnitude of the GC reaction in the PPs 
of aged mice, but that this is not obviously linked with age-associated changes in follicular T cell 
subset composition.  
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Figure 4.1: Gating strategy for germinal centre (GC) cell populations in Peyer’s patches (PPs) 
or mesenteric lymph nodes (LNs). GC cell populations in PPs and mesenteric LNs were assessed 
by flow cytometry. IgA+ B cells were defined as live IgA+B220+CD4- cells, GC B cells as live 
Bcl6+Ki67+B220+ cells. T follicular helper (Tfh) cells were defined as live CXCR5hiPD-1hiFoxp3-
CD4+ cells and T follicular regulatory (Tfr) cells as live CXCR5hiPD-1hiFoxp3+CD4+ cells. 
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Figure 4.2: Germinal centre B cells are reduced in the Peyer’s patches of aged BALB/c and 
C57BL/6 mice. Flow cytometric analysis of germinal centre (GC) cell populations in the Peyer’s 
patches (PPs) of adult (3-month-old; 3mo) and aged (22-month-old; 22mo) BALB/c and C57BL/6 
mice. (A-C) Representative flow cytometric plots (A) and quantitation of B220+Ki67+Bcl6+ GC B 
cells (B, C) in the PPs of 3-month-old and 22-month-old BALB/c mice. (D, E) Quantitation of 
B220+Ki67+Bcl6+ GC B cell percentage (D) and number (E) in C57BL/6 mice. (F-H) 
Representative flow plots (F) and quantitation of CD4+Foxp3-CXCR5+PD-1+ Tfh cells (G, H) in 
the PPs of BALB/c mice. (I, J) Quantitation of Tfh cell percentages (I) and numbers (J) in C57BL/6 
mice. (K-M) Representative flow plots (K) and quantitation of CD4+Foxp3+CXCR5+PD-1+ Tfr 
cells (L, M) in BALB/c mice. (N, O) Quantitation of Tfr cell percentages (N) and numbers (O) in 
C57BL/6 mice. Bar graphs show the combined results of 3-6 independent experiments which were 
performed with female BALB/c mice and both male and female C57BL/6 mice with a total of 
n = 11-49 mice per group. Bar height corresponds to the mean, and each circle represents one 
biological replicate. P-values were determined using the Mann-Whitney test in GraphPad Prism6.  
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Figure 4.3: Germinal centre B cells are not reduced in the mesenteric lymph nodes (LNs) of 
aged BALB/c and C57BL/6 mice. Flow cytometric analysis of germinal centre (GC) cell 
populations in the mesenteric LNs of adult (3-month-old; 3mo) and aged (22-month-old; 22mo) 
BALBc and C57BL/6 mice. (A-C) Representative flow cytometric plots (A) and quantitation of 
B220+Ki67+Bcl6+ GC B cells (B, C) in the mesenteric LNs of 3-month-old and 22-month-old 
BALB/c mice. (D, E) Quantitation of B220+Ki67+Bcl6+ GC B cell percentage (D) and number (E) 
in C57BL/6 mice. (F-H) Representative flow plots (F) and quantitation of CD4+Foxp3-
CXCR5+PD-1+ Tfh cells (G, H) in BALB/c mice. (I, J) Quantitation of Tfh cell percentages (I) and 
numbers (J) in C57BL/6 mice. (K-M) Representative flow plots (K) and quantitation of 
CD4+Foxp3+CXCR5+PD-1+ Tfr cells (L, M) in BALB/c mice. (N, O) Quantitation of Tfr cell 
percentages (N) and numbers (O) in C57BL/6 mice. Bar graphs show the combined results of 3-6 
independent repeats which were performed with female BALB/c mice and both male and female 
C57BL/6 mice with a total of 10-41 mice per group. Bar height corresponds to the mean, and each 
circle represents one biological replicate. P-values were determined using the Mann-Whitney test 
in GraphPad Prism6.  
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 The composition of the gut microbiome changes with age 
It is known that the output of the GC reaction can influence the composition of the gut microbiome 
(Ost & Round 2018). Therefore, we sought to understand whether the age-dependent change in the 
GC reaction of PPs was linked with changes in the microbiota. For this, I assessed the bacterial gut 
microbiome in C57BL/6 and BALB/c mice by 16S rDNA sequencing of DNA extracted from faecal 
pellets from 22-month-old “aged” and 3-month-old “adult” mice. Principal Coordinates Analysis 
(PCoA) showed that age impacts the composition of the microbiome and demonstrated that inter-
individual variation of the microbiome increases in aged animals (Figure 4.4A, B; Figure 4.5A). In 
BALB/c mice, six classified bacterial families were reduced in aged mice, whilst two bacterial 
families increased in abundance with age (Figure 4.4C). This corresponded to reduced gut microbial 
diversity in aged BALB/c compared to adult mice (Figure 4.4D). Interestingly, Bacteroides 
acidifaciens and Lactobacillus gasseri, both of which have been shown to induce intestinal IgA 
production, were not detected in aged BALB/c mice (Table 4.1) (Sakai et al. 2014; Yanagibashi et 
al. 2013). Aged C57BL/6 males had increased bacterial diversity (Figure 4.4E), which was 
associated with the increased abundance of seven bacterial families in these mice (Figure 4.4F). 
Bacterial diversity was not changed in aged C57BL/6 females while two bacterial families were 
significantly decreased (Figure 4.5B, C). The abundance of Bacteroides acidifaciens and 
Lactobacillus gasseri was not affected in either female or male C57BL/6 aged mice (Table 4.1), 
suggesting that the age-associated immunological phenotype is not caused by a reduction of these 
particular species. Both aged BALB/c mice and C57BL/6 males had an expansion of Firmicutes at 
the expense of Bacteroidetes at the phylum level (Figure 4.4G, H; Figure 4.6). This analysis shows 
that the composition of the gut microbiome changes with age in mice and that these age-dependent 
changes are also shaped by the sex and genetics of the host.  
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Figure 4.4: The gut microbiome changes during ageing. 16S rDNA sequencing data were 
generated from faecal pellets collected from adult (3-month-old; 3mo) and aged (21-month-old; 
21mo) BALB/c females and C57BL/6 males. (A, B) Bray-Curtis PCoA and (D, E) bacterial 
diversities (measured by Shannon index) of samples collected from 3-month-old and 21-month-old 
BALB/c mice (A, D) and C57BL/6 mice (B, E). The p-value was based on ANOVA tests. (C, F) 
Depiction of bacterial families whose abundance was significantly different between 3-month-old 
and 21-month-old BALB/c (C) and C57BL/6 (F) mice as determined by ANOVA analysis after 
cumulative-sum scaling (CSS). (G, H) Krona plots depicting the phylogenetic composition of the 
gut microbiome in 3-month-old (top) and 21-month-old (bottom) BALB/c (G) and C57BL/6 (H) 
mice. The percentages shown are averages of the samples in each age group. Samples were collected 
in 2 independent experiments for BALB/c mice and 3 independent experiments for C57BL/6 mice 
with a total of n = 5-14 mice per group. P-values are based on ANOVA tests *FDR ≤ 0.05, **FDR 
≤ 0.01, ***FDR ≤ 0.001. This figure was published in Nature Communications (Stebegg et al. 
2019). 
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Figure 4.5: Age-associated changes of the gut microbiome in female C57BL/6 mice. 16S rDNA 
sequencing data were generated from faecal pellets collected from five adult (3-month-old; 3mo) 
and five aged (21-month-old; 21mo) female C57BL/6 mice. (A) Bray-Curtis PCoA of samples 
collected from female C57BL/6 mice. (B) Shannon diversities of samples collected from female 
C57BL/6 mice. The p-value was generated from an ANOVA test. (C) Depiction of bacterial 
families whose abundance was significantly different between adult and aged female C57BL/6 mice 
as determined by ANOVA analysis after cumulative-sum scaling (CSS). *FDR ≤ 0.05, 
**FDR ≤ 0.01, ***FDR ≤ 0.001. (D) Krona plots depicting the phylogenetic composition of the gut 
microbiome in 3-month-old (left) and 21-month-old (right) C57BL/6 females. The percentages 
shown are averages of the samples in each age group. This figure was adapted from Stebegg et al. 
(Stebegg et al. 2019). 
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Figure 4.6: Age-associated changes in the taxa composition of the gut microbiome in C57BL/6 
and BALB/c mice. 16S rDNA sequencing data were generated from faecal pellets collected from 
adult and aged female BALB/c mice as well as male and female C57BL/6 mice. Taxa plots of 
bacterial phyla (A), orders (B) and families (C) detected in faecal samples from adult (3month-old) 
and aged (21-22month-old) BALB/c and C57BL/6 mice generated in QIIME2 with a total of n = 5-
10 mice per group. In (B) and (C) only the 15 most abundant bacterial orders/families are listed in 
the legend. This figure was adapted from Stebegg et al. (Stebegg et al. 2019). 
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BALB/c mice: Aged (21mo) vs Adult (3mo) 
Females 
Taxa (Species level) FDR  F  21mo 3mo 
mean 
Bacteroides_Bacteroides_caecimuris <1E-20 5600 0 7.43 
Bacteroides_Bacteroides_acidifaciens <1E-20 2400 0 9.23 
Prevotellaceae_UCG001_uncultured_bacterium <1E-20 2400 0 9.01 
Rikenellaceae_RC9_gut_group_uncultured_organism <1E-20 2300 0 8.06 
Alistipes_uncultured_bacterium <1E-20 1900 0 9.34 
Anaeroplasma_uncultured_bacterium 4.8E-09 110 8.27 0 
Parabacteroides_Parabacteroides_goldsteinii_CL02T12C30 9.1E-07 58 8.78 3.69 
Lactobacillus_Lactobacillus_gasseri 2.0E-05 39 0 5.92 
Lachnospiraceae_UCG001_uncultured_Clostridiales_bact. 0.0011 20 0 3.86 
Turicibacter_Turicibacter_sp._LA61 0.0053 15 5 0.37 
C57BL/6 mice: Aged (21mo) vs Adult (3mo) 
Males 
Bacteroides_Bacteroides_caecimuris 0.058 16 7.12 2.83 
Parabacteroides_Parabacteroides_goldsteinii_CL02T12C30 0.11 11 4.81 0.98 
Parasutterella_uncultured_organism 0.11 9.8 2.38 7.2 
unclassified_bacterium_uncultured_bacterium 0.11 9.6 12.82 13.77 
Bilophila_uncultured_bacterium 0.14 8.2 5.3 2.11 
Rikenellaceae_RC9_gut_group_uncultured_organism 0.14 7.6 6.09 2.61 
unclassified_uncultured_bacterium 0.15 7.2 8.11 5.17 
Mucispirillum_Mucispirillum_schaedleri_ASF457 0.15 6.9 4.49 0 
Lactobacillus_Lactobacillus_gasseri 0.16 6.4 5.27 9.57 
Lachnospiraceae_FCS020_group_mouse_gut_metagenome 0.18 5.9 3.91 0 
C57BL/6 mice: Aged (21mo) vs Adult (3mo) 
Females 
Parasutterella_Burkholderiales_bacterium_YL45 0.016 7.98 0 8.46 
Odoribacter_uncultured_bacterium 1 6.24 0 7.88 
Bacteroidales_Bacteroidales_bacterium 1 8.99 10.09 9.02 
unclassified_bacterium_uncultured_bacterium 1 12.6 13.51 12.69 
Ruminococcaceae_UCG014_uncultured_bacterium 1 2.56 7.19 0 
Parasutterella_uncultured_organism 1 0 2.93 0 
Lachnospiraceae_UCG006_uncultured_bacterium 1 0 4.46 0 
Ruminiclostridium_5_Ruminiclostridium_sp._KB18 1 3.26 0 3.84 
Ruminococcaceae_UCG010_uncultured_organism 1 2.92 0 3.61 
Turicibacter_Turicibacter_sp._LA61 1 7.15 2.5 8.52 
Table 4.1: Age-related changes on the species level in the gut microbiome of BALB/c and 
C57BL/6 mice. Top 9 species with the lowest false-discovery rate (FDR) p-value detected by 16S 
rDNA sequencing in 3-month-old compared to 23-month-old BALB/c and C57BL/6 mice. 
Significant changes in the abundance of bacterial species between adult and aged mice were 
determined by ANOVA analysis after cumulative-sum scaling (CSS). FDR-adjusted p-values and 
F value were calculated for each species. The table also lists the mean abundance of each species 
after CSS. This table was adapted from Stebegg et al (Stebegg et al. 2019). 
 
 4.Heterochronic faecal transplantation boosts the gut germinal centre reaction: Results 
 
92 
 Co-housing rescues the reduced PP GC reaction in aged mice  
In our initial experiments, adult and aged mice were housed separately from each other, sharing 
cages with their respective littermates. Knowing that the gut microbiome can vary between cages 
(Goodrich et al. 2014) and that co-housed mice exchange faecal bacteria by coprophagy 
(Hildebrand et al. 2013), I decided to repeat these experiments, using 3-month-old adult and 21-
month-old aged mice that were housed in the same cage for 30-40 days. To our surprise, the age-
associated reduction of GC B cells in PPs of BALB/c mice was lost upon co-housing (Figure 4.7A, 
B). This correction of the GC reaction was accompanied by an increase in Tfh cells but Tfr cell 
numbers were unchanged (Figure 4.7C-F). This demonstrates that the age-dependent deficit in the 
magnitude of PP GCs is reversible.  
To determine whether changes in the GC reaction upon co-housing were driven by the transfer of 
faecal microbiota between mice, bacterial 16S rDNA sequencing was performed on faecal pellets 
collected before and after co-housing. PCoA revealed that the microbiome of aged mice was more 
similar to that of 3-month-old adult mice after co-housing, while the microbiome of adult BALB/c 
mice was not significantly changed (Figure 4.7G). Co-housing also increased bacterial Shannon 
diversity in aged mice to levels similar to those in adult mice (Figure 4.7H). This was associated 
with the detection of bacterial species and families which were not identified in samples from aged 
mice prior to co-housing (Figure 4.7I, J), including the species Bacteroides acidifaciens and 
Lactobacillus gasseri (Table 4.2). This rescue of the diminished PP GC reaction in BALB/c mice 
was replicated in 22-month-old C57BL/6 mice upon co-housing with 3-month-old adult mice 
(Figure 4.8A-F). In C57BL/6 mice, co-housing led to reciprocal microbiota transfer between adult 
and aged mice, perhaps because there is no age-associated reduction in bacterial diversity in 
C57BL/6 mice (Figure 4.8G, H). Co-housing was associated with a trend for increased bacterial 
diversity in mice of both ages, although this was not significantly different (Figure 4.8H). Taken 
together, these data suggest that the poor PP GC reaction in aged mice can be rescued by the 
acquisition of the microbiota from younger animals. The rescue of the GC reaction in aged mice 
occurred independently of genetic background, and there was no overlap between the bacterial 
families significantly changed by age or co-housing between BALB/c and C57BL/6 mice (Figure 
4.7J, Figure 4.8I, Table 4.2). This suggests that the co-housing-dependent increase of PP GC B cells 
in aged mice is not driven by a specific bacterial family, but is a response to a comprehensive change 
in the gut microbiome. 
 
 4.Heterochronic faecal transplantation boosts the gut germinal centre reaction: Results 
 
93 
  
Figure 4.7: Co-housing boosts the germinal centre response in the Peyer’s patches of aged 
BALB/c mice. Adult and aged female BALB/c mice were co-housed for 30-40 days, then Peyer’s 
patch (PP) germinal centre (GC) cell populations were analysed by flow cytometry. The percentage 
and number of B220+Ki67+Bcl6+ GC B cells (A, B), CD4+Foxp3-CXCR5+PD-1+ Tfh cells (C, D) 
and CD4+Foxp3+CXCR5+PD-1+ Tfr cells (E, F) in Peyer’s patches. (G-J) 16S rDNA sequencing 
data were generated from faecal pellets collected from 5 adult and 5 aged BALB/c mice at the start 
and end of co-housing (n=5 mice per group). Samples were clustered by Bray-Curtis PCoA (G) and 
bacterial diversities were measured by the Shannon index (H). The overall p-value was based on 
ANOVA tests. (I) Venn diagrams showing the numbers of shared and unique bacterial species 
detected in both age groups of mice before co-housing and after co-housing. (J) Depiction of 
bacterial families whose abundance was significantly different between co-housed BALB/c mice 
as determined by ANOVA analysis after cumulative-sum scaling (CSS). *FD ≤ 0.05, **FDR ≤ 0.01, 
***FDR ≤ 0.001. Families previously found to be significantly decreased in aged versus adult 
BALB/c mice before co-housing are marked in grey. In (A-F) bar plots show the combined results 
of 2 independent experiments with a total of n = 17-18 mice per group. Bar height corresponds to 
the mean, and each circle represents one biological replicate. P-values were determined using the 
Mann-Whitney test in GraphPad Prism6. This figure was published in Nature Communications 
(Stebegg et al. 2019). 
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Figure 4.8: Co-housing boosts the germinal centre response in the Peyer’s patches of aged 
C57BL/6 mice. (A-F) Adult and aged female C57BL/6 mice were co-housed for 30-40 days, then 
Peyer’s patch (PP) germinal centre (GC) cell populations were analysed. The percentage and 
number of B220+Ki67+Bcl6+ GC B cells (A, B), CD4+Foxp3-CXCR5+PD-1+ Tfh cells (C, D) and 
CD4+Foxp3+CXCR5+PD-1+ Tfr cells (E, F) in Peyer’s patches as quantified by flow cytometry. 
16S rDNA sequencing data were generated from faecal pellets collected from 5 adult 3-month-old 
and 5 aged C57BL/6 mice before (start) and after (end) co-housing. Bray-Curtis PCoA (G) and 
Shannon diversities (H) of samples collected from adult and aged C57BL/6 mice. The overall p-
value was based on ANOVA testing. (I) Depiction of bacterial families whose abundance was 
significantly different between co-housed C57BL/6 mice as determined by ANOVA analysis after 
cumulative-sum scaling (CSS). *FDR≤ 0.05, **FDR ≤ 0.01, ***FDR ≤ 0.001. In (A-F) bar plots 
show the combined results of 2 independent experiments with a total of n = 25-30 mice per group. 
Bar height corresponds to the mean, each circle represents one biological replicate. P-values were 
determined using the Mann-Whitney test in GraphPad Prism6. This figure was published in Nature 
Communications (Stebegg et al. 2019). 
 
 
  
BALB/c: Cohousing group comparison P-value (Tukey’s test) Mean Abundance 
Taxa (Species) FDR  F  23mo start- 
23mo end 
3mo start- 
23mo end 
3mo start- 
23mo start 
3mo start- 
3mo end 
23mo 
start 
23mo 
end 
3m
o 
sta
rt 
3mo end 
Alistipes_uncultured_bacterium 1.60E-13 410 3.30E-14 1 3.20E-14 0.43 0 9.6 9.6
5 
9.13 
Prevotellaceae_UCG001_uncultured_bacterium 2.70E-12 260 1.20E-12 0.97 9.10E-13 0.98 0 9.07 9.2
5 
9.42 
Bacteroides_Bacteroides_acidifaciens 1.80E-10 140 3.70E-11 0.82 8.00E-11 1 0 10.07 9.5
7 
9.48 
Lactobacillus_Lactobacillus_gasseri 0.00012 21 0.000012 0.0039 0.034 0.029 0 10.01 4.2
6 
8.62 
Bacteroides_Bacteroides_caecimuris 0.00064 16 0.00016 0.99 0.000097 0.49 0 7.25 7.5
7 
5.75 
Anaeroplasma_uncultured_bacterium 0.001 14 0.14 0.0091 0.000095 0.49 9.47 5.85 0 2.28 
Lachnospiraceae_UCG001_uncultured_bacterium 0.0018 12 0.0085 0.29 0.00022 0.88 8.1 2.66 0 1.08 
Rikenellaceae_RC9_gut_group_uncultured_organis
m 
0.0025 11 0.025 0.087 0.00015 0.022 0 4.68 8.4
2 
3.64 
GCA900066575_uncultured_bacterium 0.014 7.8 0.12 0.00097 0.11 0.12 3.73 0 7.5
1 
3.77 
C57BL/6: Cohousing group comparison         
Parasutterella_Burkholderiales_bacterium_YL45 6.2E-08 78 0.53 1 1.1E-08 0.44 2.4E-09 1.4E-08 7.9
8 
7.16 
Ruminococcaceae_UCG014_uncultured_bacterium 0.006 12 0.24 0.94 0.00023 0.51 0.012 6.9E-04 2.5
6 
0 
Parasutterella_uncultured_organism 0.087 5.8 1 1 0.017 1 0.017 0.017 0 0 
unclassified_bacterium_uncultured_bacterium 0.087 5.8 0.62 0.65 0.005 1 0.057 0.052 12.
6 
12.2 
Lachnospiraceae_UCG006_uncultured_bacterium 0.087 5.8 0.012 0.047 0.86 0.9 0.055 0.19 0 5.7 
Odoribacter_uncultured_bacterium 0.087 5.7 0.99 0.74 0.0095 0.9 0.018 0.07 6.2
4 
6.83 
Mucispirillum_Mucispirillum_schaedleri_ASF457 0.18 4.5 0.29 0.88 0.11 0.085 0.94 0.028 2.3
8 
5.81 
Ruminiclostridium_5_Ruminiclostridium_sp._KB18 0.31 3.6 0.91 0.16 0.047 0.44 0.16 0.9 3.2
6 
4.23 
Bacteroidales_uncultured _Bacteroidales_bacterium 0.44 2.9 0.72 0.54 0.46 0.11 0.089 1 8.9
9 
9.44 
Table 4.2: Co-housing leads to species-level changes in the gut microbiome of BALB/c and C57BL/6 mice. 3-month-old and 23-month-old BALB/c and 
C57BL/6 mice were co-housed for 30-40 days, then the gut microbiome was analysed by 16S rDNA sequencing. The table generated in Calypso lists the overall 
false discovery rate (FDR)-adjusted p-values and F value for the top 9 species with the lowest FDR value. Tukey’s tests were used to calculate p-values for 
group-to-group comparisons. The table also lists the mean abundance for each species in each group after cumulative-sum scaling (CSS). This table was adapted 
from Stebegg et al. (Stebegg et al. 2019). 
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 Heterochronic FMT boosts the GC in PPs 
To investigate whether the induction of the GC reaction during co-housing was solely dependent 
on direct transmission of gut microbiota, I conducted faecal microbiota transplantation (FMT) 
experiments in which recipient mice were given a suspension of faecal pellets from donor mice by 
oral gavage. The cages were also supplemented with fresh faecal pellets and dirty bedding from 
donor mice for three weeks (Figure 4.9A, H). First, I gavaged 22-month-old C57BL/6 mice with 
faecal pellets from 3-month-old adult mice (Figure 4.9A). Twenty-three days after this treatment, 
there was an increase in GC B cell numbers in aged mice (Figure 4.9B, C). I also observed a trend 
towards increased Tfh cells in aged mice (Figure 4.9D, E) and a significant increase in their Tfr cell 
numbers (Figure 4.9F, G). To determine whether the boost in the GC reaction by FMT is exclusive 
to aged mice, 3-month-old C57BL/6 mice were gavaged with faecal pellets from 22-month-old 
adult mice (Figure 4.9H). For this experiment C57BL/6 mice were used because I had evidence of 
reciprocal microbial transfer between adult and aged mice of this strain during co-housing: this 
result indicated that the gut microbiome of both adult and aged C57BL/6 mice is receptive to 
microbial transfer and presented us with a tool to assess whether the transfer of a new microbiome 
generally enhances the GC reaction irrespective of age, or if it constitutes a unique feature in aged 
mice. FMT of younger adult mice with faecal pellets from aged mice led to an increase in GC B as 
well as Tfh cells, while Tfr cell numbers were not affected (Figure 4.9I-N). This demonstrates that 
the GC reaction in PPs is highly sensitive to changes in the gut microbiome irrespective of age. 
Furthermore, the boost of the PP GC reaction appears to be independent of the transfer of a specific 
bacterial family or species, since FMT enhanced the response in both adult and aged recipients.  
To determine whether FMT can rescue the PP GC reaction in aged mice of another strain, we 
performed FMT experiments in 22-month-old BALB/c mice (experimental set-up as in Figure 
4.9A). GC B and Tfh cells had significantly expanded in 22-month-old mice 23 days after FMT 
compared to PBS-treated control mice (Figure 4.10A-D), but Tfr cells were not changed by FMT 
treatment (Figure 4.10E, F). Bacterial 16S rDNA sequencing confirmed the successful 
establishment of an “adult” microbiome in 22-month-old mice by FMT (Figure 4.10G), with a slight 
increase in gut microbial diversity in aged mice receiving FMT (Figure 4.10H). This included the 
presence of bacterial species that were originally not detected in aged mice (Figure 4.10I). Thus, 
microbial transfer is sufficient to restore the defective GC reaction in aged mice. Our data 
demonstrate that, even though the GCs in PPs diminish during ageing, this age-associated 
phenotype is not cell-intrinsic and can be rescued by stimulation from the gut microbiome.  
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Figure 4.9: Faecal microbiota transplantation (FMT) boosts the germinal centre (GC) 
response in Peyer’s patches irrespective of age. (A-G) 21-month-old C57BL/6 males were 
gavaged with faecal pellets from adult, 3-month-old mice. (A) Experimental outline of FMT where 
aged C57BL/6 males were given a suspension of faecal pellets from adult C57BL/6 donor mice by 
oral gavage. The cages of recipient mice were supplemented with fresh faecal pellets and dirty 
bedding from these donor mice once a week. The percentage and number of B220+Ki67+Bcl6+ GC 
B cells (B, C), CD4+Foxp3-CXCR5+PD-1+ Tfh cells (D, E) and CD4+Foxp3+CXCR5+PD-1+ Tfr 
cells (F, G) in Peyer’s patches as quantified by flow cytometry. (H-N) 3-month-old C57BL/6 males 
were gavaged with faecal pellets from aged 21-month-old mice. (H) Experimental outline of FMT 
where adult C57BL/6 males were gavaged with faecal pellets from aged mice. The percentage and 
number of GC B (I, J), Tfh (K, L) and Tfr (M, N) cells were quantified by flow cytometry. Bar 
height corresponds to the mean, each circle represents one biological replicate. Bar plots show the 
combined results of 2 independent experiments with a total of n = 10-15 mice per group. P-values 
were determined using the Mann-Whitney test in GraphPad Prism6. This figure was published in 
Nature Communications (Stebegg et al. 2019). 
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Figure 4.10: Faecal microbiota transplantation (FMT) boosts the germinal centre (GC) 
response in the Peyer’s patches of aged BALB/c mice. 21-month-old BALB/c mice were given 
a suspension of faecal pellets taken from 3-month-old mice by oral gavage. The cages of aged 
recipients were supplemented with fresh faecal pellets and dirty bedding from these donors once a 
week. (A-F) Bar plots show the combined results of 2 independent experiments. The percentage 
and number of B220+Ki67+Bcl6+ GC B cells (A, B), CD4+Foxp3-CXCR5+PD-1+ Tfh cells (C, D) 
and CD4+Foxp3+CXCR5+PD-1+ Tfr cells (E, F) in Peyer’s patches as quantified by flow cytometry. 
Bar height corresponds to the mean, each circle represents one biological replicate. Bar plots show 
the combined results of 2 independent experiments with a total of n = 9-10 mice per group. P-values 
were determined using the Mann-Whitney test in GraphPad Prism6. (G-I) 16S rDNA sequencing 
data were generated from faecal pellets collected from 5 adult donor mice and 5 aged BALB/c mice 
before and after FMT. (G) Bray-Curtis PCoA of FMT samples. (H) Shannon diversities with an 
overall p-value generated from ANOVA tests. (I) Venn diagrams showing the numbers of shared 
and unique bacterial species detected in adult donor mice and aged mice before FMT (start; left) or 
after FMT (end; right). This figure was published in Nature Communications (Stebegg et al. 2019). 
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 Cross-strain FMT does not enhance the GC 
The boost of the GC reaction by heterochronic faecal transplantation in both adult and aged mice 
suggests that alterations in the microbiome can enhance the GC reaction in PPs. To determine 
whether this occurs independently of an age mismatch between the donor and the recipient, I 
performed FMT from 3-month-old BALB/c mice into 3-month-old C57BL/6 mice (experimental 
set-up as in Figure 4.9A). This approach was chosen as there are differences in the microbiome 
between these two strains (Figure 4.11A), and adult BALB/c mice have a higher bacterial diversity 
than C57BL/6 mice (Figure 4.11B). Twenty-three days after FMT, there was no increase in the 
percentage or number of GC B cells, Tfh cells or Tfr cells in C57BL/6 mice that received FMT 
compared to the PBS-treated controls (Figure 4.11C-H). This suggests that the GC reaction in PPs 
responds specifically to heterochronic faecal transplantation. 
 
 
Figure 4.11: Faecal microbiota transplantation (FMT) between adult mice of different strains 
does not affect the germinal centre (GC) response in Peyer’s patches. (A, B) 16S rDNA 
sequencing data generated from faecal pellets collected from adult 3-month-old C57BL/6 and 
BALB/c mice. (A) Bray-Curtis PCoA comparing samples from 3-month-old BALB/c and C57BL/6 
mice. (B) Shannon diversities, with a p-value based on ANOVA tests. (C-H) Three-month-old 
C57BL/6 mice were given a suspension of faecal pellets taken from 3-month-old BALB/c mice by 
oral gavage to achieve FMT. In addition, the cages of C57BL/6 recipients were supplemented with 
fresh faecal pellets and dirty bedding from BALB/c mice once a week. Control mice were gavaged 
with PBS. The percentage and number of B220+Ki67+Bcl6+ GC B cells (C, D), CD4+Foxp3-
CXCR5+PD-1+ Tfh cells (E, F) and CD4+Foxp3+CXCR5+PD-1+ Tfr cells (G, H) in Peyer’s patches 
as quantified by flow cytometry. Bar plots show the combined results of two experiments with a 
total of n = 14-15 mice per group. Bar height corresponds to the mean, each circle represents one 
biological replicate. P-values were determined using the Mann-Whitney test in GraphPad Prism6. 
This figure was published in Nature Communications (Stebegg et al. 2019). 
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 IgA-mediated control of the microbiome is not affected by 
ageing or FMT 
Our data indicated that the composition of the gut microbiome has a dominant effect on the immune 
response in PPs. The question remained whether a diminished GC response in PPs would also affect 
the gut microbiome? PPs have been reported to control the gut microbiome by giving rise to plasma 
and memory B cells secreting IgA antibodies that bind to commensals with high affinity, but IgAs 
can also be produced in the lamina propria in a GC-independent manner (Reboldi & Cyster 2016). 
The reduction of GC B cells I observed in aged mice was not associated with reduced levels of 
commensal IgA-coating in the ileum or colon of BALB/c of C57BL/6 mice (Figure 4.12A-G). Both 
cohousing and FMT boosted the GC response, still there was no change in the levels of bacterial 
IgA-coating (Figure 4.12H-K, Figure 4.13J-M). FMT did not affect the levels of PP-resident IgA+ 
B cells or free intestinal IgA in both mouse strain either (Figure 4.13A-I). This suggests that IgA-
mediated control of the gut microbiome is not affected by changes in the GC response in aged mice 
and made us question whether GC-derived IgA antibodies are indeed a major contributor to the 
control of the commensal microbiota.  
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Figure 4.12: IgA-coating of faecal bacteria is not affected by ageing or cohousing. (A-G) 
Bacterial IgA-coating was assessed in adult (3-month-old; 3mo) and aged (22-month-old; 22mo) 
mice. (A) Gating strategy for IgA-coated bacteria. (B, C) Representative flow cytometric plots of 
IgA-coated faecal bacteria isolated from the ileum (B) and colon (C) of BALB/c mice. (D-G) 
Quantitation of IgA-coating of bacteria in faecal contents isolated from the ileum (D, E) and colon 
(F, G) of adult and aged BALB/c (D, F) and C57BL/6 (E, G) mice. Bar plots show the combined 
results of 2-4 independent experiments with a total of n = 11-16 mice per group. (H-K) Bacterial 
IgA-coating was assessed in adult (3-4-month-old; 3mo/4mo) and aged (22-month-old; 22mo) mice 
after co-housing for 40 days. Quantitation of IgA-coating of bacteria in faecal contents isolated 
from the ileum (H, I) and colon (J, K) of cohoused BALB/c (H, J) and C57BL/6 (I, K) mice. Bar 
plots show the combined results of 2-4 independent experiments with a total of n = 19-30 mice per 
group. Bar height corresponds to the mean, and each circle represents one biological replicate. P-
values were determined using the Mann-Whitney test in GraphPad Prism6. This figure was adapted 
from Stebegg et al. (Stebegg et al. 2019). 
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Figure 4.13: Faecal microbiota transplantation (FMT) does not affect gut IgA responses. 21-
month-old mice were given a suspension of faecal pellets taken from 3-month-old mice by oral 
gavage. The cages of these aged recipients were supplemented with fresh faecal pellets and dirty 
bedding from adult donors once a week. A control group received PBS by oral gavage. After 3 
weeks, intestinal IgA levels were assessed in adult donor mice (4mo), aged control mice 
(23mo+PBS) and aged mice receiving FMT (23mo+FMT). (A) Representative flow cytometric 
plots for IgA+ B cells (CD4-B220+IgA+) cells in the Peyer’s patches (PPs) of adult (3-month-old; 
3mo) and aged (22-month-old; 22mo) BALB/c mice. (B-E) Quantitation of IgA+ B cells in 
percentage (B, D) and cell numbers (C, E) in BALB/c (B, C) and C57BL/6 (D, E) mice by flow 
cytometry. (F-I) Quantitation of free IgA in faecal contents isolated from the ileum (F, H) and colon 
(G, I) of BALB/c (F, G) and C57BL/6 (H, I) mice by ELISA. (J-M) Quantitation of IgA-coating 
of bacteria in faecal contents isolated from the ileum (J, L) and colon (K, M) of BALB/c (J, K) 
and C57BL/6 (L, M) mice. Bar plots show the combined results of two independent experiments 
with a total of n = 8-16 mice per group. Bar height corresponds to the mean, and each dot represents 
one biological replicate. P-values were determined using the Kruskal-Wallis test with Dunn’s 
multiple testing correction in GraphPad Prism6. This figure was published in Nature 
Communications (Stebegg et al. 2019). 
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 Reduction of PP GCs has a minimal impact on the gut 
microbiome  
Previous studies described normal levels of intestinal IgA and commensal IgA-coating in T cell-
deficient mice, suggesting that commensal-specific IgA can be produced in a GC-independent 
manner (Bergqvist et al. 2006; Bunker et al. 2015; Gärdby et al. 2003). To test this, I compared the 
microbiomes of Bcl6fl/flCd4cre/+ mice, which do not form GCs due to a failure of Tfh cell 
differentiation, with their Bcl6fl/flCd4+/+ littermates that were housed in the same cages (Hollister et 
al. 2013). PPs from Bcl6fl/flCd4cre/+ mice completely lacked Tfh and Tfr cells and had very few GC 
B cells (Figure 4.14A-F). This was associated with a significant reduction of IgA+ B cells in their 
PPs (Figure 4.14G-H). However, this did not affect commensal IgA-coating in the ileum (Figure 
4.14I), suggesting that gut bacteria are primarily coated by IgA antibodies derived from the lamina 
propria. Unexpectedly, IgA-coating in the colon, where no PPs can be found, was increased in 
Bcl6fl/flCd4cre/+ mice (Figure 4.14J), possibly due to augmented IgA production in the lamina 
propria compensating for the loss of GC-derived IgA antibodies. 
16S rDNA sequencing revealed only minor differences in microbial composition of the ileum and 
colon of Bcl6fl/flCd4cre/+ and their co-housed Bcl6fl/flCd4+/+ littermates (Figure 4.14K-Q). PCA of all 
16S rDNA sequencing samples indicated that the source organ was the biggest driver of variation 
(Figure 4.14K). Separate analysis of the samples from the ileum and colon did not reveal clustering 
of samples by genotype (Figure 4.14L, M), and no differences in bacterial diversity between 
genotype groups was observed (Figure 4.14N, O). In our experiments, gender had a stronger effect 
on clustering in the PCA plots than the lack of GCs (Figure 4.14L, M). This indicates that GC-
derived IgA is not required for the regulation of overall gut microbial composition. However, 
Deltaproteobacteria and Bacteroidia were significantly underrepresented in the ileum of 
Bcl6fl/flCd4cre/+ mice at the class level (Figure 4.14P). On the genus level, only one bacterial taxa 
was found to be significantly affected by the lack of GCs: Candidatus Arthromitus, a group of 
segmented filamentous bacteria (SFB) (Figure 4.14P) (Snel et al. 1995). This was also different 
between genotypes in the colon (Figure 4.14Q). Thus, the increase in bacterial IgA-coating 
observed in the colon of Bcl6fl/flCd4cre/+ mice does not result in global restructuring of the gut 
microbiome. Instead, the lack of GCs in PPs affects one species of SFBs. These data suggest that 
GC-derived IgA antibodies play a minor role in the control of the commensal microbiome. The 
microbiome, by contrast, is a potent regulator of the GC response in PPs.  
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Figure 4.14: Bcl6fl/flCd4cre/+ mice have reduced germinal centre (GC) responses but a near-to-
normal gut microbiome. (A-J) Characterisation of GC cell populations in the Peyer’s patches 
(PPs) and IgA-coating of faecal bacteria in Bcl6fl/flCd4cre/+ mice and their littermate controls. The 
percentage and number of B220+Ki67+Bcl6+ GC B cells (A, B), CD4+Foxp3-CXCR5+PD-1+ Tfh 
cells (C, D) and CD4+Foxp3+CXCR5+PD-1+ Tfr cells (E, F) in Peyer’s patches (PPs) as quantified 
by flow cytometry. (G, H) Quantitation of IgA+ B cell percentages (G) and numbers (H) in the PPs 
of Bcl6fl/flCd4cre/+ mice. Quantitation of IgA-coating of bacteria in faecal contents isolated from the 
ileum (I) and colon (J). Bar plots show the combined results of 2 independent experimental repeats 
with a total of n = 7-13 mice and each circle represents one biological replicate. Bar height 
corresponds to the mean, error bars to SD. P-values were determined using the Mann-Whitney test 
in GraphPad Prism6. (K-Q) 16S rDNA sequencing data were generated from the faecal contents of 
the colon and ileum collected from five Cd4cre/+ Bcl6fl/fl mice and 5 littermate controls in two 
independent experiments. All samples (K), or samples from the ileum (L) or colon (M) were 
clustered by Bray-Curtis PCoA. (N, O) Alpha diversities (measured by the Shannon index) of 
samples collected from the ileum (N) or colon (O) of Bcl6fl/flCd4cre/+ and Bcl6fl/flCd4+/+ mice. P-
values are based on ANOVA tests. (P, Q) Depiction of bacterial clades whose abundance was found 
to be significantly different between genotypes in the ileum (P) and colon (Q) as determined by 
ANOVA analysis. *…FDR ≤ 0.05, **…FDR ≤ 0.01. 
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 FMT does not enhance PP GC responses to cholera toxin 
Even though GC-derived IgA antibodies might not be required to regulate commensal bacteria, they 
were shown to provide protection against intestinal pathogens (Hashizume et al. 2008) and oral 
tolerance (Fujihashi et al. 2001). To confirm a role of the GC response in PPs in the immune 
response to foreign antigen, I performed a pilot experiment, immunising Bcl6fl/flCd4cre/+ mice and 
their Bcl6fl/flCd4+/+ littermate controls with ovalbumin (OVA) in combination with cholera toxin 
(CTx), a strong mucosal immunogen, three times over the course of three weeks. PPs from CTx-
treated Bcl6fl/flCd4cre/+ mice again had very few GC B cells, a decrease in the proportion of PP-
resident IgA+ B cells and a striking reduction in IgG1+ B cells (Figure 4.15A-F). This was associated 
with the complete loss of OVA- and CTx-specific antibody responses in the serum and in the ileum, 
indicating that the GC response in PPs is indeed essential for mucosal antibody responses against 
foreign antigens (Figure 4.15G-J).  
Kato et al. have previously linked the reduction of oral tolerance in aged mice with ageing-related 
changes in their PPs (Kato et al. 2003). Thus, the increase of intestinal infections in older individuals 
could be linked with an age-associated defect in their Peyer’s patches (Kolling et al. 2012). To 
determine whether FMT can boost the immune response to foreign antigen in aged mice, I 
immunised 23-month-old C57BL/6 mice with CTx coupled to the hapten NP (NP-CTx) by oral 
gavage three times at weekly intervals, either with or without prior FMT from 3-month-old donors. 
Assessment of mucosal antibody responses in the faecal contents of the ileum showed that there 
was no difference in anti-CTx and anti-NP IgA titres between mice that received FMT and PBS 
controls (Figure 4.16A, B). Further, there was no difference in the titre of high-affinity anti-NP2 
IgA or in the ratio of NP2/NP20 binding antibodies (Figure 4.16C, D), a measure of affinity 
maturation. Consistent with this, serum anti-CTx and anti-NP IgG1 antibody titres and affinity were 
not influenced by FMT in aged mice (Figure 4.16E-H). Assessment of the GC reaction in the PPs 
of these animals showed that immunisation with NP-CTx alone was sufficient to boost the GC 
response in 23-month-old animals independently of FMT, with no changes in Tfh or Tfr cell number 
(Figure 4.16I-N). This shows that FMT cannot enhance GC responses to immunisations with 
foreign antigen, but suggests the GC response in the PPs of aged mice can be induced by different 
immunological stimuli, such as microbial transfers or the strong immunogen CTx.  
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Figure 4.15: Tfh cells in Peyer’s patches (PPs) are required for antibody responses to foreign 
antigen. Bcl6fl/flCd4cre/+ mice and their Bcl6fl/flCd4+/+ littermate controls were immunised with 
1 mg OVA plus 50 µg CTx once a week for three weeks, then OVA- and CTx-specific antibody 
responses were assessed. (A-F) Quantitation of the percentage and number of B220+Ki67+Bcl6+ 
GC B cells (A, B), IgA+ B cells (C, D) and IgG1+ B cells (E, F) in Peyer’s patches (PPs) by flow 
cytometry. (G-I) OVA-specific (G) and CTx-specific (H) IgG1 as well as CTx-specific IgA levels 
were assessed in the serum by ELISAs. (J) CTx-specific IgA levels in faecal contents from the 
ileum were assessed by ELISA. No OVA-specific IgA antibodies could be detected in either 
Bcl6fl/flCd4cre/+ mice or Bcl6fl/flCd4+/+ littermate controls. Bar plots show the results of one 
experiment with n = 5 mice per group. Bar height corresponds to the mean, and each circle 
represents one biological replicate. P-values were determined using Mann-Whitney tests in 
GraphPad Prism6.  
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Figure 4.16: Faecal microbiota transplantation (FMT) does not enhance NP-CTx-specific 
immune responses in the gut. 21-month-old C57BL/6 mice received FMT or PBS by oral gavage 
as described above, followed by three oral immunisations with NP-CTx once a week. After three 
weeks, NP-CTx-specific antibody levels were analysed in PBS-gavaged, NP-CTx-immunised 23-
months-old C57BL/6 mice (CTx) compared to aged mice receiving FMT plus NP-CTx (FMT+CTx). 
Peyer’s patch (PP) germinal centre (GC) responses in these mice were compared to naïve, 23-
month-old C57BL/6 mice (Ctrl). (A-D) Antigen-specific IgA levels against CTx (A) and NP (B-D) 
in faecal contents from the ileum were assessed by ELISA. NP20-specific IgA (B), high-affinity 
NP2-specific IgA (C) and the ratio of NP2-to-NP20-specific IgA antibodies (D) were used as a 
measure for affinity maturation. (E-H) Antigen-specific IgG1 levels against CTx (E) and NP (F-
H) in the serum were assessed by ELISAs for CTx-specific IgG1 (E), NP20-specific IgG1 (F), 
high-affinity NP2-specific IgG1 (G) and the ratio of NP2-to-NP20-specific IgG1 antibodies (H). 
(I-N) The percentage and number of B220+Ki67+Bcl6+ GC B cells (I, J), CD4+Foxp3-CXCR5+PD-
1+ Tfh cells (K, L) and CD4+Foxp3+CXCR5+PD-1+ Tfr cells (M, N) in PPs were quantified by flow 
cytometry. Bar plots show the combined results of two independent experiments with a total of 
n = 10-13 mice per group. Bar height corresponds to the mean, and each circle represents one 
biological replicate. P-values were determined using Mann-Whitney tests (A-H) or the Kruskal-
Wallis test with Dunn’s multiple testing correction (I-N) in GraphPad Prism6. This figure was 
published in Nature Communications (Stebegg et al. 2019). 
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 Discussion  
The composition of the commensal gut flora changes with age. This linked with an increase in age-
associated morbidities such as frailty (Claesson et al. 2012; Maffei et al. 2017) and intestinal 
disorders (Biagi et al. 2010), but the cause of this shift in the gut microbial composition is unknown. 
Here we sought to determine whether there is a causal link between age-dependent changes in the 
microbiome and the defective GC reaction in PPs of aged mice. I show that the diminished GC 
reaction in the PPs of aged mice can be rescued by co-housing with younger animals, as well as by 
transplantation of faecal microbiota from adult mice. These data demonstrate that the defective GC 
response in aged mice is not a cell-intrinsic feature of the ageing immune system and can be restored 
by replenishment of the microbiome or stimulation with CTx.  
The ageing-related decline in the GC response in LNs has been linked to a decrease in the functions 
of multiple cell types, including antigen-presenting cells (APCs), T and B cells (Linterman 2014). 
However, it is not clear whether these age-associated defects are predominantly caused by 
accumulation of immune cell-intrinsic defects, or reduced stimulation of immune cells via their 
microenvironment (Weng 2006). Our data suggest that, in the PPs of aged mice, the capacity of GC 
B cells to respond to antigen is not impaired in a cell-intrinsic manner, but that they can respond to 
stimulation from the gut microbiota. Interestingly, the GC reaction in PPs was more strongly 
boosted following FMT than by co-housing. If the increase in magnitude of the GC response in 
aged mice is transient, this discrepancy could be explained by the duration of the different 
experiments, as we assessed the PPs GC reaction 23-days after FMT, and 30-40 days after the start 
of cohousing. The observation that not only microbial transfer, but also the potent mucosal 
immunogen CTx can stimulate the GC response in older animals indicates that the expansion of the 
GC reaction by FMT is not due to reactivation of commensal-specific memory B cells that persist 
in aged mice after their microbiome changes. Rather it suggests that strong immunogens, or potent 
adjuvants, can induce GC responses in the PPs of aged mice.  
Despite smaller GCs in the PPs of aged mice, the levels of commensal IgA-coating are comparable 
between older mice and younger animals, indicating that sufficient IgA is produced by a 
compensatory mechanism. IgA antibodies can be generated in a T cell-independent fashion in the 
lamina propria or in a GC-dependent fashion in PPs (Pabst 2012). Elegant studies conducted by 
Fagarasan and co-workers suggested that GC-dependent IgA antibodies are essential for the 
maintenance of microbial homeostasis. They used mice lacking either Tfh- or Tfr-dependent control 
of their GCs (Kawamoto et al. 2012; 2014) or somatic hypermutation in GC B cells (Wei et al. 
2011) to show that disruptions of the GC response in PPs leads to changes in the gut IgA repertoire 
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and in the gut microbial composition of these mice. What is more, Kubinak et al. suggested that 
Tfh cells in PPs are required to control the composition of the mucosa-resident gut microbiota in 
particular (Kubinak et al. 2015). However, other studies have shown that mice lacking T cell-
dependent immune responses (CD28-deficient mice (Gärdby et al. 2003) and CD40-deficient 
mice(Bergqvist et al. 2006)) or Tfh cells (Bcl6fl/flCd4cre/+ (Bunker et al. 2015)) have high IgA 
antibody titres, near-to-normal levels of bacterial IgA-coating, and relatively normal microbial 
composition, despite the lack of a GC response. This suggests that GC-independent IgA is sufficient 
to control the gut microbiota. To investigate the role of the GC in controlling the microbiota, I 
studied mice that lack Tfh cells and therefore do not have a good GC response. I found that only 
the abundance of one species, a type of SFB, was altered in these mice, indicating that the GC is 
not required to control gut microbial homeostasis. This is consistent with the findings of Bunker et 
al., who reported that IgA-coating of SFBs is T cell-dependent (Bunker et al. 2015). This indicates 
that GC-derived IgA antibodies only regulate a small subset of bacteria and that changes in the gut 
microbiome during ageing are not likely driven by the reduced PP GC response of aged mice.  
It is well established that the gut microbiome is affected by ageing, but there is no consensus on 
how exactly the gut microbiome changes with age. This is probably due to the high variability 
detected in microbiomes from different geographical locations in both mice and humans (Ericsson 
et al. 2015; Mueller et al. 2006; Rausch et al. 2016). Several studies on the human microbiome 
reported of reduced bacterial diversity in aged individuals (Biagi et al. 2010; Maffei et al. 2017) 
and Claesson et al. observed larger inter-individual variability in older individuals compared to 
young controls (Claesson et al. 2011). Our study reports the same general trends – increased inter-
individual variability of both aged BALB/c and C57BL/6 mice, and a reduced bacterial diversity in 
aged BALB/c mice. The differences in the microbiome observed between strains of mice and 
between the sexes of the same strain, all of which were aged in the same animal facility under the 
same environmental conditions, indicate that interactions between age, sex and genetics play a role 
in shaping age-associated alterations of the gut microbiome.  
The change in gut microbial composition with age has been linked with many age-associated 
disorders (Fransen et al. 2017; Shin et al. 2018). Transfer of an aged microbiome into germ-free 
mice causes systemic inflammation (Fransen et al. 2017; Thevaranjan et al. 2017), suggesting that 
the aged microbiome itself may contribute to so-called inflammaging. Our results indicate that 
replenishing the microbiome of aged mice with that of a younger animal can boost the local GC 
reaction, which may have implications for the overall health of the organism. Consistent with this 
hypothesis, remodelling of the gut microbiome in Drosophila melanogaster has been shown to 
increase lifespan (Obata et al. 2018; Westfall et al. 2018). Similarly, middle-aged killifish colonised 
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with a young microbiome were found to live longer than untreated fish (Smith et al. 2017) and 
bacterial-derived indoles were shown to increase the lifespan of mice (Sonowal et al. 2017). These 
data suggest that there is a direct link between the phenotypes associated with ageing and age-
associated changes in the gut microbiome. Previous studies showed that supplementation of older 
humans or mice with pre- and probiotics results in changes of gut microbial composition and can 
improve gut immunity in older individuals (Kaburagi et al. 2007; Landete et al. 2017). Further, the 
transfer of a young microbiome into aged mice increases protection against C. difficile infection 
(Shin et al. 2018), indicating that the microbiota of young animals can functionally boost intestinal 
immune protection. This makes the gut microbiome a possible target for the treatment of a range of 
age-associated symptoms. FMT (Gupta et al. 2016), probiotics (Landete et al. 2017), co-habitation 
(Song et al. 2013) and diet (Clements & R. Carding 2018) all have an impact on the composition 
of the gut microbiome and could prove to be innovative interventions to facilitate healthy ageing.  
 
Note: 
An adaption of this chapter was published in Nature Communications: Stebegg M, Silva-Cayetano 
A, Innocentin S, Jenkins TP, Cantacessi C, Gilbert C, Linterman MA. 2019. Heterochronic faecal 
transplantation boosts gut germinal centres in aged mice, Nature Communications. 10(1), 2443 
(Stebegg et al. 2019).  
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 TYPE I INTERFERON SIGNALLING 
BOOSTS T FOLLICULAR HELPER CELL 
DIFFERENTIATION IN AGED MICE  
 Abstract 
Most vaccinations prevent infectious diseases by generating long-lasting humoral immunity. In 
older people, the efficacy of vaccinations is reduced, possibly due to an age-associated deterioration 
of vaccine-specific germinal centre (GC) responses. GCs are structures that form in secondary 
lymphoid organs (SLOs) such as lymph nodes (LNs). Here, antigen-specific B cells somatically 
mutate their antigen receptor in a process known as somatic hypermutation which, when coupled 
to affinity-based selection, can improve the affinity of the B cell receptor (BCR) for antigen. Within 
GCs, antigen-activated B cells interact with a specialised population of CD4 T cells, T follicular 
helper (Tfh) cells, whose differentiation is initiated by priming by dendritic cells (DCs). Previous 
studies by others have indicated that the impaired formation of GCs in aged mice is linked with 
defective T cell priming. Here, I demonstrate that T cell priming in aged animals is impaired due to 
defective interferon (IFN) signalling in type 2 conventional DCs (cDC2s). By enhancing type I IFN 
signalling at immunisation sites using the TLR7-agonist imiquimod, I was able to restore 
CD80/CD86 expression levels on cDC2s and improve the formation of Tfh cells in aged animals. 
This demonstrates that age-associated defects in the Tfh cell response are not irreversible and that 
DCs are a potential target to improve vaccine responses in the ageing population. 
 Background 
Vaccinations are one of the most successful medical interventions for preventing infectious diseases, 
greatly contributing to the global extension of life expectancy in the 20th century. Most vaccines on 
the market provide protection by generating long-lived humoral immunity that derives from the GC 
responses as well as extrafollicular responses in the absence of an infection. Unfortunately, 
vaccinations are less effective in older people, which has been proposed to be driven by an age-
associated impairment of their GC response (Aberle et al. 2013; Gustafson et al. 2018; Linterman 
2014). GCs are specialised microstructures which form in SLOs such as LNs upon infection or 
vaccination. Here, antigen-specific GC B cells somatically hypermutate the genes encoding their 
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BCR, and this mutational process, coupled with subsequent affinity-based selection, results in the 
emergence of plasma cells and memory B cells that bind antigen with improved affinity (Stebegg, 
Kumar, Silva-Cayetano et al. 2018). Only B cells with high affinity for foreign antigen receive 
survival signals from Tfh cells and follicular dendritic cells (FDCs) in GCs, preventing the survival 
of B cells with self-reactive or non-functional antigen receptors from this random mutation process 
(Mesin et al. 2016). 
Tfh cells are generated in SLOs by priming by antigen-presenting cells (APCs). APCs provide three 
signals to drive the differentiation of Tfh cells (Krishnaswamy et al. 2018): signal one is provided 
when APCs take up antigen, internalise it and present peptide-MHC-II complexes to T cells (Webb 
& Linterman 2017). Upon activation of pattern recognition receptors (PRRs) on APCs by pathogen-
associated molecular patterns (PAMPs), they also provide signal two by upregulating their 
expression of co-stimulatory ligands such CD80 and CD86 which interact with CD28, a co-
stimulatory receptor on the surface of T cells which, when bound by its ligands, enhances T cell 
receptor (TCR) signalling and boosts Tfh cell differentiation (Krishnaswamy et al. 2018). PAMP-
dependent activation also triggers signal three – the production of cytokines implicated in Tfh cell 
priming such as IL-6, IL-12 and IL-27 (Eddahri et al. 2009; Webb & Linterman 2017). Several DC 
subtypes have been shown to activate T cells and to induce their migration to the T-B border, but 
migratory cDC2s have been proposed as the dominant Tfh cell-priming DC subset (Krishnaswamy 
et al. 2017; 2018). cDC2s have been shown to produce IL-6 and IL-27, cytokines known to favour 
Tfh cell differentiation in a type I IFN-dependent manner (Batten et al. 2010; Cucak et al. 2009; 
Gringhuis et al. 2014). Thus, cDC2 cells are potent inducers of Tfh cell differentiation and 
important to initiate GC responses.  
Ageing is correlated with reductions in GC magnitude, somatic hypermutation (SHM) and high-
affinity serum antibodies (Eaton et al. 2004; Kosco et al. 1989; Kraft et al. 1987; Linterman 2014; 
van Dijk-Härd et al. 1997; Yang et al. 1996). These defects in the output of the GC response have 
been linked with defects in the T cell compartment (Gustafson et al. 2018; Linterman 2014; 
Nikolich-Žugich 2018). Adoptive transfers of T cells from aged mice into young animals results in 
the formation of smaller GCs with reduced antibody output (Eaton et al. 2004). Increasing the naïve 
T cell output from the thymus, however, is not sufficient to rescue the ageing GC phenotype 
(Lefebvre et al. 2012). T cells from adult mice transferred into aged hosts prior to immunisation 
also form fewer Tfh cells than in adult hosts. This suggests that in addition to age-associated T-cell 
intrinsic defects, the aged microenvironment, which includes APCs, is also impaired in old age 
(Lefebvre et al. 2012).  
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In aged subjects, T cell priming by DCs has been reported to be impaired, linked with the reduced 
phagocytosis and migration of DCs in aged subjects (Agrawal et al. 2007). Furthermore, reduced 
expression of the costimulatory molecules CD80 and CD86, as well as MHC-II, on DCs has been 
observed in aged mice before and after infection (Moretto et al. 2008). This impairs the potential 
of these DCs for activating T cells via MHC-II-dependent antigen presentation. CD4 T cells from 
aged mice were also shown to be less responsive to IL-6 stimulation by DCs (Brahmakshatriya et 
al. 2017). Together, these data indicate that reduced T cell priming by DCs drives at least some of 
the age-associated defects in the GC response. What causes these defects is still unknown. 
Our study investigated whether T cell priming by DCs could be improved to enhance GC responses. 
The results presented here show that impaired T cell priming in aged animals is associated with 
reduced expression levels of the co-stimulatory ligands CD80 and CD86 on migratory cDC2s. This 
is linked with defective type I IFN signalling in the same cells. By enhancing type I IFN signalling 
at immunisation sites, I was able to restore CD80 and CD86 expression levels on cDC2s. This 
enhanced the formation of antigen-specific Tfh cells in aged animals and demonstrates a link 
between impaired T cell priming in aged animals and reduced type I IFN signalling in cDC2s. This 
reveals that age-associated defects in Tfh cell priming are not irreversible and that cDC2s could be 
a target to improve vaccination efficacy in older individuals. 
 Results 
 GC responses are impaired in aged mice 
The GC responses in aged, 22-24-month-old C57BL/6 mice after vaccination were compared to 
those in 2-3-month-old adult mice after subcutaneous immunisation with NP-1W1K in Alum. The 
use of a 1W1K peptide-conjugate allowed us to track antigen-specific T cell responses by flow 
cytometry using 1W1K-loaded MHC-II tetramers. In aged mice, there was a reduction in the 
proportion and number of Ki67+Bcl6+B220+ GC B cells compared to adult mice 7 days after 
immunisation (gating strategy in Figure 5.1; Figure 5.2A-B). This was associated with a reduction 
in GC size as observed by confocal fluorescence microscopy on day 14 after immunisation (Figure 
5.2C) and accompanied by reduced numbers of both total CXCR5hiPD-1hiFoxp3-CD4+ Tfh cells 
and antigen-specific Tfh cells in aged mice, as determined by 1W1K-coupled tetramer stains 
(Figure 5.2D-G). This confirms that GC responses in aged C57BL/6 mice are reduced in magnitude, 
which is associated with a defect in the Tfh cell compartment. 
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Figure 5.1: Gating strategy for germinal centre (GC) cell populations. 2-3-month-old adult and 
22-24-month-old aged C57BL/6 mice were immunised subcutaneously with NP-1W1K in Alum. 
Their draining inguinal LNs were analysed by flow cytometry 7 days later. GC B cells were defined 
as Bcl6+Ki67+B220+ cells, T follicular helper (Tfh) cells as CXCR5hiPD-1hiFoxp3-CD4+ cells and 
antigen-specific Tfh cells as 1W1K-I-Ab+CXCR5hiPD-1hiFoxp3-CD4+ cells. 
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Figure 5.2: Germinal centre (GC) responses are impaired in aged mice. 2-month-old adult and 
23-month-old aged C57BL/6 mice were subcutaneously immunised mice with NP-1W1K (A, B, 
D-F) or NP-KLH (C) in Alum. Their draining inguinal LNs were analysed 7 days later by flow 
cytometry (A, B, D-F) or after 14 days by confocal imaging (C). (A, B) Representative flow 
cytometric plots (A) and quantitation (B) of B220+Ki67+Bcl6+ GC B cells. (C) Confocal images 
generated by Ine Vanderleyden of draining LNs from 2-month-old and 23-month-old mice, taken 
14 days after subcutaneous immunisation with NP-KLH. 10 µm LN sections were stained with anti-
IgD (orange), anti-CD3 (green), anti-Ki67 (blue) and anti-Foxp3 (pink) antibodies. (D-G) 
Representative flow cytometric plots (D, E) and quantitation (F, G) of CXCR5hiPD-1hiFoxp3-CD4+ 
T follicular helper (Tfh) cells (D, F) and antigen-specific 1W1K-I-Ab+ Tfh cells (E, G). Bar graphs 
show the results of one of two independent experiments performed by Alexandre Bignon. Bar 
height corresponds to the mean, and each circle represents one biological replicate. P-values were 
determined using the Mann-Whitney test in GraphPad Prism6.  
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 Impaired T cell priming in aged animals 
To test whether the reduced number of Tfh cells in aged mice was caused by a defect in early APC-
dependent T cell activation and/or Tfh cell differentiation, TCRVb3+CD45.1+ cells that are specific 
for a peptide of Hen Egg Lysozyme (HEL) were taken from 3-month-old adult TCR7 mice, 
CellTrace-labelled and then adoptively transferred into either adult or aged hosts. Three days after 
subcutaneous immunisation with HEL in Alum ~ 80 % of all CD45.1+CD4+ T cells had undergone 
one or more cell division in adult hosts (gating strategy in Figure 5.3A-B; Figure 5.3C-D). In aged 
hosts, fewer TCR7 T cells had entered the cell cycle (Figure 5.3C-D). Once T cells had entered the 
cell cycle, expression of the T cell co-stimulatory receptor ICOS was comparable between T cells 
in hosts of different ages (Figure 5.3E). This indicates that the aged microenvironment results in 
impaired T cell priming, and prompts the hypothesis that this impaired priming may underpin 
reduced antigen-specific Tfh cell numbers in aged mice.  
Several DC subtypes, including LN-resident and type 1 conventional DCs (cDC1s), type 2 
conventional DCs (cDC2s) and skin-resident Langerhans cells, have been implicated in T cell 
priming. Of these, migratory cDC2 subset have been suggested as the dominant Tfh-priming DC 
subset (Krishnaswamy et al. 2017; 2018), although the route of immunisation or infection 
influences which DC subtype plays the dominant role in Tfh cell priming . To test which cell type 
is the main APC in the draining LN in our experimental set-up, mice were immunised 
subcutaneously with Ea-coupled GFP in Incomplete Freund’s Adjuvant (IFA) (Itano et al. 2003). 
This allowed us to track which cells had taken up antigen (GFP+) and which cells were presenting 
a Ea-derived peptide on MHC-II using the Y-ae antibody (Itano et al. 2003). One day following 
subcutaneous immunisation in adult mice, the majority of GFP+ APCs were migratory CD11b+ 
cDC2s (gating strategy based on Guilliams et al. 2016) in Figure 5.4A; Figure 5.4B). The number 
of antigen-bearing GFP+ CD11b+ cDC2s were reduced in the draining LNs of aged compared to 
adult mice (Figure 5.4C). Of the cDC2 cells that had taken up antigen, there was less presentation 
of peptide-MHC-II in aged mice even though levels of total MHC-II expression on the cell surface 
was unchanged (Figure 5.4D, H, I). Expression of the costimulatory ligands CD86, CD80 and the 
receptor CD40 was reduced on the surface of GFP+ CD11b+ cDC2s from aged mice (Figure 5.4E-
G, J-L). This observation is consistent with previous reports on reduced co-stimulation by DCs from 
aged mice and suggests a link between impaired T cell priming in draining LNs of aged mice and 
defects in the CD11b+ cDC2 subset (Moretto et al. 2008). 
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Figure 5.3: T cell proliferation is impaired in aged hosts. (A) 3-5 ´ 106 CellTrace violet (CTV)-
labelled Hen Egg Lysozyme (HEL)-specific TCRVb3+CD4+ cells from TCR7 mice were adoptively 
transferred into recipient mice by intravenous injections followed by subcutaneous immunisations 
with HEL in Alum. (B) On day three, cell proliferation was assessed by flow cytometry as defined 
by the serial dilution of CellTrace median fluorescence intensity (MFI) with each division. 
Transferred cells were defined by CD4 expression and the CD45.1 or CD45.2 congenic markers. 
(C-E) CellTrace-labelled HEL-specific (CTV+TCRVb3+CD4+) TCR7 cells were adoptively 
transferred into 2-3month-old and 22-24-month-old C57BL/6 recipients, which were subsequently 
immunised with HEL in Alum subcutaneously in the hind flank. Three days after immunisation, 
proliferation of CD45.1+CD4+ T cells was analysed by flow cytometry. (C) Representative flow 
cytometric plot of divided CD45.1+CD4+ cells in 2-3-month-old (white) and 22-24-month-old 
(grey) C57BL/6 recipients. (D-E) Quantitation of the proportion of divided CTV+CD45.1+CD4+ 
cells (D) and their ICOS expression (E) in 2-3-month-old and 22-24-month-old C57BL/6 recipients. 
Bar graphs show the results of one of two independent experiments performed by Alexandre Bignon. 
Bar height corresponds to the mean, and each circle represents one biological replicate. P-values 
were determined using the Mann-Whitney test in GraphPad Prism6. Only p-values ≤ 0.05 are 
shown. 
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Figure 5.4: cDC2s from aged mice have an impaired activation phenotype. 2-3-month-old mice 
were immunised subcutaneously with Ea-GFP in IFA. Antigen-bearing GFP+ and antigen-
presenting Y-Ae+ dendritic cells (DCs) in draining inguinal lymph nodes (LNs) were analysed 24 
hours after immunisation. (A) Gating strategy for DC subsets. All antigen-carrying DCs were 
defined as GFP+CD11chiMHC-IIhiLineage-(CD3-B220-CD19-)CD64-F4/80- events. Type 1 
conventional DCs (cDC1s) were defined as Xcr1+CD172a- DCs and were subdivided into CD103+ 
and CD103- cDC1s. Langerhans cells were defined as CD24+CD172a+Xcr1- DCs. Type 2 
conventional DCs (cDC2s) were defined as CD24-CD172a+Xcr1- DCs and were subdivided into 
CD11b+ and CD11b- cDC2s. (B) Quantitation of GFP+ cells from different DC subsets in the 
draining LNs of 2-3-month-old mice. (C) Quantitation of GFP+CD11b+ cDC2s in the draining LNs 
of 2-3-month-old and 22-24-month-old mice 24 hours after immunisation with Ea-GFP in IFA. (D-
G) Representative histograms for median fluorescence intensity (MFI) levels of Y-Ae (D), CD40 
(E), CD80 (F) and CD86 (G) on the surface of GFP+ CD11b+ cDC2s from 2-month-old and 23-
month-old mice. (H-L) Quantitation of median fluorescence intensity (MFI) levels of Y-Ae (H), I-
Ab (C57BL/6 MHC-II) (I), CD40 (J), CD80 (K) and CD86 (L) on the surface of GFP+CD11b+ 
cDC2s in adult and aged mice. Bar graphs show the results of one of two independent experiments 
performed by Alexandre Bignon. Bar height corresponds to the mean, and each circle represents 
one biological replicate. P-values were determined using the Mann-Whitney test in GraphPad 
Prism6. 
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 Interferon signalling is reduced in cDC2 cells from aged mice 
To test a possible link between impaired T cell priming and reduced antigen presentation by cDC2s 
in aged mice, we utilised H2+/- mice that carry only one allele encoding MHC-II. cDC2s from H2+/- 
mice present less antigen on their surface 24 hours after immunisation with Ea-GFP in IFA than 
cDC2s from H2+/+ control mice (Figure 5.5A), which recapitulates the phenotype observed in aged 
mice (Figure 5.4H). Despite reduced antigen-presentation, T cell proliferation of CellTrace-labelled 
TCR7 T cells adoptively transferred into HEL-immunised H2+/- and H2+/+ hosts was comparable 
(Figure 5.5B, C). This indicates that reduced early T cell priming in aged mice is not due to reduced 
antigen presentation. To assess whether impaired T cell priming in aged mice was instead caused 
by reduced CD80/CD86 co-stimulation by cDC2s, I performed adoptive T cell transfers into 2-
month-old C57BL/6 mice treated intraperitoneally with 500µg Abatacept, an FDA-approved 
CTLA4-IgG1 fusion protein which binds to CD80/86 with high affinity and blocks CD28 co-
stimulation. Abatacept completely blocked CD45.1+CD4+ T cell proliferation, confirming a strong 
dependency of T cell priming on CD80/CD86 co-stimulation (Figure 5.5D, E) (Platt et al. 2010). 
This suggests a possible link between the age-associated reduction in CD80/CD86 expression on 
cDC2s and reduced T cell priming in aged mice.  
Next, we decided to investigate the underlying cause for age-associated changes in cDC2s. For this, 
Alexandre Bignon and Danika Hill generated RNA sequencing data from sorted GFP+ CD11b+ 
cDC2s isolated from 2-month-old and 23-month-old mice 24 hours after immunisation with Ea-
GFP in IFA (gating strategy shown in Figure 5.4A). RNA sequencing analysis by Christel Krueger 
revealed 700 genes that were differentially expressed between cDC2s from young and aged mice. 
Principal component analysis demonstrated distinct clustering of samples from 2-month-old 
compared to 23-month-old mice (Figure 5.6A). Pathway enrichment analysis revealed that the 
cellular response to IFNb, a pathway which had previously been linked with DC-dependent T cell 
priming, was one of the cellular pathways most affected by age (Figure 5.6B) (Cucak et al. 2009). 
Of the genes that make up the “cellular response to IFNb” signature, the average expression of most 
genes was reduced in cDC2s from aged mice in the RNA sequencing data set (Figure 5.6C). I 
confirmed that Ifnb1 was expressed early after Ea-GFP in IFA immunisation in the draining LN by 
RT-qPCR, peaking 6 hours after immunisation in adult mice (Figure 5.6D). This early wave of 
Ifnb1 was followed by induction of the interferon-inducible myxovirus resistance gene Mx1, a 
canonical type I interferon-stimulated gene (ISG), which peaked at 14-24 hours after immunisation 
(Figure 5.6E). RT-qPCR of GFP+ CD11b+ cDC2 cells sorted from an independent cohort confirmed 
reduced Mx1 mRNA levels in cDC2 from 23-month-old mice compared to 3-month-old mice, 
demonstrating that type I IFN signalling is reduced in cDC2s of aged mice 24 hours after Ea-GFP 
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in IFA immunisation (Figure 5.6F). This reduction in ISG expression in aged mice could be 
recapitulated in whole LNs mRNA (Figure 5.6G), suggesting that the age-associated reduction in 
type I IFN signalling is not specific to cDC2s in aged mice.  
Cucak et al. have previously reported that type I IFN signalling in DCs is essential for Tfh cell 
priming and type I IFNs have been shown to enhance protective immune responses upon influenza 
vaccination in mice (Cucak et al. 2009; Proietti et al. 2002). The type I IFN family of proteins is 
comprised of up to 20 members which are divided into IFNα and IFNβ subtypes (Rauch et al. 2013). 
IFNβ can be produced by almost all cell types when their PRRs are exposed to PAMPs, while IFNα 
is predominantly produced by immune cells such as plasmacytoid dendritic cells (pDCs) (Ivashkiv 
& Donlin 2014). Both forms of type I IFNs bind the interferon alpha receptor (IFNαR), a 
heterodimeric complex of IFNAR1 and IFNAR2 chains. The intracellular domain of this receptor 
is associated with JAK1 and Tyk2 kinases which phosphorylate STAT1 and STAT2 molecules 
upon IFN-induced activation. These form part of the transcriptional complex ISGF3 (interferon-
stimulated gene factor 3) which regulates the expression of several hundred interferon-stimulated 
genes (ISGs), including Mx1 and Ifit1 (Interferon-induced protein with tetratricopeptide repeats 1) 
(Hoffmann et al. 2015). In DCs, type I IFN signalling has been shown to enhance the expression of 
the co-stimulatory molecules CD80 and CD86 as well as the Tfh cell differentiation-inducing 
cytokine IL-6 (Hassanzadeh-Kiabi et al. 2017; Luft et al. 1998). Hence, we hypothesised that 
reduced type I IFN signalling in cDC2s of aged mice could be linked with defective T cell priming 
and impaired GC responses in these mice. 
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Figure 5.5: T cell priming is abrogated upon blockade of CD80/86 co-stimulation. (A-C) 
CellTrace violet (CTV)-labelled HEL-specific TCRVb3+CD45.1+CD4+ cells were adoptively 
transferred into H2+/+ and H2+/- mice, followed by subcutaneous immunisations with HEL in Alum. 
On day 3, proliferation of CD45.1+CD4+ T cells was analysed by flow cytometry. These 
experiments were performed by Michelle Linterman. (A) Quantitation of Ea-peptide presentation 
on CD11b+ cDC2s as determined by Y-Ae surface staining. (B-C) Representative flow cytometric 
plot (B) and quantitation (C) of divided CTV+CD45.1+CD4+ cells in H2+/- and H2+/+ recipients. (D-
E) CellTrace(CTV)-labelled HEL-specific TCRVb3+CD45.1+CD4+ cells were adoptively 
transferred into C57BL/6 mice, directly followed by subcutaneous immunisations with HEL in 
Alum and intraperitoneal injections with 500 µg Abatacept or PBS. On day 3, proliferation of 
CD45.1+CD4+ T cells was analysed by flow cytometry. Representative flow cytometric plot (D) 
and quantitation (E) of divided CTV+CD45.1+CD4+ cells in mice treated with Abatacept or PBS. 
Bar graphs show the results of one of two independent experiments. Bar height corresponds to the 
mean, and each circle represents one biological replicate. P-values were determined using the 
Mann-Whitney test in GraphPad Prism6. Only significant p-values ≤ 0.05 are shown. 
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Figure 5.6: Reduced type I interferon (IFN) signalling in cDC2s from aged mice. (A-C) RNA 
sequencing data were generated by Danika Hill and Alexandre Bignon from sorted GFP+ CD11b+ 
cDC2s isolated from 2-month-old and 23-month-old C57BL/6 mice 24 hours after subcutaneous 
immunisation with Ea-GFP in IFA. (A) Principal component analysis of the most variable genes in 
samples from young 2-month-old (blue) and aged 23-month-old (pink) mice. (B) Cellular pathways 
significantly affected by age as determined by Christel Krueger by Pathway Enrichment Analysis. 
(C) Average RPKM (read per kilobase million) expression of IFNβ-responsive genes in GFP+ 
CD11b+ cDC2s as determined by RNA sequencing. (D-E) Ifnb1 (D) and Mx1 (E) mRNA expression 
in whole LN mRNA taken 0, 6, 14 and 24 hours after subcutaneous immunisation of 2-month-old 
mice with Ea-GFP in IFA (F-G) 2-month-old and 23-month-old C57BL/6 mice were 
subcutaneously immunised with Ea-GFP in IFA. 24 hours later, Mx1 mRNA levels were 
determined in sorted GFP+ CD11b+ cDC2s (F) or extracts of whole draining LNs (G) by RT-qPCR. 
Bar graphs show the results of one of two independent experiments (D, E) or the combined results 
of two experiments (F, G). Bar height corresponds to the mean, and each circle represents one 
biological replicate. P-values were determined using the Mann-Whitney test in GraphPad Prism6. 
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 Lack of type I IFN signalling in DCs is linked with impaired 
Tfh cell formation  
To test this hypothesis, I first examined whether a loss of type I IFN signalling recapitulates the 
phenotype of cDC2s from aged mice. Adult C57BL/6 mice were treated with an anti-IFNAR1 
blocking antibody followed by subcutaneous immunisation with Ea-GFP in IFA 20 hours later. 
One day after immunisation, blockade of type I IFN signalling did not affect antigen presentation 
or CD40 expression by GFP+ CD11b+ cDC2s (gating strategy shown in Figure 5.7; Figure 5.8A, 
B), but the expression of the co-stimulatory ligands CD80 and CD86 was significantly reduced 
(Figure 5.8C, D). This indicates that a blockade of type I IFN signalling can partly recapitulate the 
ageing cDC2 phenotype.  
To determine whether loss of IFNaR signalling also impacts T cell priming, I adoptively transferred 
IFNaR-sufficient HEL-specific TCR7 into Ifnar1-/- or WT control mice immunised with HEL in 
Alum. Fewer T cells entered the cell cycle in Ifnar1-/- hosts (Figure 5.8E, F), recapitulating the 
defect in T cell priming seen in aged mice. When this experiment was repeated using ovalbumin 
(OVA)-specific OTII cells transferred into recipient mice immunised with OVA in Alum, the same 
effect was seen (Figure 5.8G, H). To test whether Tfh cell formation after immunisation is also 
affected in mice lacking type I IFN signalling only in DCs, Ifnar1fl/fCd11ccre/+ mice, and their 
Ifnar1fl/flCd11c+/+ littermate controls were inoculated subcutaneously with NP-1W1K in Alum. 
Fewer Tfh cells formed in Cd11ccre/+Ifnar1fl/fl mice seven days after immunisation compared to their 
littermates (Figure 5.8I, J). This shows that the lack of type I IFN signalling can mimic age-
associated defects both in T cell priming and their subsequent differentiation into Tfh cells. This 
could be due to reduced CD28-dependent T cell co-stimulation, as both ageing as well as IFNAR1 
blockade were associated with reduced expression levels of CD80 and CD86, the costimulatory 
ligands for CD28, on antigen-presenting cDC2s. 
Reduced type I IFN signalling in DCs could be driven to two factors: decreased levels of type I 
IFNs in their microenvironment or a reduction in the IFN responsiveness of DCs in aged animals. 
As described above, I observed that Mx1 mRNA levels were not only reduced in sorted cDC2 cells, 
but also in whole LN extracts of immunised mice. This suggests a reduced production of type I 
IFNs in the draining LNs of aged mice. Upon infection, pDCs quickly produce large amounts of 
type I IFN in the LNs of both humans and mice, and this response has been reported to be impaired 
in aged mice and humans (Agrawal 2013; Agrawal et al. 2017; Panda et al. 2010; Sridharan et al. 
2011; Stout-Delgado et al. 2008). I observed reduced proportions and numbers of pDCs in the LNs 
of aged 23-month-old mice compared to adult controls both at the steady-state and 24 hours after 
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immunisation with Ea-GFP in IFA (Figure 5.9A-D). This suggests that the reduction in type I IFN 
signalling in cDC2s is due to a loss of IFN-producing pDCs in the LNs of aged mice. 
 
 
Figure 5.7: Gating strategy for the quantitation of GFP+ CD11b+ cDC2s and plasmacytoid 
dendritic cells (pDCs). Mice were immunised subcutaneously with Ea-GFP in Alum. 24 hours 
later, pDCs and antigen-bearing GFP+ CD11b+ cDC2s were analysed by flow cytometry or - in the 
case of cDC2s - sorted for RT-qPCR. GFP+ CD11b+ cDC2s were defined as live CD11b+CD24-
GFP+CD11chiMHC-IIhiLineage-(CD3-CD19-) events. pDCs were defined as live CD317(=PDCA-
1)+CD11c+CD11b-B220+ events. 
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Figure 5.8: Lack of type I interferon (IFN) signalling in DCs impairs Tfh cell differentiation. 
(A-D) Flow cytometric analysis of CD11b+ cDC2s isolated from mice intraperitoneally injected 
with anti-IFNAR1 blocking or isotype control antibodies 20 hours prior to subcutaneous 
immunisation with Ea-GFP in IFA. (A) Quantitation of Ea-peptide presentation on GFP+ CD11b+ 
cDC2s as determined by Y-Ae stains 24 hours after immunisation with Ea-GFP in IFA. (B-D) 
Quantitation of median fluorescence intensity (MFI) levels of CD40, CD80 and CD86 on the 
surface of GFP+ CD11b+ cDC2s in mice treated with anti-IFNAR1 blocking or isotype control 
antibodies. (E-F) CellTrace(CTV)-labelled Hen Egg Lysozyme (HEL)-specific 
TCRVb3+CD45.1+CD4+ cells from TCR7 mice were adoptively transferred into Ifnar1-/- and 
control mice, which were subsequently immunised with HEL in Alum. On day three, proliferation 
of CD45.1+CD4+ T cells was analysed by flow cytometry. (E-F) Representative flow cytometric 
plot (E) and quantitation (F) of divided CTV+CD45.1+CD4+ cells. (G-H) CellTrace(CTV)-labelled 
ovalbumin (OVA)-specific TCRVa2+CD45.1+CD4+ cells from OTII mice were adoptively 
transferred into Ifnar1-/- and control mice, which were subsequently immunised with OVA in Alum. 
On day three, proliferation of CD45.1+CD4+ T cells was analysed by flow cytometry. (G-H) 
Representative flow cytometric plot (G) and quantitation (H) of divided CTV+CD45.1+CD4+ cells. 
(I-J) Flow cytometric analysis of CXCR5hiPD-1hiFoxp3-CD4+ T follicular helper (Tfh) cells 
isolated from Ifnar1fl/flCd11ccre/+ or Ifnar1fl/flCd11c+/+ control mice 7 days after immunisation with 
NP-1W1K in Alum. Quantitation of Tfh cell numbers (I) and proportion of CD4+ T cells (J) on day 
7. Bar graphs show the results of one (E-H) or one of two (A-D, I-J) independent experiments. Bar 
height corresponds to the mean, and each circle represents one biological replicate. P-values were 
determined using the Mann-Whitney test in GraphPad Prism6. 
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Figure 5.9: Numbers of plasmacytoid DCs (pDCs) are reduced in the lymph nodes (LNs) of 
aged mice. (A-B) Flow cytometric quantitation of the proportion (A) and number (B) of pDCs in 
the inguinal LNs of unimmunised 2-month-old and 23-month-old C57BL/6 mice. (C-D) Flow 
cytometric quantitation of the proportion (C) and number (D) of pDCs in the inguinal LNs of 2-
month-old and 23-month-old C57BL/6 mice 24 hours after immunisation with Ea-GFP in IFA. Bar 
graphs show the results of one of three independent experiments. Bar height corresponds to the 
mean, and each circle represents one biological replicate. P-values were determined using the 
Mann-Whitney test in GraphPad Prism6. 
 
 Imiquimod-induced type I IFN signalling rejuvenates cDC2s 
in aged mice 
Next, I investigated whether artificially boosting the production of type I IFN could rejuvenate the 
cDC2 phenotype in aged mice. For this, 23-month-old C57BL/6 mice were topically administered 
Aldara, a cream containing 5 % of the TLR7-agonist imiquimod, a strong inducer of type I IFN 
responses (Moore et al. 2001; Reiter et al. 1994). This cream was applied on top of the injection 
sites directly after subcutaneous immunisations with Ea-GFP in IFA (experimental set-up shown 
in Figure 5.10A). 24 hours later, I observed increased expression of the ISGs Ifit1 and Mx1 in sorted 
GFP+ CD11b+ cDC2s isolated from imiquimod-treated 23-month-old mice compared to aged 
controls that were immunised but did not receive imiquimod (Figure 5.10B, C). This was associated 
with an increase in the proportions and total numbers of both total and GFP-positive CD11b+ cDC2s 
in draining LNs (Figure 5.10D-G). Further, these cells expressed higher levels of CD80 and CD86, 
while antigen-presentation and CD40 expression was not affected (Figure 5.10H-O). This 
demonstrates that promoting type I IFN signalling in DCs can rescue the age-dependent co-
stimulatory defects observed in cDC2s from aged mice. This mirrors the results from IFNAR1 
blocking experiments, where blockade of type I IFN signalling in cDC2s resulted in reduced 
expression levels of CD80 and CD86, while antigen-presentation and CD40 expression were not 
affected. This shows that the topical application of imiquimod onto immunisation sites induces type 
I IFN signalling and potently enhances the activation and recruitment of cDC2s into the draining 
LNs of aged mice.  
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Figure 5.10: Imiquimod rejuvenates cDC2s in aged mice. (A) Schematic representation of the 
experimental set-up. 23-month-old mice were subcutaneously immunised with Ea-GFP in IFA. 
Half of the mice were topically treated with imiquimod cream on top of their immunisation sites. 
24 hours later, GFP+ CD11b+ cDC2 cells were sorted by FACS for RT-qPCR (B-C) or analysed by 
flow cytometry (D-K). (B-C) Ifit1 (B) and Mx1 (C) mRNA expression in sorted GFP+ CD11b+ 
cDC2s were analysed by RT-qPCR. (D-G) Flow cytometric quantitation of the proportions (D, F) 
and numbers (E, G) of total (D, E) and GFP+ (F, G) CD11b+ cDC2 cells. (H-K) Representative 
histograms for median fluorescence intensity (MFI) levels of Y-Ae (H), CD40 (I), CD80 (J) and 
CD86 (K) on the surface of GFP+ CD11b+ cDC2s in 23-month-old mice with or without imiquimod 
treatment compared to 2-month-old control mice. (L-O) Quantitation of MFI levels of Y-Ae (L), 
CD40 (M), CD80 (N) and CD86 (O) on the surface of GFP+ CD11b+ cDC2s in 23-month-old mice 
with or without imiquimod treatment. Bar graphs show the results of one of two independent 
experiments. Bar height corresponds to the mean, and each circle represents one biological replicate. 
P-values were determined using the Mann-Whitney test in GraphPad Prism6. The mouse artwork 
was kindly provided by Alice Denton. 
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 Imiquimod enhances Tfh cell priming in aged mice 
These findings raised the question of whether imiquimod treatment could ultimately boost the 
defective Tfh cell responses in aged animals. To test this, I analysed GC responses on day 7 in 23-
month-old mice which were, or were not, treated topically with imiquimod after subcutaneous 
immunisation with NP-1W1K in Alum (experimental set-up shown in Figure 5.11A). In these 
experiments, imiquimod potently induced the expansion of both total and antigen-specific Tfh cell 
numbers (Figure 5.11B-E). This was linked with a small, but significant, increase in the number of 
GC B cells in imiquimod-treated mice compared to aged control mice (Figure 5.11F-G). Together, 
these results show that restoration of type I IFN signalling in aged mice after vaccination rescues 
defective Tfh cell differentiation, likely due to improved T cell activation by cDC2s with adequate 
levels of type I IFN signalling, but is not sufficient to completely rejuvenate GC B cells responses.  
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Figure 5.11: Imiquimod boosts antigen-specific Tfh cell differentiation in aged mice. (A) 
Schematic representation of the experimental set-up. 23-month-old mice were subcutaneously 
immunised with NP-1W1K in Alum. Half of the mice were topically treated with imiquimod cream 
on top of their immunisation sites. 7 days later, draining LNs were analysed by flow cytometry. (B-
E) Representative flow cytometric plots (B, D) and quantitation (C, E) of CXCR5hiPD-1hiCD4+ T 
follicular helper (Tfh) cells (B, C) as well as antigen-specific 1W1K-I-Ab+ Tfh cells (D, E). (F-G) 
Representative flow cytometric plots (F) and quantitation (G) of B220+Ki67+Bcl6+ GC B cells. Bar 
graphs show the combined results of three independent experiments. Bar height corresponds to the 
mean, and each circle represents one biological replicate. P-values were determined using the 
Mann-Whitney test in GraphPad Prism6. The mouse artwork was kindly provided by Alice Denton. 
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 Discussion  
Vaccination responses in older individuals are reduced, at least in part due to age-associated defects 
in the GC response and the subsequent reduction in the generation of high-affinity antigen-specific 
antibodies (Gustafson et al. 2018; Linterman 2014). A potent GC response is dependent on the 
formation of Tfh cells for Tfh cell-mediated B cell help (Vinuesa et al. 2016). Here, we show that 
the development of antigen-specific Tfh cells is impaired in aged mice, and that this is associated 
with an altered phenotype of cDC2s, the main antigen-presenting cell type in the LN after 
subcutaneous protein immunisation. RNA-sequencing of cDC2s from aged mice revealed a 
defective type I IFN response, resulting in the reduced expression of the co-stimulatory ligands 
CD80 and CD86. Based on this finding, we decided to treat aged mice with the type I IFN-inducing 
TLR7 agonist imiquimod, to increase levels of IFN signalling in cDC2s. This ultimately increased 
formation of Tfh and GC B cells in aged mice upon immunisation. Taken together, this highlights 
cDC2s as an exciting therapeutic target for the improvement of vaccine efficacy in the ageing 
population, potentially by using imiquimod or other adjuvants that promote of type I IFN signalling. 
Recently, type I IFNs have emerged as potent vaccine adjuvants (Bracci et al. 2008; Proietti et al. 
2002). They were found to boost humoral antibody responses in mice by exerting direct effects on 
B cells (Le Bon et al. 2006), as well as T cells (Le Bon et al. 2006; Nakayamada et al. 2014; Riteau 
et al. 2016) and DC cells (Cucak et al. 2009; Le Bon et al. 2001). In DCs, type I IFN was shown to 
promote the expression of co-stimulatory molecules and pro-inflammatory cytokines (Moretto et 
al. 2008). Signalling downstream of IFNaR additionally promotes the secretion of IL-6 and IL-1β 
by DCs, which were shown to enhance the expression of Bcl6, CXCR5 and ICOS by Tfh cells 
(Barbet et al. 2018; Cucak et al. 2009). Taken together, these studies demonstrate a clear link 
between type I IFN signalling in DCs and their potential for T cell priming. Here, we describe a 
link between defective T cell priming in aged mice and reduced type I IFN signalling in cDC2s. 
Consistent with data from Moretto et al., we observed reduced expression levels of the co-
stimulatory ligands CD80 and CD86 on DCs from aged mice (Moretto et al. 2008). Moretto et al. 
have shown that IL-15 treatment can rescue the expression of CD86 on DCs from one-year-old 
mice (Moretto et al. 2008). I found that imiquimod-boosted type I IFN signalling can also potently 
increase CD80 and CD86 expression on cDC2s in aged mice. This is associated with the improved 
generation of antigen-specific Tfh cells in these mice, providing novel mechanistic insights into the 
drivers of age-associated defects in GCs. 
Several strategies are currently being used to enhance the GC response of aged individuals to 
infections and vaccinations. Modifications of the vaccine adjuvant (Frech et al. 2005) or 
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administration of increased antigen doses (Remarque et al. 1993) can improve vaccination 
responses in older subjects. Hung et al. have previously shown that topical imiquimod treatment at 
the time of vaccination potently enhances immune responses to influenza vaccination in both young 
and older individuals (Hung et al. 2014; 2016). This is exciting, as it suggests - together with the 
data presented here - that the age-related defect in the GC response is not irreversible, and can be 
targeted therapeutically to improve immune protection in older individuals. Our study provides 
novel mechanistic insights into how imiquimod might enhance vaccination responses in vivo. In 
mice, the beneficial effect of imiquimod has previously been linked with direct effects of imiquimod 
on B cells in vitro as well as improved IL-6 cytokine production by and CD80/CD86 expression on 
DCs in young mice (Fehres et al. 2014; Li et al. 2018; Thomsen et al. 2004). My data confirm that 
imiquimod boosts GC responses in aged animals by enhancing cDC2-dependent T cell priming and 
Tfh cell differentiation. This highlights cDC2s as an important target for improved vaccination 
strategies in older individuals and suggests possible applications for imiquimod in promoting 
vaccine responses in the ageing population. 
 
Note: 
This project was started by Alexandre Bignon, who generated all data depicted in Figures 5.1, 5.2, 
5.3, 5.4, 5.6A-C. He performed initial GC and DC phenotyping experiments, generated the DC 
RNA sequencing data together with Danika Hill, Edward Carr, Michelle Linterman and Christel 
Krueger and also started validating the RNA sequencing results. When he left the lab, I followed 
up on the role of type I IFN signalling in cDC2s from aged mice and performed all imiquimod 
experiments under the supervision of Michelle Linterman (Figures 5.5D-E, 5.6D-G, 5.7, 5.8, 5.9, 
5.10, 5.11).
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 DISCUSSION 
The immune system has evolved to respond to its environment, to sense tissue damage, infections 
and changes in normal homeostasis. As a result, immune cells and their functions are dynamically 
regulated by changes in their microenvironment. In this thesis, I demonstrate that stress and ageing 
have key roles in CD4 T cell differentiation and in the formation of the GC response. My results 
further demonstrate that changes in the environment are able to stimulate the aged immune system 
and can be used to potentiate immune responses in older individuals. 
 ER stress: a novel driver of Th17 cell pathogenicity? 
In this thesis, a link between ER stress and Th17 cell differentiation and pathogenicity is described. 
This could provide an explanation why Th17 cells have been implicated in both protective and 
pathogenic immunity: while they are crucial for barrier immunity, they have also been implicated 
in the pathogenesis of autoimmune disease, such as rheumatoid arthritis and multiple sclerosis 
(Stockinger & Omenetti 2017). Work from both in vitro and in vivo settings identified that Th17 
cell pathogenicity is linked with their propensity to adopt a Th1-like cell phenotype and produce 
GM-CSF and IFNg under the influence of IL-23 (El-Behi et al. 2011; Ghoreschi et al. 2010; Hirota 
et al. 2011; Jain et al. 2016; McGeachy et al. 2007). After the initial implication of IL-23 in Th17-
driven pathology, it has become clear that other environmental factors, such as high salt 
concentrations or the presence of different AhR ligands, can also influence Th cell differentiation 
and pathogenicity (Quintana et al. 2008; Veldhoen et al. 2008a; Wu et al. 2013). The data presented 
here reveal that the ER stress-inducer CPA drives the generation of Th17 cells with a pathogenic 
gene expression signature. This suggests that ER stress, a common feature of inflammatory sites, 
could be a driver of Th17 cell pathogenicity in autoimmune disorders. To test whether there is a 
broad role for stress in the differentiation of pathogenic Th17 cells, it would be interesting to 
investigate whether other stress conditions, such as BrPA or nutrient deprivation, can also induce 
the formation of pathogenic Th17 cells. To determine whether my findings have implications for 
human autoimmune diseases, it would be important to determine whether there is a link between 
stress and Th17 cell-driven pathology in humans.  
The ER stress response was found to be highly active in inflammatory lesions of MS patients 
(Mháille et al. 2008) as well as in EAE, where it was described to promote inflammation and 
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pathology (Deslauriers et al. 2011; Meares et al. 2014; Mháille et al. 2008). This prompts the 
hypothesis that ER stress in the CNS promotes EAE pathology by driving the local generation of 
pathogenic Th17 cells. ER stress is induced by inflammation, and, when triggered, enhances the 
secretion of pro-inflammatory cytokines such as IL-23, IL-6, TNF-a and type I IFNs (Bettigole & 
Glimcher 2015; Hu et al. 2011; Martinon et al. 2010; Smith et al. 2008), creating a feed-forward-
loop in which the inflammatory microenvironment might potentiate the development of 
autoimmune disorders (Sprenkle et al. 2017). In our adoptive-transfer EAE experiments, ER stress-
generated Th17 cells caused the delayed onset of typical EAE clinical symptoms, but triggered 
atypical symptoms of Th17-mediated brain inflammation. This could point to an increased 
pathogenic potential of ER stress-generated Th17 cells in the brain in vivo. To test this, e-Th17 cells 
need to be characterised further: ER stress-induced changes in Th17-to-Th1 plasticity, a common 
feature of EAE as measured by the IFNg production of ex-Th17 cells (Hirota et al. 2011), could be 
tested in vivo using adoptive transfers of Rosastop-tdRFPIl17aCre cells. In these experiments, it would 
also be important to study the potential of e-Th17 cells to infiltrate the CNS, a hallmark of EAE 
pathology (Rostami & Ciric 2013). Furthermore, it would be interesting to assess the pathogenic 
potential of e-Th17 cells in other Th17-cell mediated diseases. To determine whether e-Th17 cells 
have a broad role in Th17-driven pathology, arthritis or Helicobacter pylori-induced inflammation 
could be induced and studied in Xbp1fl/flCd4cre/+ mice, which lack Xbp1-mediated ER stress 
responses in T cells. These experiments would further test the hypothesis that there is a link between 
Th17 cell-mediated disorders and ER stress. 
Another open question is whether physiological levels of ER stress can drive Th17 cell 
differentiation in vivo? We observed the delayed onset of EAE symptoms in TUDCA-treated or 
Xbp1fl/flRag1cre/+ mice with repressed ER stress responses, suggesting that suppression of ER stress 
response pathways lessens EAE pathology in vivo. To determine whether ER stress drives EAE by 
directly acting on T cells, these experiments could be repeated using Xbp1fl/flCd4cre/+ or 
Xbp1fl/flIl17acre/+ mice that lack an ER stress response in all T cells or Th17 cells specifically, or by 
inducing adoptive-transfer EAE using MOG-specific T cells from 2D2 mice with a specific deletion 
in Xbp1. ER stress levels in T cells could be measured in different disease settings using the Xbp1-
luciferase mouse model generated by Spiotto et al. (Spiotto et al. 2010), to test whether the 
generation of pathogenic Th17 cells is indeed associated with ER stress conditions in vivo. Together, 
these experiments would build on the work presented here to further understand the contribution of 
ER stress to in vivo pathogenesis. 
Elevated ER stress responses are a common feature of neuroinflammation and other inflammatory 
disorders (Sprenkle et al. 2017). In this study, treatment of mice with the ER stress inhibitor 
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TUDCA delayed the onset of EAE in mice suggesting that this FDA-approved drug could be used 
to slow disease progression in MS patients. However, there are concerns about the potential side-
effects of ER stress inhibitors when systemically administered to patients, as the ER stress response 
is an essential pathway important for normal homeostasis in all cells (Hetz et al. 2013). Instead of 
targeting the ER stress response pathway, our data suggest that therapeutic efforts could also more 
directly target ER stress-generated Th17 cells. The gene signature of ER stress-generated Th17 cells 
reported here, together with the pathogenic Th17 cell gene signature proposed by Lee et al. (Lee et 
al. 2012), might help to guide the development of novel therapies which specifically target 
pathogenic Th17 cells at sites of inflammation without affecting protective Th17 cells at barrier 
sites.  
 The GC response in ageing 
Ageing results in a plethora of biological changes which can influence immune cells in a cell-
intrinsic manner and in a cell-extrinsic way by changes in their microenvironment (López-Otín et 
al. 2013; Nikolich-Žugich 2018). The relative contribution of these effects to age-associated 
immune defects is difficult to disentangle, though. On a molecular level, all human cells experience 
age-related telomere shortening, the accumulation of genetic mutations, epigenetic changes, 
defective mitochondria and an increased burden of unfolded proteins which is associated with 
alterations in the ER stress response and protein degradation (Brown & Naidoo 2012; López-Otín 
et al. 2013). On the cellular level, ageing affects the communication between cells, tissue 
regeneration is reduced and senescent cells, that secrete pro-inflammatory mediators, accumulate 
over time (Linterman 2014; López-Otín et al. 2013; Tchkonia et al. 2013). In lymphocytes 
specifically, the reduced production of lymphoid precursors in the bone marrow and the prolonged 
exposure to antigens over the life-time additionally leads to an age-related increase in memory cells 
and a reduction in the pool of naïve T and B cells (Nikolich-Žugich 2018). The GC response has 
also been described to be impaired in aged mice and humans, resulting in the reduced formation of 
high-affinity plasma cells and serum antibody levels (Eaton et al. 2004; Kosco et al. 1989; Kraft et 
al. 1987; Linterman 2014; van Dijk-Härd et al. 1997; Yang et al. 1996). This is associated with an 
increased susceptibility to infections and decreased vaccination efficacy in older individuals 
(Linterman 2014).  
GCs are complex structures consisting of multiple cell types including stromal cells, GC B cells, 
Tfh cells and Tfr cells. Age-associated defects in the output of the GC response have been linked 
with changes in all of these cell types (Gustafson et al. 2018; Linterman 2014; Nikolich-Žugich 
2018). This makes it difficult to dissect the contributions of ageing-related changes in individual 
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cell types to changes in the GC output. What is more, ageing seems to affect GCs in PPs differently 
from GCs in the spleen and LNs. In this thesis, I describe distinct age-associated changes in 
environmental stimuli which shape GC responses in the PPs and draining LNs of aged mice: the 
gut microbiome and type I IFN signalling, respectively.  
 Cross-talk between the gut microbiome and GC responses in 
the PPs of aged mice 
 Ageing differentially affects GC responses in PPs and LNs  
PPs are unique SLOs in that they take up antigens directly from the gut lumen and always contain 
GCs due to constant antigenic stimulation from the gut microbiota and exposure to food antigens 
(Kawamoto et al. 2014; Reboldi & Cyster 2016; Stebegg, Kumar, Silva-Cayetano et al. 2018). PPs 
are also differently affected by ageing compared to other lymphoid tissues: like LNs, PPs show an 
age-associated reduction in the proportion of GC B cells, however there is an increase in somatically 
mutated antibodies in the gut of aged mice, while in LNs SHM is reduced with advancing age 
(Banerjee et al. 2002; González-Fernández et al. 1994). What is more, both BALB/c and C57BL/6 
mice exhibit reduced antigen-specific antibody responses in the gut (Kato et al. 2003; Kawanishi 
& Kiely 1989; Koga et al. 2000), but the levels of total secreted IgA in the intestine are not 
negatively affected (Senda et al. 1988; Thoreux et al. 2000). The data presented here confirm that 
the GC response in the PPs of aged mice is diminished, but that they age differently from GCs in 
mLNs and other peripheral LNs, where not only GC B cells, but also Tfh and Tfr cell numbers are 
affected by age. This demonstrates the unique effect of ageing on PPs compared to other SLOs. 
Unlike peripheral lymphoid tissues, the gut is constantly exposed to antigenic stimulation from the 
commensal microbiome. There are also specialised mechanisms of immune regulation in GCs in 
PPs, potentially to favour the generation of a highly diverse IgA pool in response to the constant 
exposure to microbial antigens (Reboldi & Cyster 2016; Stebegg, Kumar, Silva-Cayetano et al. 
2018).	This has been linked with unique properties of DCs, Tfh cells and Tfr cells in PPs compared 
to LNs (Stebegg, Kumar, Silva-Cayetano et al. 2018), which may impact how ageing affects these 
cell types and the PP GC response.	
 The IgA-mediated control of the gut microbiome is largely GC 
independent 
Fagarasan and co-workers have implicated IgA antibodies produced in a GC-dependent manner in 
PPs in the control of gut microbial homeostasis (Kawamoto et al. 2012; 2014; Wei et al. 2011). 
There is conflicting evidence, however, from mice lacking either T-dependent immune responses 
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(CD28-deficient mice (Gärdby et al. 2003) and CD40-deficient mice (Bergqvist et al. 2006)) or Tfh 
cells (Bcl6fl/flCd4cre/+ (Bunker et al. 2015)). These animals, all of which lack functional GC 
responses, have high mucosal IgA antibody titres and near-to-normal levels of bacterial IgA-coating 
were reported in Bcl6fl/flCd4cre/+ mice, suggesting that GC-independent IgA is the main regulator of 
the gut microbiome. Despite smaller GCs in the PPs of aged mice, I did not observe any defects in 
the total levels of mucosal IgA or commensal IgA-coating in older mice. This suggests that 
sufficient IgA is produced by a compensatory mechanism in a GC-independent manner and that 
changes in the gut microbiome during ageing are not likely driven by the reduced PP GC response 
of aged mice.  
To test this hypothesis and rule out a role of the GC in controlling the gut microbiota, we studied 
Bcl6fl/flCd4cre/+ mice that lack Tfh cells and therefore do not have good GC responses. I found that 
only the abundance of one species, a type of SFB, was affected in the gut of these mice, indicating 
that PP GCs are not required to control the composition of the gut microbiome as a whole, but may 
have a role in controlling particular bacterial species. This addresses a controversial topic in the 
field and suggests that GCs contribute little to the overall IgA-mediated control of the gut 
microbiota. I hypothesise that current discrepancies in the literature could be linked with disparities 
in the composition of the gut microbiome in different animal facilities. Several mouse disease 
phenotypes have been shown to be affected by the presence or absence of SFB in the gut and my 
16S rDNA sequencing data suggest that these bacteria are amongst the few whose abundance is 
regulated by GC-dependent IgA antibodies (Ericsson et al. 2015; Ivanov et al. 2009; Lee et al. 
2011; Wu et al. 2010). Thus, changes in the PP GC response are expected to have a more 
pronounced effect in animals carrying SFB than in animals lacking this taxa. Bcl6fl/flCd4cre/+ mice 
housed at the Babraham Institute harbour only low levels of SFBs and do not exhibit changes in 
their gut microbiome compared to littermate controls, while SFBs constitute a large proportion of 
the gut commensals detected in mice used by Fagarasan and co-workers, which experience large 
differences in their gut microbiota composition upon changes in GC-dependent IgA production 
(Kawamoto et al. 2014; Suzuki et al. 2004). These differences could explain how the GC-dependent 
control of only a very limited set of bacterial taxa can have global effects on gut microbial 
composition in some mice. This also highlights that vendor- and facility-specific differences in the 
composition of the gut microbiome cannot be neglected when studying the cross-talk between the 
gut microbiome and the gut immune system.  
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 No obvious effects of FMT on antigen-specific GC responses in the 
PPs of aged mice 
Even though the importance of GC-derived IgA antibodies for controlling the gut microbiome is 
under debate, they have a clear role in the protection against intestinal pathogens (Hashizume et al. 
2008) and oral tolerance (Fujihashi et al. 2001). Kato et al. linked impaired oral tolerance in aged 
mice with impaired PP GCs (Kato et al. 2003), associated with defective M cell maturation in the 
PPs of aged mice (Kobayashi et al. 2013). Thus, the increase in intestinal infections in the elderly 
could be linked with an age-associated defect in their Peyer’s patches (Kolling et al. 2012). In this 
thesis, I describe an age-associated reduction in PP GC B cells, which is reverted by the acquisition 
of the microbiome of a younger animal. This demonstrates that the poor GC reaction in aged animals 
is not irreversible, and can be boosted by changes in the gut microbiome.  
Shin et al. demonstrated that the microbial transfer of a young microbiome into aged hosts increases 
protection against C. difficile infections in these mice (Shin et al. 2018). Also in humans, FMT has 
proven to be an effective treatment against C. difficile infections in both young and older individuals 
(Friedman-Korn et al. 2018; Mamo et al. 2018). Two mechanisms for how FMT enhances 
protection against C. difficile infections have been proposed: the induction of protective mucosal 
immune responses or restoration of microbiota-dependent protection (Khoruts & Sadowsky 2016). 
In the experiments reported here, FMT did not improve local or systemic immune responses to NP-
CTx in aged mice, suggesting that FMT does not enhance immune responses to this antigen under 
the conditions used. Before completely excluding any beneficial effects of FMT on antigen-specific 
PP GC responses, however, some open questions should be addressed: is the effect of FMT and co-
housing on the composition of the gut microbiome transient or stable? Similarly, is the boost in GC 
B cells in the PPs of aged mice upon microbial transfer transient or stable? Prolonged co-housing 
experiments and an extension of the observation period after FMT could help to answer these 
questions. Maybe FMT could enhance antigen-specific immune responses if NP-CTx 
immunisations are performed at a later time point, when the gut microbiome and the effects of FMT 
on the PP GC reaction have stabilised? 
Another unanswered question is whether microbial transfers boost the PP GC reaction by antigenic 
stimulation, by acting as an adjuvant for existing GCs, or a combination of the two. Both FMT and 
the administration of the strong immunogen CTx were found to boost GC B cell numbers in the 
PPs of aged mice. This indicates that the expansion of the GC reaction by FMT is not due to 
reactivation of commensal-specific memory B cells. Rather, it suggests that both FMT and CTx 
boost PP GC reactions in an antigen- or adjuvant-like manner. Sequencing analysis of the B cell 
repertoires in aged mice which received FMT and PBS-treated control mice could help to 
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distinguish between these two mechanisms. If FMT acted as an adjuvant, this should lead to the 
numerical expansion of pre-existing GC B cell clones, while antigenic stimulation would result in 
the emergence of new clones, which would potentially be shared amongst FMT recipients. 
Answering the questions above could help to reveal or refute any potential beneficial effects of 
FMT on antigen-specific GC responses in the gut.  
 Rejuvenation of the gut microbiome as a potential intervention to 
improve healthy ageing 
Age-associated changes in the composition of the gut microbiome have been linked with increased 
frailty and systemic inflammation (Claesson et al. 2012; Fransen et al. 2017; Maffei et al. 2017). 
Germ-free mice were found to live longer than their SPF counterparts (Thevaranjan et al. 2017) and 
short-lived Killifish colonised with a young microbiome were found to live longer than untreated 
fish (Smith et al. 2017). The supplementation of older individuals and aged mice with pre- and 
probiotics was also found to improve gut immunity in the elderly (Kaburagi et al. 2007; Landete et 
al. 2017). This suggests a direct effect of the rejuvenation of the gut microbiome in aged individuals 
on intestinal health as well as lifespan.  
We were able to demonstrate that cohousing is very effective in altering the composition of the 
microbiome of aged mice and that one single FMT, even without previous antibiotic treatment, is 
sufficient to achieve the same effect. This raises the question whether FMT from young donors or 
cohabitation with young individuals could also improve healthspan in older individuals? FMT is 
already in routine use for the treatment of C. difficile infections in aged patients in the UK (NICE 
guidelines, 2014). A long-term follow-up study of patients who received FMT from a younger 
donor as a successful treatment of their C. difficile infection could reveal potential beneficial effects 
of FMT on other age-associated disorders. These studies might also uncover associations of any 
FMT-associated health benefits with the transfer of certain bacterial species. However, I detected 
no conservation of the bacterial species transferred from adult into aged mice during co-housing or 
FMT between C57BL/6 and BALB/c mice. This could indicate that rejuvenation of the gut 
microbiome exerts its effects by reintroducing bacterial functions shared between taxa, such as the 
generation of short-chain fatty acids or other bacterial metabolites, or by the simple transfer of 
antigen back into aged mice, rather than the transfer of specific bacterial species with immunogenic 
properties. Metagenomics studies could reveal such shared bacterial functions, which are missing 
in the gut microbiome of aged animals and are replenished by microbial transfers from adult mice 
(Alves et al. 2018).  
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Cohabitation has also been described to have strong effects on both the gut microbiome and the 
cellular composition of the immune system, with people living together sharing more bacterial 
species and having more similar immunoprofiles than individuals from different households (Carr 
et al. 2016; Song et al. 2013). What is more, Claesson et al. observed a significant decrease in gut 
bacterial diversity in aged individuals living in long-stay care compared to community dwellers and 
this was associated with increased age-associated frailty (Claesson et al. 2012). This suggests a 
possible link between environmental factors, gut microbiota composition and the immune system 
not only in mice and fish, but also in humans. In addition to cohabitation and FMT (Gupta et al. 
2016), probiotics (Landete et al. 2017) and diet (Clements & R. Carding 2018) also have a strong 
impact on the composition of the gut microbiome. Separately or in combination, they could prove 
to be effective interventions to promote intestinal health and healthy ageing.  
 T cell priming in aged mice is improved by enhanced type I 
IFN signalling in cDC2s 
Immune responses of older individuals to infections or vaccinations are reduced, at least in part due 
to defects in the GC response and a subsequent reduction in the generation of antigen-specific 
antibodies (Gustafson et al. 2018; Linterman 2014). This is associated with increased infection-
related morbidity and mortality in the elderly (Linterman 2014) and creates a burden for public 
healthcare in ageing societies (WHO 2011). Therefore, there are many efforts to enhance GC-
dependent vaccination responses in older individuals, e.g. to influenza vaccinations. Injections of 
increased antigen doses (Remarque et al. 1993) and modifications of the vaccine adjuvant (Frech 
et al. 2005) were found to improve vaccination responses in older subjects. Recently, type I IFNs 
have also emerged as potent vaccine adjuvants (Bracci et al. 2008; Proietti et al. 2002). The TLR7-
agonist imiquimod induces the production of type I IFNs in vivo and potently enhances influenza 
vaccine responses in older individuals (Hung et al. 2014; 2016). This demonstrates that age-related 
defects in vaccine responses are not irreversible, and can be targeted therapeutically to improve 
immune protection in older individuals. Our study provides novel mechanistic insights into how 
imiquimod might enhance vaccination responses in vivo.  
 The age-associated reduction of the GC response is linked with 
defects in several GC cell types 
By boosting type I IFN signalling in DCs at the time of immunisation using imiquimod, Tfh cell 
differentiation was improved in aged mice. This restoration of Tfh cell responses corresponded to 
a significant, but small, increase in the formation of GC B cells, indicating that impaired GC 
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responses in aged mice are only partly driven by a reduction in Tfh cells, and are also linked with 
age-associated defects in other GC components (Linterman 2014). B cells from aged mice, when 
transferred into young hosts, were found to have reduced rates of SHM, but were otherwise fully 
capable of forming GCs in a young environment (Yang et al. 1996). This suggests that the impaired 
expansion of GC B cells in aged mice is primarily due to B cell-extrinsic defects. Sage et al. reported 
on reduced B cell help by Tfh cells in aged mice, which was not linked with a reduction in Tfh cells, 
but with the reduced expression of the important co-stimulatory molecules ICOS and CD40L on 
the surface of aged T cells, combined with increased levels of co-inhibitory PD-1 (Sage et al. 2015). 
Also in humans, B cell help from memory Tfh cells during recall responses was found to be 
impaired (Yu et al. 2012). In this thesis, I demonstrated that administration of imiquimod at the 
time of immunisation potently enhances the generation of Tfh cells in aged mice, but I didn’t test 
the ability of these Tfh cells to provide B cell help. B cell co-cultures with Tfh cells as well as flow 
cytometric analysis of CD40, ICOS, IL-21 and IL-4 expression by Tfh cells after immunisation 
with or without imiquimod could reveal potential beneficial effects of imiquimod not only on Tfh 
cell formation, but also Tfh cell-dependent B cell help.  
In addition to defects in the T cell (and DC) compartment, FDCs in aged mice form smaller 
networks and retain fewer antigen-immune complexes 24 hours after immunisation compared to 
adult mice (Turner & Mabbott 2017). Sage et al. also reported on an increase of suppressive Tfr 
cells in the LNs of aged BALB/c mice (Sage et al. 2015), which we confirmed in our lab. Taken 
together, this suggests that the defect in GC B cell expansion observed in aged mice is not only 
linked with a defect in T cell priming, but possibly also with reduced B cell help from Tfh cells, 
reduced antigen retention on FDCs and increased suppression by Tfr cells. Thus, in addition to 
imiquimod, further therapeutic routes targeting FDCs, Tfr cells and Tfh cell-mediated B cell help 
need to be explored for full restoration of GC B cell formation and antibody production in aged 
mice.  
 Imiquimod: a potential vaccine adjuvant in humans 
In humans the topical application of imiquimod on injection sites can potently enhance antibody 
production in response to vaccination (Hung et al. 2014; 2016). This suggests that in humans, 
imiquimod might be sufficient to not only boost T cell priming but also B cell responses. So, does 
imiquimod act via a similar mechanism in both mice and humans? Using human skin explants, 
Fehres et al. demonstrated that imiquimod also enhances migration and CD80/86 expression of 
human DCs from young donors (Fehres et al. 2014). To confirm that this action mode of imiquimod 
is retained in older individuals, in vitro experiments with DCs isolated from the blood or skin 
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biopsies of older compared to younger individuals are required. Circulating peripheral blood Tfh 
cells can be used as biomarker for Tfh cell responses in SLOs and could be analysed by flow 
cytometry to assess the effect of imiquimod treatment on Tfh cell differentiation and overall GC 
responses in vivo (Heit et al. 2017; Linterman & Hill 2016). What is more, fine needle aspirates of 
lymph nodes coupled with flow cytometry have recently emerged as a promising method to 
quantitatively monitor germinal centre activity in primates and humans where lymph nodes are not 
easily obtained (Havenar-Daughton et al. 2016; Silowash et al. 2016). These fine needle aspirates 
could provide additional insights into the effect of imiquimod on DCs, Tfh cell formation and GC 
B cell responses in aged humans in vivo. This could help the design of novel type I IFN-based 
adjuvants or other DC-targeted adjuvants with enhanced efficacy in the elderly, based on the novel 
link between defective type I IFN signalling in DCs with age-associated defects in the GC response 
reported in this thesis.  
In conclusion, the work reported here revealed that adaptive immunity is strongly influenced by 
environmental changes. Both cellular stress as well as ageing have previously been reported to exert 
global effects on immune cell functions (Bettigole & Glimcher 2015; Montecino-Rodriguez et al. 
2013). The data presented here reveal a previously unknown role for the ER stress response in 
inducing Th17 differentiation, potentially associated with Th17 cell pathogenicity in autoimmune 
disorders. The studies of GC responses in aged mice presented here further revealed that not only 
the gut microbiome, but also DCs are exciting targets to improve GC responses in ageing. Taken 
together, this demonstrates that environmental stimuli shape adaptive immunity by enhancing T 
helper cell differentiation and the germinal centre response. 
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